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Abstract 
The skin is an extremely complex organ and its natural function is to act as a barrier by 
restricting the entry of foreign substances as well as preventing the loss of water and other fluids. 
Transdermal microneedle arrays provide a minimally invasive means of delivering drugs into the 
body via the skin. The challenge to effective microneedle penetration is to bypass the inherent 
elasticity of the stratum corneum, the skin’s uppermost layer. The advent of microneedle 
technology is promising and numerous studies have been conducted on its applications to skin, 
with most of the work centred on skin models that have inadequate underlying substrates to 
support skin. 
In this thesis, a representative experimental model of skin was developed accounting for 
mechanical contributions from subcutaneous layers comprising tissue fluid and muscle mimics in 
order to characterise skin’s interaction with microneedles in vitro. Neonatal porcine skin from the 
abdominal and back regions, several concentrations of porcine-derived gelatine gels acted as the 
subcutaneous tissue fluid mimic and Perma-Gel®, a type of polymer used in ballistics testing was 
the muscle mimic. These layers of biological material made up the representative in vitro skin 
model. Micromechanical tests using a dynamic nanoindentation technique was conducted on the 
individual layers that made up the skin model in order to establish their mechanical 
characteristics such as elastic modulus, shear storage modulus, shear loss modulus and loss 
factor. The average elastic modulus was 24.49 ± 5.47 kPa for abdominal skin and 45.89 ± 9.61 
kPa for back skin; for the gelatine gels at 67%, 80% and 88%, it was 63.11 ± 6.23 kPa, 34.56 ± 
3.16 kPa and 11.3 ± 1.64 kPa respectively; the Perma-Gel® exhibited the highest elastic modulus 
of 80.73 ± 2.67 kPa in the skin model. The overall mechanical behaviour of these layers in the 
skin model contributed to its interaction with microneedles. 
Two types of polymethylmethacrylate microneedles were used for the work in this thesis i.e. 
Design 1 and Design 2; the microneedles varied in height, needle density, base diameter and 
interspacing. Design 1 and 2 microneedles were applied to the skin model using a custom-made 
impact test setup system. The results of the initial tests using Design 1 microneedles on back skin 
model at 88% gelatine gel concentration demonstrated that optimal penetration was achieved with 
9.33 ± 2.76 N insertion force and at an insertion velocity of 2.96 ms-1. Methylene blue, histology 
staining and quantitative image analysis were used to analyse microneedle perforation quality. 
The microneedle penetration studies using Design 1 microneedles were reproducible and laid out 
the optimal conditions for the tests that involved the Design 2 microneedles on abdominal and 
back skin models at all gelatine gel concentrations. The mechanical properties for the skin models 
influenced the outcome of the penetration tests, as smaller deformations occurred within the 
stiffer back skin model as compared to the abdominal skin model. It was also found that for the 
impact test setup, microneedle geometry in terms of projections did not play a significant role in 
how microneedles interfaced with skin, as other parameters such as the insertion force and 
insertion velocity were more paramount. 
Further tests were carried out using a clinical applicator provided by Renephra in order to 
compare results of their in vivo studies with the in vitro work carried out in this thesis. Although 
the insertion force produced by the clinical applicator was 2–7 times the magnitude of the 
insertion produced by the impact applicator, reproducible penetration of skin occurred. A 
comparison study was carried out on the clinical applicator and the impact applicator and it was 
found that the impact applicator was the preferred approach for microneedle application to skin 
because more effective microneedle penetration of skin could be achieved at a relatively low 
insertion force and a low insertion velocity as compared to the clinical applicator.  
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Chapter 1 
1.   Introduction 
1.1   General Introduction  
There are a number of diseases like kidney failure, heart failure that lead to a build-up of fluid 
and oedema in the body. Fluid overload assessment therapies, which are mentioned in more 
detail in Section 1.2.1 and fluid overload management, mentioned in greater detail in Section 
1.2.2 have advantages and disadvantages to their use, however, to improve patient prognosis 
and long-term recovery, the development of technologies that maintain the fluid volume level 
as close to the normal body fluid of the patient is necessary (Elsayed and Stack, 2015). 
Hence, Renephra Ltd is developing a novel approach using microneedles to address the issue 
of fluid overload, which involves a minimally invasive means of accessing the interstitial 
fluid (ISF) in the skin. This new approach involves the slow removal of fluids and toxins 
from the body. Renephra’s technology would be sympathetic towards the environment as it 
does not require water usage, minimal power required to operate, is portable (Wang et al., 
2005) and will therefore not contribute to the carbon footprint. Outside the UK, the 
technology will have a significant potential in developing countries with weak healthcare 
infrastructure and inability to implement energy-intensive and costly medical interventions 
(Wang et al., 2005). The aim of this project was to understand the insertion parameters 
required to obtain optimal insertion of microneedles into skin in order to facilitate fluid 
removal. The proposed novel solution is covered in Section 1.3. 
1.2 The Effects of Fluid Overload and Oedema 
The accumulation of fluid around the lungs, the heart and pericardium or the abdominal 
cavity and subcutaneous tissues can cause peripheral oedema because abnormal levels of 
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fluid can move from the intravascular space and build-up in the interstitial space (Lo Gullo et 
al., 2015). Therefore, oedema can be defined as a substantial swelling caused by a build-up of 
ISF (Ely et al., 2006). The build-up of ISF takes place in the pleural, pericardial and 
peritoneal spaces and subcutaneous tissue planes (Lo Gullo et al., 2015). 
Within the interstitial space, there is transportable free fluid like water, collagen, elastin and 
gel-like ground substances. The combination of these components influence the mechanical 
behaviour of tissues (Guyton et al., 1971). In oedematous tissue, the interstitial spaces contain 
an abnormally high quantity of fluid, which affects its mechanical characteristics. This excess 
fluid creates stress and strain within the collagen and elastin fibres in the skin and diminishes 
the elasticity of the tissue and lowers the viscosity in ground substance (Guyton et al., 1971). 
Moreover, the severity and speed at which oedema develops affects the structural and 
mechanical integrity of the tissue (Guyton et al., 1971). Oedema in skin can be described as 
subcutaneous pitting or subcutaneous non-pitting oedema. The glycosaminoglycan content in 
healthy tissue enables it to produce a high resistance to displacement of ISF (Levick, 1987). 
To establish whether a patient has subcutaneous pitting oedema, a finger is pressed to the area 
of skin with swelling for 10 seconds, which leaves a dent. The dent will slowly fill back in, 
with the skin returning to its original state (Renephra, 2015). For subcutaneous non-pitting 
oedema however, after depressing the area affected by swelling, no dent is observed in the 
skin. Subcutaneous non-pitting oedema is usually hard and can be attributed to fibrous or 
fatty tissue growth (Bates et al., 1994). 
Furthermore, fluid overload in the interstitial space can be caused by liver failure, renal 
failure, heart failure, protein loss, dietary noncompliance (Cho and Atwood, 2002) or drug 
induced (Singh et al., 2007). Some of the medical symptoms of fluid overload are weight gain 
(Nesto et al., 2003), oedema (Ely et al., 2006), loud snoring (Ely et al., 2006), sleep apnoea 
(Parker, 2003) or shortness of breath (Flores and Rider, 2016). 
3 
  
Fluid overload can be used as a biomarker for indicating heart failure in patients (Chin et al., 
2014). A significant proportion of hospital admissions for heart failure are due to fluid 
overload (Peacock et al., 2009) and findings by Adams et al. indicated that the manifestations 
of peripheral oedema occurred in 66% of hospitalised patients with heart failure (Adams et 
al., 2005). Furthermore, globally heart failure is a common occurrence (Mendez and Cowie, 
2001) that increasingly affects an ageing population (McMurray and Stewart, 2000). Despite 
the reduction in the number of deaths caused by cardiovascular disease, the frequency of 
heart failure however is on the rise (Gibbs et al., 1998) and the long-term prospects of 
recovery poor (Croft et al., 1999). Additionally, heart failure poses a major economic burden, 
with it accounting for 1–2% of health care expenditure in the UK and some developed 
countries (Berry et al., 2001). The health care expenditure for heart failure in the UK is a 
combination of direct and indirect cost, which is circa £1.12 Billion (Cook et al., 2014). In his 
study, Sutton (1990) projected that hospital admissions for heart failure would be between 
100 000 to 200 000 admissions annually (Sutton, 1990). Over a decade later, Stewart et al. 
reported 140 000 hospital admissions (Stewart et al., 2002). 
Fluid overload is also linked with mortality or cardiovascular morbidity in patients with 
advanced Chronic Kidney Disease (CKD) (Tsai et al., 2015). The rates of prevalence of CKD 
appear to be increasing globally and are likely to increase further as a consequence of ageing 
populations and the increased prevalence of Type II diabetes mellitus (Hamer and El-Nahas, 
2006). CKD is characterised depending on the stage at which the disease has progressed to 
(see Table 1 for definitions). The Glomerular Filtration Rate (GFR), which is a measure of 
the amount of blood that passes through the glomerulus, the filtering unit of the kidney each 
minute falls as the disease progresses (Kerr, 2012). Fatality could occur within a few months 
of a patient reaching CKD stage 5 if untreated. Ferrario et al. demonstrated how fluid 
overload coupled with factors such as hyper-sympathetic activity, which include increased 
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heart rate, increased respiration, increased blood pressure, perspiration and elevated body 
temperature are connected with increased risk of cardiovascular mortality in CKD stage 5 
patients (Ferrario et al., 2014). 
Table 1 Definition and stages of CKD (Adapted from Kerr, 2012). 
CKD stage 
GFR 
(ml/min/1.73 m
2
) 
Description 
1 ≥90 Normal or increased GFR, but with other evidence of 
kidney damage 
2 60 – 89 Slight decrease in GFR, with other evidence of kidney 
damage 
3A 45 – 59 Moderate decrease in GFR, with or without other 
evidence of kidney damage 3B 30 – 44 
4 15 – 29 Severe decrease in GFR, with or without other 
evidence of kidney damage 
5 <15 CKD stage 5 
 
Previous studies showed that 6–8.5% of adults in England have CKD stages 3–5 and that the 
number of patients being treated for CKD stage 5 had risen by 35% in five years, with the 
highest level of incidence among the elderly. Furthermore, in 2009/10, 1.81 million people 
were recorded as having CKD stages 3–5 in the UK (Kerr et al., 2012). The overall annual 
cost of CKD in the UK is estimated at £1.44 to £1.45 Billion (Kerr, 2012). In the UK alone, 
7000 patients a year progress to CKD stage 5 (Morton et al., 2010). Once kidney function has 
declined to CKD stage 5, Renal Replacement Therapy (RRT), such as kidney replacement or 
dialysis treatment becomes necessary. 
Lymphoedema is a chronic condition characterised by oedema and typically occurs in one or 
more limbs and in some instances involving the trunk, head or genital area (Moffatt et al., 
2003). It is a serious complication resulting from treatments for cancer and as such there is no 
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proven drug treatment for it (Moffatt et al., 2003). Hence, novel fluid removal treatments, 
such as Renephra’s device would be extremely beneficial for lymphoedema patients.  
There are a number of treatment therapies available for assessing and managing fluid 
overload and a brief overview is discussed in the next section. 
1.2.1 Overview of current fluid overload assessment methodologies 
Despite significant developments in science, there remains a significant barrier in dispensing 
effective treatment options for fluid overload. Furthermore, the clinical evaluation of fluid 
overload caused by cardiac failure is expensive and challenging (Frank Peacock and Soto, 
2010). Moreover, as heart failure predominantly affects the ageing population (adults over 75 
years old), this means that clinical trials of potential assessment or treatment therapies are 
often performed on younger, healthier subjects and as such the outcomes of these endeavours 
may not be applicable (Kitzman and Rich, 2010; Rich et al., 2016). 
Measuring a patient’s dry weight is a potential assessment solution for fluid overload. The 
accurate estimation of dry weight is necessary in reaching a state of normal body fluid; this is 
because the symptoms of hypervolemia exhibit inadequately low sensitivity rates (Frank 
Peacock and Soto, 2010). There are issues however surrounding the optimal approach of 
assessing dry weight and using this approach on its own could lead to a patient’s demise. 
Another approach is thermo-dilution, which is the measurement of the quantity of 
extravascular lung water present in the lung. This method has not gained significant 
popularity due to clinicians’ reluctance in depending solely on lung water measurements 
(Brown et al., 2009). 
Body Composition Monitor (BCM) is a well-known method of fluid overload assessment. 
BCM measures the hydration levels in CKD patients (Hung et al., 2014). It works because of 
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the ability of high-frequency current to pass through the total body water. On the contrary, 
this is not the case with low-frequency current, which cannot bypass the cell membranes and 
it therefore passes through the extracellular water (Moissl et al., 2006). A disadvantage to the 
BCM is that it cannot distinguish between increased extracellular fluid volume resulting from 
increased intravascular volume as opposed to increased interstitial volume (Tsai et al., 2015). 
BCM can be used as an assessment tool in detecting patients with CKD stages 3–5 (Hung et 
al., 2014). 
A variation to BCM is the Bioimpedance Vector Analysis (BIVA). BIVA also assesses tissue 
hydration and some of its benefits are that it is a non-invasive, uncomplicated to use and a 
reproducible way of evaluating hydration levels and body composition of patients on dialysis 
(Onofriescu et al., 2014). 
A novel way of evaluating fluid overload is conducting a post-mortem coherence tomography 
of the dead patient. Unfortunately, a disadvantage to this approach is that it is challenging to 
distinguish between fluid overload in a post-mortem coherence tomography compared to a 
pre-mortem coherence tomography. Moreover, the likelihood and accuracy of fluid 
estimation in the interstitial space can be utilised in the evaluation of fluid overload in pre-
mortem conditions (Lo Gullo et al., 2015). 
1.2.2 Overview of current fluid overload management therapies 
Poor patient response to diuretics is linked to advanced heart failure, renal damage, diabetes 
and can act as a primary indicator for re-admitting a patient to hospital and mortality (Valente 
et al., 2014). Intravenous diuretics in large doses can be administered to some diuretics 
resistant patients (Costanzo et al., 2005). However, diuretics does not improve the clinical 
outcomes (Bart, 2009) and some of the adverse effects of intravenous diuretics are skin 
reaction, interstitial nephritis and hearing loss to name a few (Brater, 1998). Furthermore, 
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studies have shown that diuretic resistance develops in some heart failure patients (Kramer et 
al., 1999). 
Dialysis is a machine-assisted blood filtration technique that removes waste and excess fluid 
from the blood in a dialyser. It requires surgical intervention, whereby a doctor creates 
permanent access to the blood stream, via the arm or thigh (Roth et al., 2012). Dialysis is an 
invasive treatment option for acute renal failure and has grown to become the leading rescue 
therapy for patients with CKD stage 5, without which would lead to a patient’s imminent 
demise (Cavalli et al., 2010). For patients on dialysis, fluid overload is a common occurrence 
as well as other risk factors such as hypertension, left ventricular hypertrophy and death due 
to cardiac failure (Kalantar-Zadeh et al., 2009; Seibert et al., 2013). Antlanger et al. suggests 
that achieving a state of normal body fluid volume is key for maintaining the well-being of 
patients on dialysis (Antlanger et al., 2013). A drawback to dialysis is that it is related to poor 
long term clinical outcomes, high risk of death (Bleyer et al., 1999), expensive (Feest et al., 
2004), is also one of the most water and power intensive of all healthcare therapies and 
disregards the environmental impact it creates (Agar, 2012). 
This project aims to conduct a fundamental study on microneedles interaction with skin for 
the purpose of advancing Renephra’s novel device. Microneedle technology is discussed in 
more detail in Section 2.5.  
1.3 Proposed Novel Solution for Fluid Overload Relief 
The novel medical device is for the relief of fluid overload, which should reduce the amount 
of oedema and lead to improved patient well-being. Fluid overload is associated with kidney 
and heart failure diseases (Peacock et al., 2009; Tsai et al., 2015), which affects a significant 
proportion of patients who are unresponsive to diuretic treatment (Valente et al., 2014). 
Consequently, the patients need hospitalisation for intravenous diuretics (Costanzo et al., 
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2005) and in extreme cases requires the invasive dialysis treatment option (Grassmann et al., 
2005). 
1.3.1 Access to interstitial fluid via skin 
One of the health challenges associated with heart and kidney disease is the onset of oedema. 
Removing ISF from skin in oedematous patients instead of blood via dialysis is feasible 
because blood and ISF are dynamic and interconnected compartments hence, fluid and toxins 
are shared between compartments (Ebah, 2012). Thus, extracting the ISF from skin 
eliminates the surgical intervention required to access the blood. The challenge however is 
overcoming the uppermost layer of skin (stratum corneum), which is designed to act as a 
barrier to prevent foreign objects from gaining entry and fluid loss by the body. A suitable 
device for bypassing the barrier characteristics of the stratum corneum, the skin’s uppermost 
layer are microneedle arrays. 
1.3.2 Microneedle arrays to breach skin’s barrier 
Microneedles are suitable to breach the stratum corneum in order to access the ISF in skin’s 
epidermal layer, dermal layer and fluid located subcutaneously. Microneedle arrays for 
transdermal drug delivery purposes were first patented by Gerstel and Place in 1976 (Gerstel 
and Place, 1976). It was not until the advancements in the micro-fabrication industry in the 
1990s however that the devices could be manufactured and tested (Henry et al., 1998). To 
date, microneedles are primarily used for drug delivery (Kim et al., 2012). Renephra has 
therefore found an innovative use for microneedles for the purpose of ISF extraction and the 
anticipation is for this approach to be used at a commercial level. 
1.3.3 Transdermal Fluid Removal technology 
The first generation Transdermal Fluid Removal (TFR) technology for fluid extraction was a 
combination of a hollow microneedle array with a fluid capturing hydrogel pouch able to 
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absorb large capacities of fluid. When the microneedle array is inserted into skin, the fluid is 
drawn up the microneedles by capillary action and captured by the hydrogel pouch. The 
initial application of the microneedle array to skin was by manual approach and then later 
with a spring-driven applicator. The preliminary study using human subjects highlighted that 
TFR required further development to make it a suitable device for managing fluid overload 
(Renephra, 2012). In particular, the unreliability and unpredictability associated with manual 
application of microneedles such as, dependence on fluid pressure and the inability to 
quantify insertion force demonstrated the limitations with this approach. Furthermore, the 
spring-driven microneedle applicator was also a crude way of controlling the insertion force 
or insertion velocity.  
Ebah (2012) demonstrated the feasibility of TFR technology on 6 healthy volunteers and 37 
CKD patients attending renal clinics or wards at Manchester Royal Infirmary (CMFT). ISF 
was extracted from 68.8% of patients, where successful microneedle penetration occurred 
and showed that microneedles caused no pain or bleeding in over 95% of applications (Ebah, 
2012). Ebah (2012) also noted that CKD patients had raised interstitial pressures and ISF 
volumes compared to healthy subjects. The raised level of interstitial pressure in CKD 
patients with obvious oedema is a combination of a build-up of interstitial compartment fluid 
volume, pre-existing oedema and tissue mechanical characteristics. In addition, Ebah (2012) 
noted that the time taken for oedema to refill the depressed area could be a significant 
parameter in the clinical assessment of oedema.  
The latest generation of the device uses microneedles to access fluid located in the 
epidermis/dermis and negative pressure used to extract fluid from skin and subdermis. The 
microneedle array is applied to the skin using an applicator. Once applied, it is removed after 
several seconds and microchannels are created in the top layers of the skin allowing for fluid 
to flow. Negative pressure is then applied to remove excess ISF and collect it in a canister 
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attached to a pump. Fig. 1 illustrates the possible concept of the look of the device. Renephra 
intends that the final product would be a wearable technology that could be self-administered 
by the patient or carer.  
 
Figure 1 Renephra’s wearable transdermal microneedle fluid overload relief technology. 
As swelling resulting from fluid retention can occur all over the body or only in one part of 
the body (Levick, 1987), which is why current treatment therapies like dialysis have created 
access to the bloodstream via the arm or the thigh for the removal of blood including fluid 
and toxins and the replacement with clean oxygenated blood or using diuretics for the 
removal of excess fluid in the body irrespective of where the oedema is located. For example 
fluid overload, in heart failure patients was pulmonary oedema (Cotter et al., 2008) and in 
kidney failure patients was lower-extremity oedema and pulmonary oedema (Kalantar-Zadeh 
et al., 2009). Furthermore, as blood and ISF are dynamic and interconnected compartments, 
this means that fluid and toxins are shared between compartments (Ebah, 2012). Hence the 
device could potentially be used on various sites on the body. The work in this thesis focused 
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on two anatomical regions of neonatal porcine skin i.e. the abdominal tissue and back tissue 
due to their differences in thickness and stiffness. The physiological properties of neonatal 
porcine skin are similar to human skin (Lo Presti et al., 2012) and the stiffness is within the 
range of values for the stiffness of human tissue (Groves, 2011). 
The device will use technology developed by Renephra Ltd where the skin is pierced with a 
small cluster of microneedles. More recent studies by Renephra demonstrated that following 
the bypass of the stratum corneum by microneedle intervention, this fluid is readily 
accessible. Using microneedles and negative pressure, the fluid extraction rates of 2 
ml/cm
2
/hr were achieved along with fluid volume extracted, which was > 5 ml in patients 
with severe oedema. The fluid extraction process lasted over four hours, with approximately 
60 ml of fluid removed over 7 cm
2
 small surface area in some patients. The extracted fluid 
volume increased linearly with time (r=0.24, p=0.008). This indicates that an appropriate 
microneedle surface area of 50 cm
2
 used for a period of 8 hours could result in the extraction 
of up to 800 ml and could be potentially clinically significant. Furthermore, clinicians 
estimate that a significant volume for such a device will be between 250 and 1000 ml per day 
(Renephra, 2015). 
Fig. 2 shows the most recent progress with the proposed TFR technology, using a clinical 
applicator that comprises a spring and hammer driven mechanism (Renephra, 2015). The 
proposed device removes excess fluid from the body via the skin. A vacuum chamber is then 
placed over the microneedle perforated site to draw up liquid, which is collected in a canister. 
The images show the successful extraction of ISF from a patient in a clinical research at the 
CMFT. The potential device if developed would be a huge benefit to thousands of patients in 
the UK and hundreds of thousands globally. It would enable patients take advantage of a 
home/community based, minimally invasive, bloodless and self-administered fluid removal 
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therapy to manage fluid overload symptoms, improve outcomes and quality of life whilst 
preventing hospitalisations and thus potentially reducing costs to the National Health Service. 
 
Figure 2 The Transdermal Fluid Removal technology (a) microneedle placed on patient, (b) clinical 
applicator used to insert microneedles into skin, (c) skin after microneedle treatment with no bleeding or 
lasting damage to skin (d) gauze placed on skin to absorb some of the ISF, (e) fluid extraction using 
negative pressure therapy and (f) extracted fluid passing through tube. 
Fluid overload or oedema due to heart failure or kidney failure affects an ageing population 
and as such it is important to understand how skin’s subcutaneous layer is affected by the 
ageing process. The subcutaneous tissue is diminished in some regions of the body such as 
the face, shins, hands and feet, whilst in other regions such as the abdomen in men and the 
thighs in women, it is increased (Fenske and Lober, 1986). Furthermore, in adults, the deep 
dermis or subcutaneous tissues is composed of several layers of fat separated by connective 
tissue septa (Ryan, 1995). Some adipose tissue in the subcutaneous layer actually extends 
into the dermis (Ryan, 1995). Dermal echogenicity indicates the distribution of fluid in the 
dermis. For intradermal echogenicity, there was a pattern in the different types of oedema 
implying that localisation of fluid varies in the dermis, from sub-epidermal 
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(lipodermatosclerosis), uniform (lymphoedema), to deep dermal (heart failure) (Gniadecka, 
1996). Furthermore, magnetic resonance imaging showed that water content is particularly 
increased in the sub-epidermal layer of aged skin and decreased echogenicity (Gniadecka et 
al., 1994). Decreased echogenicity may also be attributed to changes in the collagen fibre 
arrangement (Gniadecka et al., 1994). The work in this thesis focused on a skin model that 
comprised a full thickness skin sample, a subcutaneous mimic of varying water content 
concentration and a muscle mimic. There are many limitations with developing an in vitro 
model of skin that can adequately mimic the in vivo behaviour of oedematous skin, however, 
in future; fluid could be injected into a membrane placed within the subcutaneous layer of the 
in vitro model.  
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1.4  Research Project Plan 
This research programme will build on Renephra’s background Intellectual Property and 
early stage TFR technology by conducting comprehensive experimental studies focusing on 
the biomechanical interaction of the microneedle device with skin. CMFT’s preliminary 
study using human subjects however, has identified several areas where the technology needs 
further development to make it a robust fluid overload management treatment therapy. 
1.4.1 Aims and Objectives 
The overall aim of this project was to determine quantitatively the parameters for repeatable 
and reproducible insertion of microneedles into skin. The specific objectives were: 
The first objective was to conduct an experimental analysis of the mechanical properties of 
skin. This involved the determination of an ideal skin model and micromechanical 
characterisation of each of the layers in the skin model and their contribution to the overall 
properties of the skin. 
The second objective was to develop an in vitro impact applicator system for microneedles to 
quantify the optimal insertion force and insertion velocity. This involved the use of three 
types of microneedles to determine the optimum system for skin penetration. 
The third objective was to determine the insertion force from the clinical applicator used in 
CMFT study. The results from the clinical applicator study were compared with the results of 
the impact applicator study. 
The fourth objective was to assess the perforated skin model through various image analysis 
techniques. This involved the visual examination of the perforated skin following staining 
and analysis of the histology images of breach area created in skin with microneedles.  
15 
  
Chapter 2 
2.   Literature Review 
2.1   Introduction 
This section will detail the relevant literature. It will provide an overview of skin and its 
mechanical properties. In addition, it will also review and discuss various types of 
microneedle devices, microneedle applicators, mechanics of skin penetration and techniques 
for imaging perforated skin. 
2.2   The Anatomy of Skin 
Skin is the largest organ of the human body and covers a surface area of between 1.5–2 m2 
and functions as a regulator of heat and water loss from the body (Pegoraro et al., 2012). The 
large surface area of skin offers ideal and multiple sites to administer therapeutic compounds 
for both local and systemic actions. Furthermore, due to skin’s highly efficient self-repairing 
barrier, it is designed to keep the internal organs protected and prevent foreign matter from 
entering the body. In vivo, skin is in a process of continually regenerating itself and provides 
immunological and histological reactions to external insults such as infection, temperature 
extremes, dehydration and mechanical trauma (Williams, 2004).  
The skin is composed of three primary layers, which are the epidermis, dermis and 
hypodermis (Pegoraro et al., 2012) as represented schematically in Fig. 3. 
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Figure 3 Schematic diagram showing skin layers: hypodermis, dermis and epidermis. (a) represents blood 
vessels, (b) lymph vessels, (c) nerve endings and (d) hair follicles. Sweat glands and sense receptors have 
not been shown in the figure. 
2.2.1    Epidermis 
The epidermis is in constant interaction with the environment and can be considered as being 
composed of four or five individual layers (Pegoraro et al., 2012) and is illustrated in Fig. 4. 
 
Figure 4 Schematic diagram showing the layers of the epidermis: stratum corneum, stratum granulosum, 
stratum spinosum and the basal layer. 
The outermost layer of the epidermis, the stratum corneum is in direct contact with thermal, 
mechanical and chemical insults to which the body is exposed (Wilkes and Wildnauer, 1973). 
It is 10–20 m thick and is made up of 10–30 thin layers of dead keratinocytes (Pegoraro et 
al., 2012). The dead layer of keratinised tissue varies in thickness depending on anatomical 
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site. The keratinisation process leads to the development of fibrous protein, which forms up 
to 50% of the stratum corneum layer and contributes substantially to its mechanical 
behaviour (Wilkes and Wildnauer, 1973). In the basal layer, the keratinocytes multiply 
through cell division and undergo multiple stages of differentiation in becoming corneocytes 
as they travel towards the skin surface. The thickness of each corneocyte is about 500 nm and 
40–50 m in diameter (Elias, 1983). Furthermore, it has been observed that the thickness of 
the epidermal layer can increase significantly as a result of oedematous state (Chao et al., 
2012). Oedema refers to the swelling of tissue that results from excessive accumulation of 
ISF in tissue, which alters the skin’s properties and is prevalent in patients with heart failure. 
2.2.2    Dermis 
The dermal layer lies between the epidermis and subcutaneous tissues that consists of 
connective tissue. It is separated into two layers, which are the papillary region that is 
adjacent to the epidermis and the reticular dermis, which comprises a deeper thicker area 
(James et al., 2006). The dermis is 0.9–1.3 mm and varies depending on region (Lasagni and 
Seidenari, 1995). The dermis also houses the blood vessels, lymph vessels, nerve endings 
with few myelinated fibres, sense receptors, hair follicles, sebaceous glands and sweat glands. 
The dermis provides the overall mechanical support for skin as well as supplying the 
epidermis with nutrients since it does not contain blood vessels (Pegoraro et al., 2012). 
2.2.3    Hypodermis 
The hypodermis also known as the subcutaneous tissue is the deepest layer of the skin. The 
subcutaneous fatty tissue can be divided into the superficial adipose layer, which contains 
small, tightly packed fat lobules within the septa and the deep adipose layer containing large, 
irregular and disorganised fat lobules. The deep adipose layer is also connected to the muscle. 
The thickness of the adipose layer is fairly consistent throughout the body and this differs 
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from the deep adipose layer, where there are variations with respect to anatomical site 
(Markman and Barton, 1987). The subcutaneous layers play an important role in the 
mechanical properties of skin. In the body, subcutaneous adipose tissue contributes to skin 
deformation during loading and load transfer from skin to deeper layers (Geerligs et al., 
2010a). The main functions of the subcutaneous layer are insulation and shock absorption. Its 
abundance in collagen and fat means that it acts as an energy reservoir (Pegoraro et al., 
2012). 
2.3   The Mechanical Characteristics of Skin 
There is increased interest in the mechanical behaviour of skin due to the development of 
micro-devices for drug delivery into the upper layers of skin (Crichton et al., 2013). Skin 
provides a mechanical defence and acts as a chemical barrier, limiting infiltration by foreign 
substances (Hendriks, 2005). It is subjected to pre-stress and exhibits anisotropic (Lanir and 
Fung, 1974; Fung, 1993), non-linear (Barbenel and Evans, 1977) and viscoelastic (Agache et 
al., 1980; Khatyr et al., 2004) characteristics. These mechanical characteristics are influenced 
by elastin, proteoglycan, collagen and ISF (Lanir and Fung, 1974; Oomens et al., 1987) and 
also differs due to age (Daly and Odland, 1979; Leveque et al., 1980), anatomical site 
(Sandby-Moller et al., 2003) and level of hydration (Tagami et al., 1980). Although the 
overall mechanical behaviour of skin is dominated by the dermal layers, the influence of the 
stratum corneum on the global behaviour of skin cannot be ignored (De Rigal and Leveque, 
1985; Hendriks, 2005). The general behaviour of the stratum corneum is highly influenced by 
environmental properties such as temperature and relative humidity, both in vivo and in vitro 
(Hendriks, 2005). In addition, mechanical disturbances to the stratum corneum are used to 
highlight metabolic activities in order to preserve its barrier function (Yuan and Verma, 
2006). 
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Early research demonstrated that skin is non-linear, viscoelastic and anisotropic (Veronda and 
Westmann, 1970). The viscoelastic property of skin means that the mechanical response to 
loading involves both a viscous component associated with hysteresis or energy dissipation 
and an elastic component associated with energy storage, as shown in Fig. 5. The stratum 
corneum is the stiffest of the skin’s layers and is therefore the least extendable under applied 
load. It also exhibits less viscoelasticity and pre-conditioning behaviour compared to the 
other layers but still maintains a non-linear stress-strain relationship under applied load. 
 
Figure 5 Hysteresis as observed in the stress-strain behaviour of a viscoelastic material during cyclic 
loading. 
An observation made by Agache et al. for a strain–time curve showed that if a load was 
applied to skin, the curve obtained could be split into three parts. The first part corresponded 
to a purely elastic deformation, the second part of variable creep corresponded to the 
viscoelastic phase and the third corresponded to a constant creep phase (Agache et al., 1980; 
Khatyr et al., 2004). The typical stress-strain curve of human skin showed a gross re-
alignment of the collagen fibres in the direction of extension in phase 1, while phase 3 
illustrated the stress-strain characteristics of aligned collagen fibres. Phase 2 demonstrated the 
progressive alignment within the dermis. The tangent AB gave a measure of the elastic 
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modulus of the fully aligned collagen fibres. The intercept A at tangent AB indicated the 
strain required to align the collagen fibres in the direction of loading and is therefore a 
measure of the extensibility of the skin in that direction (Gibson et al., 1968). 
 
Figure 6 Typical stress-strain relation for skin in uniaxial tension obtained at a constant rate. The curve is 
subdivided into three sections in accordance with the mechanism of deformation. (Figure adapted from 
(Gibson et al., 1968)). 
An important component of soft tissue is its fibrous structure and in particular, the 
arrangement of its collagen fibres. These fibres have a significant influence on the 
mechanical properties of the tissue and provide its anisotropic characteristics (Ogden, 2009). 
The mechanical behaviour of human skin differs across anatomical site and from person to 
person. The anisotropy of skin and the fact that it is locally orthotropic was reported by 
Langer (1861), who observed that circular holes punched in the skin of cadavers relaxed into 
elliptical shapes. He drew lines (subsequently called Langer lines) through the principal axes 
of the elliptic cut-outs, which approximate the direction of collagen bundles within the skin 
(Khatyr et al., 2004). According to Leveque et al., the viscoelastic behaviour of skin and the 
relative quantity of components such as collagen, elastin and ground substance influence the 
way in which skin is deformed. 
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It has been established in the literature that skin is in tension in the natural “relaxed” state’ in 
vivo (Alexander and Cook, 1977; Holt and Evans, 2009), thereby making accurate predictions 
of the mechanical behaviour of the skin challenging (Wilkes et al., 1973). Additionally, skin 
elastic tension is lower in childhood and higher adulthood; however, it declines in old age 
(Kirk and Kvorning, 1949). 
In order to measure the biomechanical properties of skin, the techniques and interpretation of 
two distinct categories of in vitro and in vivo methodologies must be considered. 
2.3.1    In vitro techniques 
In vitro testing contributes significantly to the characterisation of skin and developing 
constitutive models to understand its mechanical behaviour. The advantages of experimental 
testing in vitro skin sections is that it is relatively inexpensive, ethical considerations play a 
minor role in obtaining samples and the test results can be used as an indicator for in vivo 
tests. The disadvantages however are that the skin sections are treated in isolation away from 
its normal setting and as such is not connected to surrounding tissue, nutrients or blood 
supply. This makes replicating skin’s in vivo behaviour with in vitro techniques challenging. 
Typically, in vitro techniques can be used to define three mechanical properties of soft tissue, 
which are its elastic modulus, creep and breaking strains (Edwards and Marks, 1995). 
Furthermore, in vitro techniques test property rather than function (Edwards and Marks, 
1995). Generally, in vitro tests are performed on excised strips of skin from deceased or 
biopsy samples from living human subjects. 
As the various techniques of in vitro testing have already been extensively covered in other 
literature e.g. Moronkeji and Akhtar (2015), only a brief overview of uniaxial tensile and 
indentation tests are provided in this section. 
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2.3.1.1 Uniaxial tensile tests 
Uniaxial testing is easily one of the most accessible methods of mechanically testing skin. It 
has been used over the last 50 years to determine the material behaviour of skin in vitro. 
Previous studies by Ridge and Wright on strips of biopsy and autopsy skin demonstrated the 
relationship between the properties of skin and the alignment of collagen fibres (Ridge and 
Wright, 1966). Later, tests by Dunn and Silver (1983) showed the extensibility of skin, which 
reached an engineering strain of 100% and that the difference between the maximum elastic 
modulus for constant strain rate tests was 1.59 MPa ± 47% and 3.16 MPa ± 62% for the 
stress-relaxation tests (Dunn and Silver, 1983). A typical stress-strain curve is shown in Fig. 
7, the different phases have been previously described in Section 2.3. 
 
Figure 7 Stress-strain curve of skin obtained from the abdominal region of a 45 year old female subject (Daly and 
Odland, 1979). The graph shows the skin’s profile as nonlinear with its mechanical behaviour falling into 3 different 
categories (where A = phase 1, B = phase 2 and C = phase 3). 
2.3.1.2 Indentation tests 
Within biomechanics and biomaterials characterisation, indentation has become a feasible 
technique for the local mechanical evaluation of tissue. For in vitro characterisation of skin 
biomechanics, indentation testing is a valuable technique. This is because it offers the 
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opportunity to determine the mechanical properties of very localised regions of skin 
compared to in vivo methods (Ebenstein and Pruitt, 2004). 
Some examples of indentation tests of skin include its use to characterise the 
micromechanical properties of murine skin (Kendall et al., 2007), porcine skin (Jee and 
Komvopoulos, 2014) and stratum corneum samples of human skin (Pailler-Mattei et al., 
2007b). The spatial resolution of the indentation measurements can be controlled by changing 
the indenter tip size. For example, Geerligs et al. used a 500 µm radius tip to characterise ex 
vivo abdominal skin obtained from patients undergoing abdominoplasty surgery (Geerligs et 
al., 2011). Their aim was to characterise the entire epidermis (stratum corneum and 
epidermis) rather than to assess a specific, localised region of the skin. In contrast, using a 
small tip (1–10 m) results in very local properties being determined, particularly as the 
diameter of each corneocyte (40–50 m) is larger than a small tip (Elias, 1983; Pailler-Mattei 
et al., 2007a). 
Furthermore, Crichton et al. demonstrated that the mechanical characteristics of skin are 
influenced by the diameter of the probe used for indentation. Their work showed that the 
elastic modulus reduces with increased probe size and the data has been presented in Table 2. 
They suggest that the larger diameter probes are likely to cause a larger skin deflection before 
puncture and that the smaller probes will require greater structural integrity to bear the greater 
skin stiffness and forces. It was also postulated that the variation of elastic modulus with 
diameter of the probe may have been due to an aspect of stress-distribution within the skin by 
the stratum corneum and viable epidermis. The viable epidermis comprises the remaining 
layers that make up the epidermis and serve to regularly renew the stratum corneum 
(Prausnitz and Langer, 2008). 
  
24 
  
Table 2 Average elastic modulus of each probe size for nanoindentation tests performed on mice ears 
(Reproduced from (Crichton et al., 2013)). 
Probe Size (m) Elastic Modulus, Mean ± SD (MPa) 
0.5 29.70 ± 21.26 
1.0 11.15 ± 4.90 
2.5 8.19 ± 5.26 
5.0 3.26 ± 2.01 
10.0 1.31 ± 0.80 
20.0 0.86 ± 0.44 
 
The stress-strain curve in Fig. 8 depicts the locations along the curve where the elastic 
modulus or ultimate tensile strength (UTS) was taken for each study in Table 4. 
 
Figure 8 The stress–strain curve illustrating an abdominal porcine skin sample under uniaxial loading (Reproduced 
from (Zak et al., 2011)). 
Table 3 presents a summary of the in vitro tests for human and porcine skin using indentation 
and tension methodologies. The table demonstrates that skin site, orientation and test 
approach influence the results of the mechanical characterisation of skin.  
Ultimate Tensile Strength (D) 
Elastic Modulus (B) 
Elastic Modulus (C) 
Elastic Modulus (A) 
S
tr
es
s 
Strain 
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Table 3 Average elastic modulus for in vitro tests of human and porcine skin. In cases, where the elastic 
modulus has not been reported, the UTS values have been used and is denoted by 
*
. 
Experimental 
Technique 
Elastic 
Modulus 
/ UTS* 
(MPa) 
 
Location  
on Stress 
/  Strain 
Curve 
Skin Site 
 
Skin 
Details 
Orientation References 
Tension 
83.3± 
34.9 
B Back Human 
Perpendicular 
Parallel  
45 degrees 
(Ni Annaidh 
et al., 2012) 
(2.50 ± 
2.10)  
B 
Abdomen 
Porcine Parallel 
(Zak et al., 
2011) (7.17 ± 
2.84)  
Back 
3 ± 1.5* 
D Forehead 
Human 
Perpendicular 
(Jacquemoud 
et al., 2007) 
5–1000* 
1–25 * 
D 
Stratum 
corneum 
Parallel 
 
Perpendicular 
(Wu et al., 
2006) 
Indentation 
0.6 
- 
Abdomen 
(ex vivo) 
- 
(Geerligs et 
al., 2011) 
0.0085 
Dermal 
equivalents 
(Zahouani et 
al., 2009) 
100–
1000 
Various 
(Wilkes and 
Wildnauer, 
1973) 
Ni Annaidh et al. reported significant variations in the mechanical properties between 
samples of human skin from the back region at different orientations in terms of elastic 
modulus and the maximum tensile strength. In contrast, there were comparable results at 
ultimate failure and this was attributed to the interplay between orientation and skin site. 
Tests on abdominal and back neonatal porcine skin produced different values of elastic 
modulus (Zak et al., 2011), indicating that the back skin with the higher elastic modulus is 
stiffer than the abdominal skin. Zahouani et al. used dermal equivalents, which were made 
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from human fibroblasts put on a dermal substrate to demonstrate the contributions of the 
dermis and their results were comparable with the in vivo study of indentation tests on the 
volar forearm (see Table 4). Generally, the outcome of the mechanical characterisation of 
skin demonstrates how skin region, test approach, indenter type and size influence the results 
of the elastic modulus. 
2.3.2    In vivo techniques 
In vivo tests are useful because it provides information of how the skin reacts to the 
application of external forces such as compression and indentation on the body (Edwards and 
Marks, 1995). Several non-invasive techniques have been developed for measuring the 
mechanical properties of skin in vivo. The values obtained from these techniques are mainly 
descriptive (Hendriks et al., 2003a) and as Pailler-Mattei et al. demonstrated the large 
variation of elastic modulus for skin is profoundly influenced by the technique used (Pailler-
Mattei et al., 2008). 
Attempts have been made more recently to develop indentation testing as a tool for 
determining the in vivo properties of skin in a more quantitative manner (Pailler-Mattei et al., 
2008a). Indentation tests involve the application of a known load (Bader and Bowker, 1983), 
or displacement to the skin, where the elastic modulus and other parameters are determined 
using contact mechanics models. In addition, uniaxial tensile testing on skin in vivo, also 
provides useful mechanical data as demonstrated by Meijer et al., whereby a tension test 
device was developed where pads were attached to human skin to induce deformation (Meijer 
et al., 1999). 
As the various techniques of in vivo testing have already been extensively covered in other 
literature (Moronkeji and Akhtar, 2015), this section is a brief overview of the outcome of 
previous indentation studies and have been presented in Table 4. Nachman and Franklin 
27 
  
(2016) conducted indentation tests on the volar forearm of a healthy subject and obtained the 
reduced elastic modulus. Their results were comparable to the outcome of the indentation 
tests by Pailler et al. When their results were compared to reduced elastic modulus in the 
study by Groves (2011), the outcome was a significant difference. This wide variation in the 
reduced elastic moduli may be attributed to the size of the indenter head, where a large 
indenter head produces a low reduced elastic modulus, whilst a small indenter head produces 
a high value. Furthermore, Groves (2011) used two geometrically different indenter heads of 
varying sizes. It was observed that the reduced elastic modulus for the spherical indenter on 
skin was lower than that of the cylindrical indenter. Thus, the variation in the values for the 
reduced elastic modulus is typical for biological material; however, the characterisation of the 
mechanical properties of skin is also influenced by indenter size and type. 
Table 4 Comparison of published elastic modulus results on the volar forearm of human skin using 
indentation methods in vivo. 
Indenter 
Elastic  
Modulus  
(kPa) 
Reduced Elastic 
Modulus  
(kPa) 
References 
Spherical 
(R = 2 mm) 
- 8.9–9.7 
(Nachman and 
Franklin, 2016) 
Spherical 
(R = 3.175 mm) 
- 
9.5 
(Pailler-Mattéi and 
Zahouani, 2006) 
Conical 12.5 
(Pailler-Mattei et 
al., 2008) 
Spherical 
(R = 3.175 mm) 
8.3 
(Zahouani et al., 
2009) 
Spherical 
(R = 0.7938 mm) 
39.64 ± 10.19 47.19 
(Groves, 2011) 
Cylinder 
(R = 0.25 mm) 
65.86 ± 13.37 78.41 
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2.4   In Vitro Biomechanical Experiment on Skin and its Sub-
layers 
In this section, the different experimental tissues and materials that have been used to 
biomechanically represent human skin are reviewed. 
2.4.1    The skin mimic 
Murine and porcine skins have been used increasingly in the literature as a substitute for 
human skin. According to Fourtanier and Berrebi (1989), neonatal porcine skin is a superior 
model for human skin in terms of hair sparseness and physical properties (Fourtanier and 
Berrebi, 1989); hence, neonatal porcine skin is preferred over tissue from older pigs. 
Neonatal porcine skin also exhibits close biomechanical properties to human skin (Shergold 
et al., 2006) and is readily available. Donnelly et al. also used neonatal porcine skin for their 
microneedle application studies due to these reasons (Donnelly et al., 2010). Furthermore, as 
mentioned in the previous section, Zak et al. carried out uniaxial tests on neonatal porcine 
skin and documented the elastic modulus for various skin locations. 
The literature also suggests that murine skin behaves similar to human skin for microneedle 
penetration studies (Kochhar et al., 2013b). There is an apparent difference in biomechanical 
behaviour for murine skin compared to human skin ex vivo. This is because under low loads 
human skin undergoes more extension than murine skin (Groves et al., 2013). Also, murine 
skin is thinner than human skin (Ding et al., 2009) with a significantly thinner epidermal 
layer (Li et al., 2015). It is therefore important that these factors are taken into consideration. 
Crichton et al. also stated that the mechanical behaviour of mice skin was comparable to 
human skin and cited the similarity in their results with indentation test results carried out by 
Geerligs et al. on frozen human tissue (Geerligs et al., 2011). Geerligs et al. used an ex vivo 
abdominal human tissue and reported that the elastic modulus of the stratum corneum (2.6 ± 
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0.6 MPa) was greater than the epidermis (1.1 ± 0.2 MPa). They also showed that a reduction 
in the stiffness of the viable epidermis causes an increase in indentation depth. 
Zahouani et al. showed that the dermis made a significant contribution to skin because of its 
load bearing capabilities and reported the importance of a full thickness skin sample 
(Zahouani et al., 2009). Other work demonstrated the similarity in stiffness between dermal 
equivalents and the volar forearm (Pailler-Mattéi and Zahouani, 2006; Pailler-Mattei et al., 
2008), which indicated that during in vivo tests, the mechanical contribution from the dermis 
was prominent. Furthermore, it is easier to penetrate the human epidermis without the dermal 
layer (Li et al., 2015). Pailler-Mattei et al. ex vivo tests on the stratum corneum layer only, 
yielded a low elastic modulus (7–8 kPa) as compared to the result of the indentation test on 
abdominal tissue shown in Table 3. 
Based on the literature, neonatal porcine skin appears to be a more suitable substitute 
compared to murine skin because of its similarities to human skin in terms of its mechanical 
behaviour and physiological structure (Fourtanier and Berrebi, 1989; Shergold et al., 2006). 
2.4.2    The subcutaneous mimic 
As previously stated, the subcutaneous layers play a vital role in the mechanical properties of 
skin. The thickness of the subcutaneous layer varies between 5.0–15.0 mm in the elderly 
(Renephra, 2012). Using an ultrasound indentation system, Zheng et al. reported that the 
effective elastic modulus of the subcutaneous tissue of the forearm increased from 14.0 ± 5.0 
kPa to 58.8 ± 1.7 kPa during contraction of the muscles. This indicated that soft tissues 
increase in stiffness as the corresponding muscles contract (Zheng et al., 1999). 
As early as 1912, Schade (1912) discovered that there was a significant difference in 
behaviour of normal tissue compared to oedematous tissue, as the time required for the skin 
to return to its initial condition following the removal of a weight took longer for the 
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oedematous tissue (Schade, 1912). Using the same approach, Kirk and Kvorning (1949) 
demonstrated the contrast between young and old subjects. Following the removal of a 
weight on the skin, the indentation was greater in the young subjects compared to the old 
subjects and there was an almost instantaneous recovery of the skin to its original state in 
young subjects compared to the old subjects (Kirk and Kvorning, 1949). In their study, 
Radhakrishnan et al. demonstrated that acute intestinal oedema causes a decrease in tissue 
stiffness (Radhakrishnan et al., 2007). Therefore, tissue stiffness is influenced by fluid 
content. Furthermore, Guyton et al. carried out an extensive study on ISF pressure (Guyton et 
al., 1971), where he recorded the pressures for the various kinds of oedema and ISF (see 
Table 5). 
Table 5 The interstitial fluid pressures as they relate to oedema (Guyton et al., 1971). 
Fluid Content Pressure (mmHg) Pressure (kPa) 
Subcutaneous pitting oedema 0 – 6 0 – 0.8 
Subcutaneous pitting oedema following 
fluid injection in tissues 
15 – 20 
 
2.0 – 2.67 
 
Non-pitting oedema 12 – 15 1.6 – 2.0 
In tissue engineering applications, gelatine gel is often used as a mimic for natural tissues 
(Ahearne et al., 2005), as it can be used to simulate the viscosity and density of living human 
tissue and therefore, acts as a good representation for human tissue (Kwon and Subhash, 
2010). Awad et al. demonstrated that the collagenous material present in gelatine gel 
provided its stiffness and mechanical strength (Awad et al., 2004). Mridha and Odman, 
(1985) and Mridha et al. used two mechanical techniques to determine the mechanical 
behaviour of subcutaneous pitting oedema. Their first technique, the mechanical impedance 
method is a semi-quantitative method that describes the inertial, elastic and frictional 
properties of tissues subjected to external deformation. Mridha and Odman (1985) 
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demonstrated the difference in mechanical impedance of subcutaneous oedematous tissues 
compared to normal tissue. A compression was applied to gelatine gel concentrations of 80%, 
84%, 88%, 92% & 96% water content by weight and the static force was measured from the 
resulting deformation of the gelatine gel. They observed that softer structures, such as high 
water content gelatine gels and subcutaneous pitting oedema tissues had lower mechanical 
impedance compared to non-pitting oedema, which exhibited higher mechanical impedance. 
The water content in the gelatine gels highly influenced the outcome of the mechanical 
impedance tests (Mridha and Odman, 1985). 
The second technique, which is the mechanical pulse wave propagation method, uses 
velocity, attenuation and frequency to assess the mechanical behaviour of soft tissues. This is 
because the mechanical properties of skin are linked to its water content and as a 
consequence, the propagation velocity, attenuation and frequency in the gelatine gels are 
influenced by its water content. The technique was used to determine the mechanical 
behaviour of the same specific concentrations of the gelatine gels mentioned above, normal 
tissues from several anatomical regions and oedematous tissue from different patients. The 
propagation velocity for 80%, 84%, 88%, 92% and 96% gelatine gel concentrations were 
3.05 ± 0.10 ms
-1
, 2.02 ± 0.38 ms
-1
, 1.13 ± 0.21 ms
-1
, 0.77 ± 0.08 ms
-1
 and 0.33 ± 0.03 ms
-1
 
respectively. The results showed that an increase of water content in the gelatine gel 
concentrations resulted in a decrease of the propagation velocity. For the tests carried out on 
10 healthy subjects, the velocity varied from 1.72–8.18 ms-1; for pitting oedema, it ranged 
from 1.19–3.18 ms-1 and for non-pitting oedema, it was between 13.27–14.70 ms-1. Based on 
their findings, velocities for pitting oedema compared to the velocities of 80%, 84% and 88% 
gelatine gel concentrations. Overall, the propagation velocity of mechanical pulse waves was 
found to be lower in pitting oedema than for normal tissues and higher in non-pitting oedema 
(Mridha et al., 1992). Finally, their study demonstrated that subcutaneous pitting oedema 
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could be characterised by measuring the velocity of the mechanical pulse wave propagation. 
It should be noted however that the mechanical pulse wave propagation method only applies 
to subcutaneous pitting oedema, where techniques based on the displacement of fluid due to 
external compression are not pertinent (Mridha et al., 1992). 
By altering the water content of these gels and subsequently varying its mechanical 
properties, the opportunity to determine experimentally the influence of subcutaneous tissue 
on microneedle performance could be investigated. 
2.4.3    The muscle mimic 
Pailler-Mattei et al. showed that the mechanical properties of the subcutaneous layers and the 
muscles influence the mechanical properties of skin. Their work involved indentations to 
assess the impact of the subcutaneous layers and muscles. The outcome was a reduced elastic 
modulus of the muscle, which was between 32 kPa and 96 kPa. Tsaturyan et al. also showed 
that the elasticity modulus for the papillary muscle of a rat decreased with increased quantity 
of sodium chloride and increased with reduced quantity of sodium chloride (Tsaturyan et al., 
1984). Based on these findings, it is important to take into consideration the contributions 
from the subcutaneous layers and muscles to the elastic modulus of skin. 
Generally, ballistic gelatin can be used to simulate the behaviour of a projectile on human 
tissue (Thali et al., 2002). Kwon and Subhash (2010) showed that the initial elastic modulus 
for ballistic gelatin was 10.9 kPa. They also reported that when loading rate increased, the 
compressive strength increased from 3 kPa at a strain rate of 0.0013 s
-1
 to 6 MPa at a strain 
rate of 3200 s
-1
 (Kwon and Subhash, 2010). A material similar to ballistic gelatine, Perma-
Gel
®
 is also a suitable substitute for muscle. Although Perma-Gel
®
 is not ballistic gelatine, its 
advantages are that it can be used at room temperature unlike ballistic gelatine that has to be 
used at 4°C or lower. In addition, it has many of the same characteristics as 10% ballistic 
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gelatine (Moy et al., 2011) and is used for ballistic testing of ammunition (Ryckman et al., 
2012). Therefore, Perma-Gel
®
 is an ideal candidate as a muscle mimic (Caron-Laramee and 
Brouillette, 2014). 
2.4.4    Summary of experimental models of skin and its sub-layers 
The summary of the elastic moduli of skin and its sub-layers are presented in Table 6. The 
wide variation of values for skin and each sub-layer is typical for biological material. The 
data presented was used to develop the representative in vitro skin model, with elastic 
modulus properties in the range of 39.64–65.86 kPa for skin, 14.0–58.8 kPa for subcutaneous 
tissue mimic and 32–96 kPa for muscle mimic for the microneedle penetration studies carried 
out in this thesis. 
Table 6 The elastic modulus of skin and its sub-layers obtained from the literature, * denotes reduced 
elastic modulus and ** denotes pressure values. 
Material Region 
Elastic Modulus 
(kPa) 
References 
Skin 
Neonatal porcine 
abdomen 
2.50 ± 2.10 × 10
3
 
(Zak et al., 2011) 
Neonatal porcine 
back 
7.17 ± 2.84 × 103 
Human back 83.3± 34.9 × 10
3
 
(Ni Annaidh et al., 
2012) 
Human forearm 
39.64 ± 10.19 
65.86 ± 13.37 
(Groves, 2011) 
Human abdomen 0.6 × 10
3
 (Geerligs et al., 2011) 
Subcutaneous tissue 
Human forearm 
14.0 ± 5.0 
58.8 ± 1.7 
(Zheng et al., 1999) 
Pitting oedema 0–0.8** 
 
(Guyton et al., 1971) 
Pitting oedema with 
fluid injected 
2.0–2.67** 
Non-pitting oedema 1.6–2.0** 
Muscle 
Human forearm 32–96* 
(Pailler-Mattei et al., 
2008) 
Ballistic gelatine 10.9 
(Kwon and Subhash, 
2010) 
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2.4.5    Limitations of the experimental model 
The work in this thesis focused on a skin model that comprised a full thickness skin sample, a 
subcutaneous mimic of varying water content concentration and a muscle mimic. There are 
many limitations with developing an in vitro model of skin that can adequately mimic the in 
vivo behaviour of oedematous skin. For example, the way in which the subcutaneous tissue 
changes with disease (Section 1.3.3) was beyond the scope of this thesis.  
Furthermore, the natural tension of skin (as discussed in Section 2.3) was not considered in 
this experimental model due to the number of variables that were already under consideration 
for the experimental analysis. A postulation would be that due to the varied mechanical 
properties of the different water content gelatine gels, the skin tension would vary due to the 
contributions from the different gelatine gels.  
2.5   Microneedle Arrays 
This section introduces the various types of microneedles and its manufacturing process. An 
overview of how microneedles are applied to skin is mentioned as well as a review of its role 
in delivering drugs and extracting fluid from the body. 
2.5.1    Microneedle designs 
 
Microneedle arrays are a promising minimally invasive means of delivering drugs into the 
body via skin or extracting ISF from skin, for example for glucose measurement (Mukerjee et 
al., 2003). They are sub-millimetre projections capable of penetrating the stratum corneum 
and are typically made from a range of different materials including silicon (Henry et al., 
1998), polysilicon (Zahn et al., 2000), polymers (Park et al., 2005), metal (Martanto et al., 
2004) and sugars (Lee et al., 2011). 
Most types of microneedles are typically fabricated as an array of up to hundreds of needles 
over a base substrate. Solid arrays, solid arrays coated with therapeutic compound, 
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biodegradable arrays of microneedles and hollow microneedles are the four main categories 
of microneedles, as shown in Fig. 9. Solid arrays can be used to pierce skin, discarded and the 
drug applied to the perforated area (Arora et al., 2008). For the coated microneedles with 
therapeutic compound, the drug is released upon successful penetration of skin. 
Biodegradable microneedle arrays are made from biodegradable or water soluble polymers 
that dissolve readily in skin. Hollow arrays, which use the same concept as the hypodermic 
needle can be used to access the fluid bed in the epidermis (Kim et al., 2012). 
 
 
Figure 9 The four main types of microneedle design: (a) solid array inserted into skin; solid array coated 
with therapeutic compound; dissolving microneedles; hollow microneedles (b) drug is applied after 
perforation created by solid array; therapeutic compound is released with insertion; biodegradable 
microneedles are absorbed by skin along with therapeutic compound; therapeutic compound is released 
via the hollow area in the microneedle. (Figure adapted from (Kim et al., 2012)). 
Microneedles are designed to bypass the stratum corneum in order to transport therapeutic 
compound into the epidermal layer. Microneedle drug delivery is not associated with pain or 
bleeding compared to conventional hypodermic needles because there are no nerve endings 
or vasculature within the epidermis (Arora et al., 2008). Moreover, the microchannels in skin 
created by the microneedles perforating the stratum corneum offers a user-friendly means of 
drug delivery (Prausnitz, 2001). 
The design of the microneedle can increase skin permeability for drug delivery, with 
particular attention given to parameters such as tip radius, base radius, interspacing, number 
(a) 
(c) 
(b) 
(d) 
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of needles per array and penetration depth (Olatunji et al., 2009), as well as the mechanical 
behaviour of skin during its interaction with microneedles. 
2.5.2    Microneedle fabrication methods and materials 
Microneedle arrays have been manufactured using a variety of materials including silicon 
(Henry et al., 1998), polysilicon (Zahn et al., 2000), polymers (Park et al., 2005) and 
electrodeposited metals (Davis et al., 2005). Although there are advantages to using different 
materials to fabricate microneedles, each material has its own limitations which affect 
microneedle performance and effectiveness. Brittle materials such as silicon and glass can 
affect the structural integrity of the microneedle whereas polymers possess low elastic moduli 
and hardness. Electrodeposited metals such as nickel are known skin irritants (Garner, 2004). 
Hence, the use of biocompatible bulk titanium substrates eradicates fracture-induced failure 
common in more brittle elements while retaining adequate mechanical rigidity. Therefore, 
biocompatible bulk titanium is an ideal material for use in drug delivery applications (Parker 
et al., 2007). Moreover, polymer microneedles are easily fabricated and cost effective (Barrett 
et al., 2015) and are also an ideal material for the manufacture of microneedles. 
Based on the attributes of polymers, microneedles manufactured from polymers were used 
for the work carried out in this thesis. 
Table 7 provides a summary of the fabrication process and materials of the four main types of 
microneedle designs. 
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Table 7 Examples of previous published work on microneedles manufacturing processes. 
 
Microneedle 
Type 
 
Manufacturing 
Methods 
Materials 
 
Delivery Studies in Mammals 
Skin 
In vivo Ex vivo 
Solid Arrays Reactive ion 
etching 
(Henry et al., 
1998) 
 
Electrical 
discharge 
machining 
(McAllister, 
2003) 
 
Photochemical 
etching 
(Martanto et al., 
2004) 
 
Silicon (Henry 
et al., 1998) 
 
Stainless steel 
(Martanto et al., 
2004) 
 
Polymers 
(Donnelly et al., 
2011) 
Insulin vaccine 
(Martanto et al., 
2004) 
Fluorescence 
and dyes 
(Henry et al., 
1998; 
McAllister, 
2003) 
Coated Solid 
Arrays 
Electrospinning 
(Sawicka et al., 
2007) 
 
   
Biodegradable 
Arrays 
Micromoulding 
(Donnelly et al., 
2011) 
Sugars (Lee et 
al., 2011) 
 
Biodegradable 
polymers (Park 
et al., 2005) 
 
Hydrophilic 
molecules (Lee 
et al., 2011) 
 
Hollow Arrays Micromoulding 
(Davis et al., 
2005) 
 
Reactive ion 
etching 
(Mukerjee et al., 
2004) 
Polymers 
(Davis et al., 
2005) 
 
Silicon 
(Mukerjee et al., 
2004) 
Insulin (Davis 
et al., 2005) 
 
 
Microneedles with long microneedle projections (1500 m) can cause pain comparable to 
that of a hypodermic needle in patients (Gupta et al., 2011). This indicated that for the design 
of the microneedle, the length of the microneedle projection was the most important aspect in 
the measurement of pain (Gill et al., 2008). 
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In this project three different geometries of polymeric microneedles were utilised of which 
one was for a pilot study (polyetheretherketone/PEEK) and the other two 
(polymethylmethacrylate/PMMA) were primarily used to determine penetration intensity and 
effectiveness. These microneedles were chosen because they have previously been used in 
medical application studies carried out by Renephra. During the pilot study, the PEEK 
microneedles caused damage to the tissue and it was hard to reproduce perforations, therefore 
PMMA microneedles were used for the bulk of the work in this thesis.  
2.5.3    Application of microneedles in fluid extraction 
A study by Mukerjee et al. describes the use of an array of hollow silicon microneedles for 
effective transdermal extraction of minute samples of human ISF (Mukerjee et al., 2003). 
Further work by Wang et al. provided the first demonstration of ISF extraction from skin’s 
dermis following microneedles insertion in hairless rats and human subjects in vivo. The ISF 
glucose concentration measured with a conventional electrochemical glucose monitor was 
commensurate with glucose levels in blood (Wang et al., 2005). Later, studies by Khanna et 
al. used microneedles for ISF sampling, by accessing the fluid in the dermal layer (Khanna et 
al., 2008). 
There are several mechanisms through which fluid can be extracted using microneedles, 
which are capillary action, osmosis and negative pressure therapy. These fluid removal 
mechanisms are governed by some equations (Samant and Prausnitz, 2016). The relationship 
between flux (Q), diffusion (De), surface area (A), concentration difference (C) and the 
thickness of the barrier to diffusion (L) is described in Equation 1 for capillary action using 
Fick’s Law. 
𝑄 =  𝐷𝑒 .  
∆𝐶
𝐿
 .  𝐴        Equation 1 
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The influence of the osmotic permeability coefficient (Pw) for permeation under osmotic 
gradient is shown in Equation 2. 
𝑄 =  𝑃𝑤 .  𝐴 .  ∆𝐶         Equation 2 
Using Darcy’s Law, the relationship between permeability (), the viscosity () and change 
in pressure (P) for negative pressure therapy is given by Equation 3. 
𝑄 =  
𝐾
𝜇
 .  
∆𝑃
𝐿
 .  𝐴         Equation 3 
Using these equations, Samant and Prausnitz stated that the predicted flow rate using 
capillary action is 0.09 nL/min/MN, it is 1 nL/min/MN for osmosis and for negative pressure 
therapy is 12.6 nL/min/MN. The negative pressure therapy is potentially an ideal option for 
ISF extraction as it could yield more than 12 times the amount of fluid compared to the other 
mechanisms (Samant and Prausnitz, 2016). Therefore, the potential predicted flow rate for a 
PMMA array of 1316 microneedles is 118.44 nL/min for capillary action, 1316 nL/min for 
osmosis and 16581.6 nL/min for negative pressure therapy. For a PMMA array of > 6000 
microneedles is 540 nL/min for capillary action, 6000 nL/min for osmosis and 75600 nL/min 
for negative pressure therapy. 
The main motivation of this project is to obtain a greater understanding of microneedle 
interaction with skin to facilitate better fluid removal. 
2.6   The Mechanics of Microneedle Perforation of Skin 
The penetration of soft tissue by sharp implements is of widespread importance, particularly 
for technological applications such as the perforation of human skin by microneedles for 
administering drugs or fluid extraction. To date, in vitro tests using microneedles have been 
performed on various skin models. The challenge of mimicking the mechanical properties of 
skin with consideration given to contributions from skin’s individual layers coupled with its 
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interaction with microneedles remains. This section considers the mechanics behind 
microneedles interaction with skin. 
2.6.1    Insertion force as determined numerically 
Kong et al. reported the outcome of numerical simulations of a single microneedle insertion 
into a multi-layered human skin. The outcome of their study demonstrated the feasibility of 
predicting the deformation and failure of skin. In addition, the insertion force of a 
microneedle during the insertion process was determined as ≈0.35 N and the point of 
insertion into skin was identified as a sudden decrease in force on the force–displacement 
curve. This result was in agreement with experimental studies by Bischoff et al. and Davis et 
al. (Bischoff et al., 2000; Davis et al., 2004). Furthermore, the numerical results showed that 
the stiffness, failure stress, thickness of the stratum corneum, needle tip area and the needle 
wall angle are primary control parameters for insertion of the tapered microneedles used in 
their study into the multi-layered human skin (Kong et al., 2011). For hollow microneedles 
with a large tip diameter however, a large wall thickness resulted in a high insertion force and 
for hollow microneedles with a small tip diameter, the wall thickness had almost no effect on 
the insertion force (Kong et al., 2011). This indicated the influence of microneedle geometry 
on insertion force. It appeared that contributions from parameters such as dermal thickness 
and the hypodermis was almost negligible (Kong et al., 2011). This observation was not 
consistent with work by other researchers. According to Zahouani et al. contributions from 
the dermal layer should not be ignored (Zahouani et al., 2009). More recently, Li et al. in 
their study further added that full thickness skin was paramount to understanding microneedle 
application to skin (Li et al., 2015). 
Moreover, Groves et al. developed a numerical multi-layered skin model i.e. epidermis, 
dermis and hypodermis using the Ogden material model to describe the hyperelastic 
properties of each layer of human skin. Further, it was successfully used for a single 
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microneedle application to skin and the results showed that it could predict skin deformation 
at a micron scale (Groves et al., 2012). A combination of work by Kong et al. and Groves et 
al. could lead to promising outcomes in the development of specific microneedle geometries 
for various skin types, as the numerical analysis has demonstrated the importance of 
microneedle geometry for successful microneedle perforation of skin. 
A detailed coverage of the numerical modelling of microneedle studies is beyond the scope of 
this thesis. 
2.6.2    Microneedle insertion force and insertion velocity 
Davis et al. demonstrated using several microneedle geometries that insertion force varied 
linearly with the effective area of contact between the needle tip and skin. The measured 
insertion forces were between 0.1–3 N for manual application (Davis et al., 2004). Verbaan et 
al. conducted a study, which demonstrated that with an electrical applicator, microneedle 
penetration could be improved with a higher insertion velocity. Their setup provided the 
ability to deliver low density microneedle arrays into dermatomed human skin at 1 or 3 ms
-1 
(Verbaan et al., 2008). Donnelly et al. noted that an adequate insertion force and insertion 
velocity was required to overcome the inherent elasticity present in the stratum corneum for 
successful microneedle application. It was reported that a large insertion force applied at low 
speed barely penetrated the stratum corneum, however, a smaller force at a higher speed 
perforated it (Donnelly et al., 2010). Further studies by Donnelly et al., in which a 
compression force was used for microneedle application, showed that 600 m and 900 m 
needle projections perforated neonatal porcine skin at a low application force of > 0.03 
N/microneedle. In addition, Olatunji et al. conducted similar tests using a compression force 
at low insertion velocities of 1 mms
-1
 to determine the influence of microneedle interspacing 
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on insertion force and found that insertion force was dependent upon microneedle 
interspacing and the number of microneedles. 
More recently, van der Maaden et al. demonstrated that the stratum corneum layer could be 
overcome in a reproducible manner using an impact-insertion applicator at a fixed insertion 
velocity of 3 ms
-1
 and insertion forces ranging from 3.43–22.1 N. Their study showed that 
when microneedles were manually inserted onto ex vivo human skin, perforations were 
visible following staining indicating approximately 81% microneedle penetration. However, 
after the stratum corneum was stripped, only 46% microneedle penetration was visible. 
Furthermore, it was also demonstrated that the manual application device resulted in low 
penetration efficiencies. In contrast, with a microneedle impact-insertion applicator efficient 
and reproducible penetration of high-density microneedles into skin was found. Fig. 10 shows 
both microneedle applicators and their perforations on skin. 
 
Figure 10 Microneedle application using (a) silicon microneedle array mounted on a manual insertion device, (b) an 
impact-insertion applicator, (c) perforations created using the impact-insertion applicator on the stratum corneum 
and (d) after stratum corneum removal showing that the perforations travelled beyond this layer (Reproduced from 
(van der Maaden et al., 2014)). 
2.6.3    Microneedle applicators 
Microneedles puncture skin by overcoming the inherent elasticity of the stratum corneum to 
create temporary microchannels for fluid to travel through (Kochhar et al., 2013b). However, 
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for effective and reproducible performance of these microneedles in drug delivery 
applications or fluid extraction, irrespective of design constraints such as, material, height 
and needle density, it is imperative that they successfully penetrate skin (Davis et al., 2004). 
The irregular surface topography of skin remains a significant challenge for reproducible 
microneedle penetration. It is for this reason that an appropriate device is required to ensure 
that microneedle penetration of skin occurs in a repeatable and predictable manner (Bouwstra 
et al., 2009). 
Various designs of the microneedle delivery apparatus have been developed in the literature 
such as a Dermaroller
®
 (Badran et al., 2009), syringe applicators (Haq et al., 2009), actuator 
driven applicator (Bouwstra et al., 2009), electrically driven applicator (Verbaan et al., 2008) 
and an impact applicator (van der Maaden et al., 2014) to determine a suitable way of 
breaching skin’s barrier. In some instances manual application of the microneedle was 
introduced to skin (Verbaan et al., 2007; Verbaan et al., 2008), however, this approach did 
not always yield reproducible penetration. Fig. 11 shows several examples of microneedle 
applicators. There have been several review papers on microneedle applicators and therefore 
detailed coverage of it is beyond the scope of this project. 
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Figure 11 Microneedle applicators (a) Microstructured Transdermal System (MTS), (b) microinfusor, (c) 
Macroflux®, (d) Microneedle Therapy System (MTS Roller™), (e) Microtrans™, (f) h-patch™ , (g) micronjet and (h) 
Intanza
®
 (Reproduced from (Indermun et al., 2014)). 
2.6.4    Microneedle geometry 
Design considerations of the microneedle in terms of its length, pitch, density, radius and 
shape are important because it affects its interaction with skin and how readily the drug is 
permeated (Olatunji et al., 2009; Olatunji et al., 2013). These parameters also contribute to 
the force at which the microneedle is fractured. The sharpness of the microneedle tip is 
another significant geometrical feature as it has a direct effect on the insertion force into skin 
(Davis et al., 2004; Park et al., 2005). Another microneedle design feature that is subject to 
various definitions is the aspect ratio, which has been described as the base over tip diameter 
(Huang and Fu, 2007). It has also been defined as the ratio of the microneedle length to the 
tip diameter and as the length over width of the microneedles (Davis et al., 2005). Al Qallaf 
et al. have said that the aspect ratio relates to the ratio of the pitch between two microneedles 
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to the microneedle radius. The aspect ratio is an important design feature that should not 
exceed 2.0 to avoid overlapping between microneedles. Furthermore, if the value < 2.0, the 
needles are placed too close to each other (Al-Qallaf and Das, 2008). Microneedle geometries 
can differ from 50–250 m in base width, 150–1500 m in length and 1–25 m in tip 
diameter (Arora et al., 2008). 
Fig. 12 shows the dye stained images from the study by Xiang et al., whereby it was revealed 
that if the spacing between two adjacent microneedles was larger than 400 μm, more than 
95% of the microneedles successfully perforated the tissue. If however, there was smaller 
spacing between the microneedles, there was reduced penetration. Previous work indicated 
that increasing the number of needles on an array can lead to an increase in the rate of 
transdermal drug delivery (Yan et al., 2010). Later on, Section 2.7.1 explains dye staining 
techniques in more detail. 
 
Figure 12 Dye staining shows the effect of microneedle interspacing perforation quality on rat skin (a) 250 m (b) 300 
m (c) 350 m and (d) 400 m. Scale bar represents 500 m (Reproduced from (Xiang et al., 2015)). 
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2.6.5    Microneedle studies on in vitro skin models 
Over the years various types of in vitro skin models have been used to demonstrate the 
interaction between skin and microneedles. The work carried out by Park et al. placed a heat 
stripped epidermis from a human cadaver on ten layers of tissue paper to provide a ‘tissue-
like’ mechanical support before a 5 × 20 array of bevelled-tip microneedles was pierced into 
it at a force of 4 N. Their study demonstrated the improved skin permeability with increased 
numbers of microneedles on the array (Park et al., 2005). In the work by Verbaan et al., 
dermatomed human skin was placed on a Styrofoam support to protect the microneedles from 
damage. The skin was pierced using a manual applicator at approximately 50 N pressure 
(Verbaan et al., 2007). The height of the microneedle projections was varied for insertion into 
skin, with 900 m, 700 m and 550 m perforating the tissue. The 300 m microneedle did 
not cause any perforations in the tissue. The intensity of the Trypan blue dye adhering to the 
microchannels created in the skin was greater for the longer microneedles than for the shorter 
microneedles (Verbaan et al., 2007). Later on, Section 2.7.1 discusses dye staining techniques 
like Trypan blue in more detail. 
Badran et al. also used human skin from the abdominal region in their skin model. The 
subcutaneous fat was completely removed; the surface of the skin cleaned with PBS solution 
and then allowed to dry under ambient air conditions for 20 mins. The skin was then wrapped 
in foil and stored at −26°C until use. The skin was placed on filter paper soaked in PBS 
solution supported by cork plates. Their study showed that penetration and permeation of 
hydrophilic model drugs were enhanced after skin perforation with the Dermaroller
®
 
(microneedle applicator). The Dermaroller
®
 with the longest microneedle length (500 m) 
was the most promising for drug delivery into skin and the Dermaroller
®
 with the shortest 
microneedle length (150 m) led to a pronounced deposition of the model drugs in the 
stratum corneum (Badran et al., 2009). 
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Yan et al. also considered the effects of microneedle length and density on microneedle 
perforation quality. The difference with the above mentioned studies was that the human 
epidermal membrane was placed on a soft sponge pad as an underlying substrate. Their study 
showed that the longer microneedle length (650 m) resulted in a pronounced deposition of 
the model drug across skin compared to the shorter microneedle length (≤ 300 m). In 
addition, the increase of the microneedle length beyond 650 m did not produce a significant 
increase in drug delivery and that the less dense microneedle arrays were more effective in 
boosting drug delivery (Yan et al., 2010). 
Studies by Donnelly et al. and Olatunji et al. used dental wax as their underlying substrates 
for neonatal porcine skin. The tissue was preserved at −20°C until use. The skin model was 
perforated at low compression forces of approximately 0.03 N/microneedle. 
An 8 × 8 microneedle array was inserted into excised pig skin cadaver. The hair was removed 
using an electric hair clipper and then hair removal cream. The skin samples were cleaned 
and stored at −80°C until use. The subcutaneous fat was removed using a scalpel and the skin 
fixed fully stretched on a thin 7–8 mm thick layer of modelling clay to act as the tissue-like 
mechanical support. The microneedles were manually inserted by applying thumb pressure 
for approximately 1 min. The tissue was stained with Trypan blue dye for 5 mins to highlight 
perforations in the stratum corneum. Haematoxylin and Eosin (H&E) staining were used to 
visualise the perforation detail and showed that skin layers had been breached. This therefore 
suggested that the encapsulated drug could be delivered efficiently. In addition, it also 
demonstrated that thumb pressure provided adequate force to penetrate skin (Kochhar et al., 
2013a; Kochhar et al., 2013b). 
As microneedle length affects its performance in skin, the microneedles used in this thesis 
were in a range of 352–650 m long. Additionally, the spacing was kept between 360–1000 
48 
  
m and it was also important that the microneedles were medical grade allowing for their use 
for in vivo studies. 
The ideal preservation technique for the excised skin is to snap freeze the tissue sample in 
super-cooled isopentane and then store at –80°C. Snap freezing reduces the chance of water 
present in the sample forming ice crystals during the freezing process, and better maintains 
the integrity of the sample (Graham et al., 2011). The tissue preservation approach in some of 
the studies could have influenced the outcome of the microneedle perforating the skin model. 
Furthermore, in the studies where only the epidermal layer was placed on the substrate, the 
mechanical contributions from the dermal layer were ignored and this could have affected the 
outcome of the tests. This is because the dermal layer provides significant mechanical 
strength to skin (Zahouani et al., 2009). In addition, the mechanical contribution from the 
various substrates was not taken into consideration in these skin models, as these substrates 
would behave in a mechanically different way to the actual underlying substrates of skin such 
as tissue fluid and muscle. This therefore would make it challenging to predict microneedles 
response to skin in a consistent manner. 
This project aims to develop a more representative in vitro skin model overcoming the 
limitations of these earlier studies. 
2.7   Assessment of Microneedle Perforation of Skin 
Staining is one of the methods used in determining successful perforation of skin following 
microneedle application. Staining of tissues involves getting the dye to the site of attachment 
through diffusion and holding the dye to its substrate through propulsion (Dapson, 2005). 
This section aims to review some of the available methodologies that are appropriate for this 
study. 
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2.7.1    Dye staining 
The more commonly used dyes for staining microneedle perforated skin samples are Trypan 
blue and methylene blue dyes. 0.4% Trypan blue solution is normally used as a cell stain to 
examine cell viability using the dye exclusion test. This test can be carried out whenever cell 
viability is required to be established in a prompt and thorough manner. Moreover, the dye 
exclusion test is based upon the principle that viable cells do not absorb impermeable dyes 
such as Trypan blue, but instead dead cells are permeable and absorb the dye (Strober, 2001). 
Fig. 13 shows images of microneedle perforations stained with Trypan blue. 
 
Figure 13 Dissolving microneedle arrays perforation of 6–8 weeks old female mice skin under various loads and 
stained with Trypan blue. (a) 1 N, (b) 2 N and (c) 4 N (Reproduced from (Qiu et al., 2015)). 
Methylene blue is used as a histological stain in biological experiments. At room 
temperature, it appears as a dark green powder that dissolves moderately in water to form a 
deep blue solution. The perforated tissue is soaked in methylene blue solution for a given 
duration in order to detect if any microchannels have been created. The staining is as a result 
of the methylene blue dye attaching itself to the proteins that exist within the tissue (Jones et 
al., 2008). Fig. 14 presents images of methylene blue staining. 
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Figure 14 Solid maltose microneedle perforation of hairless rat skin and stained with methylene blue. (a) Array of 
microneedles perforations and (b) magnified view of the perforations (Reproduced from (Kolli and Banga, 2008)). 
Both Trypan blue and methylene blue provide the same level of information when used for 
the assessment of microneedle perforation. The limitation with both dye techniques is that it 
is impossible to determine how deeply the microneedles have travelled through the layers. 
2.7.2    Histological staining 
The Haematoxylin and Eosin stain (H&E) is the most widely used stain in histological 
laboratories. It has the ability to demonstrate a wide range of normal, abnormal cell and tissue 
components. It is a relatively simple stain useful for conducting microscopic examination of 
tissue that has been paraffin embedded or cryosectioned (Larson et al., 2011). It can be 
performed manually or by automation and typically the manual technique is usually carried 
out for economic reasons and sample volume (Fischer et al., 2008). Haematoxylin exhibits a 
deep blue-purple colour and stains nucleic acids by a complex, incompletely understood 
reaction. Eosin is pink and stains proteins non-specifically. For example, in a typical tissue 
the nuclei are stained blue, compared to the cytoplasm and extracellular matrix that are 
stained in varying degrees of pink. Thus, this dye combination is capable of emphasising the 
fine structures of cells and tissues (Chan, 2014). Careful adherence to H&E staining protocol 
allows for the detection of many tissue subtleties that are necessary for accurate analysis 
(Cardiff et al., 2014). 
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Histology evaluation using H&E staining can also be used to define the layers of skin such as 
the stratum corneum, epidermis, dermis and hypodermis. An advantage to H&E staining is 
that the depth of microchannels created by microneedles within skin’s layers can be readily 
assessed (Li et al., 2015). Fig. 15 shows examples of H&E sections of skin. 
 
Figure 15 Images of H&E sections of previous studies (a) black arrow indicates microneedle perforation in 
rat skin (Reproduced from (Kochhar et al., 2013a)) (b) black arrow indicates microneedle perforation in 
rat skin (Reproduced from (Li et al., 2015)) (c) cross-section of porcine skin (Reproduced from (Dabboue 
et al., 2015)) and (d) cross-section of human skin (Reproduced from (Dabboue et al., 2015)). 
The disadvantages to this method is that only a small portion of the tissue can be sectioned, 
which means that useful information is lost with the tissue that is discarded. It involves time-
consuming fixing, sectioning and staining steps. By comparing histological results with non-
invasive imaging technique, Coulman et al. reported that histological measurements lead to 
overestimation of measurements (Birchall et al., 2005; Coulman et al., 2010). Furthermore, 
there are slight inaccuracies with the measurements of the microchannels created in skin 
following microneedle application due to skin retraction caused by the removal of the 
microneedles before staining (Donnelly et al., 2010; Loizidou et al., 2016). Despite these 
limitations, using histology for the light microscopic assessment of skin biopsies is still 
regarded as the benchmark in dermatology (Holme et al., 2014; Newton et al., 2015). 
2.7.3    3D image analysis 
The emergence of Optical Coherence Tomography (OCT) and micro X-ray Computed 
Tomography (XMT) as imaging tools for soft tissue could provide the opportunity to image a 
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whole sample of microneedle treated tissue, without going down the laborious route of H&E 
staining.  
Fercher et al. first suggested the use of OCT for medical diagnostic applications in order to 
visualise transparent tissues of the eye (Fercher et al., 1988). OCT can produce high 
resolution cross-sectional imaging of biological tissues in vivo and in real time (Huang et al., 
1991; Liu et al., 2013). The major advantage of OCT is that it is capable of penetrating depths 
of 2 mm within skin and it can provide cross-sectional imaging of the epidermis and upper 
dermis in vivo (Fercher, 2010). 
XMT is another powerful method for non-destructive imaging of soft tissue that involves a 
high resolution imaging technique, which has gained wide use within the scientific 
community (Schambach et al., 2010). Traditionally, XMT has been predominantly used for 
the imaging of bone structures (Buie et al., 2007). The challenge with XMT of soft tissue is 
as a result of its low inherent X-ray contrast (Pauwels et al., 2013; Walton et al., 2015). The 
use of contrast agents on soft tissue can overcome this limitation. However, there is still 
limited knowledge about contrast agents or staining protocol for XMT compared to light and 
electron microscopy imaging (Pauwels et al., 2013). Recently, Loizoudou et al. used XMT 
scanning in their work for the 3D visualisation of microneedle skin penetration (Loizidou et 
al., 2016). 
2.8    Summary 
This chapter has reviewed literature relevant to the anatomy of skin, mechanical properties of 
skin, microneedles and its application as a device to infuse or extract fluid in skin, as well as 
techniques for determining successful microneedle perforation of skin. Microneedles are a 
suitable tool for enabling the administration of therapeutic compounds to the ideal site 
provided by skin. To accomplish reproducible microneedle interaction with skin, an 
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understanding of the mechanical characterisation of skin is necessary. This literature review 
gave an overview of in vitro and in vivo techniques for the mechanical testing of skin, which 
indicated that test methodology, skin site, test condition and indenter type significantly 
influenced the outcome of the elastic modulus. 
The mechanical contributions from the skin’s sub-layers such as the dermis can influence 
microneedle performance. The role of the subcutaneous fluid and muscle to the overall 
mechanical behaviour of skin is also important and could determine microneedles interaction 
with skin. 
The review has also highlighted the need to establish a mechanism for reproducible 
microneedle perforation of skin, with particular attention given to the design of the 
microneedle applicator. The different types of microneedle applicators varied from a manual 
applicator using thumb pressure to a spring-driven applicator to an electric-driven applicator 
or an impact applicator. Evidently, for successful and reproducible microneedle perforation 
of skin, an external delivery device for microneedle application is necessary. Furthermore, an 
adequate insertion force and insertion velocity is necessary for successful microneedle 
application to skin. 
The skin models used in several of the studies lacked representative underlying substrates for 
the skin. In some instances, only the epidermal layer and underlying substrates were 
considered, thus ignoring significant mechanical contributions from the dermal layer. Sample 
preservation also varied for each study, as the tissue was not snap frozen in super-cooled 
isopentane before it was stored at temperatures of −20°C, −26°C and −80°C following 
excision. This may have introduced some level of compromise to the integrity of the tissue 
and therefore, may have potentially influenced the outcome of the experimental analysis.  
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A number of approaches were used for assessing successful microneedle perforation of skin, 
with dye staining being the most common in establishing disruption to the stratum corneum. 
One study stripped the stratum corneum following microneedle application to determine if 
the perforations had travelled beyond the layer. In addition, histological staining techniques 
were also used to determine the penetration depth through the layers of skin. Moreover, 
emerging technologies within biomedical research such as OCT and XMT could also be 
utilised in providing this detail. 
Based on the literature review, this study will develop a representative in vitro model of skin 
that is within the range of elastic moduli in the literature, then using indentation techniques to 
determine the biomechanical properties of each layer in the skin model and developing a 
microneedle applicator that involves the use of force and velocity. The outcome of 
microneedle application to skin would be determined using imaging techniques such as 
methylene blue and histology staining.  
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Chapter 3 
3. Material and Methods 
3.1   Introduction 
The details of the experimental work of microneedle perforation of skin are discussed in this 
section. Based on the review of previous studies, it is clear that microneedle geometry, 
applicator insertion force or velocity and skin model play a major role in achieving successful 
interaction between microneedles and skin. This chapter provides a detailed description of the 
skin model, microneedles, microneedle applicators, experimental methods and image analysis 
techniques used not only to achieve the primary aims and objectives established in Section 
1.3 but to also address the topics summarised in Section 2.8. 
3.2   The In Vitro Skin Model 
In this thesis, a representative in vitro skin model was developed for microneedle application 
and is explained in detail in this subsection.  
3.2.1 Neonatal porcine skin 
Five fresh suckling pigs (7–10 weeks old) were obtained from a local abattoir. Skin samples 
from the back and abdomen were dissected within 3–4 hours and immediately snap-frozen by 
placing in super-cooled isopentane and were subsequently stored at –80°C until required. 
Prior to testing, the skin tissue was de-thawed for 30 mins. Commercial hair removal cream 
for normal skin (Veet, Reckitt Benckiser Group, Berkshire, UK) was applied to the skin 
surface for 5 mins to remove any hair. The samples were kept hydrated in PBS solution. 
As stated in Section 1.3.3. Renehpra’s device could potentially be used on various sites in the 
human body. It is for this reason that the work in this thesis focused on two anatomical 
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regions of neonatal porcine skins i.e. the abdominal tissue and back tissue due to their 
differences in thickness and stiffness. Skin properties such as thickness various considerably 
across different regions of the human body (Lee and Hwang, 2002); hence these two types of 
porcine skin provide a useful method of determining how the device may work in different 
parts of the human body.   The physiological properties of neonatal porcine skin are similar to 
human skin (Lo Presti et al., 2012) and the stiffness is within the range of values for the 
stiffness of human tissue (Groves, 2011). 
3.2.2 Gelatine gels as a representation of subcutaneous tissue fluid 
Gelatine gel is formed because of the structural and chemical degradation of collagen (Lee 
and Mooney, 2001). Gelatine powder is a translucent, colourless, brittle solid substance and 
the type used in this study was derived from collagen obtained from porcine extract (Sigma-
Aldrich 48723-500G-F, Fluka). 
3.2.2.1 Determination of gelatine gels concentration 
The primary application of the TFR technology is to use microneedles to gain access to the 
epidermis in the skin in order to extract fluid from patients with fluid overload or oedema. 
For the effective application of microneedles to skin, consideration must be given to how 
fluid overload in the in vitro skin model is represented. As mentioned in the literature review, 
gelatine gels present an ideal approach for mimicking oedema in the in vitro skin model. 
There are two forms of oedema, subcutaneous pitting oedema and subcutaneous non-pitting 
oedema as previously described in Section 1.1. There lies a significant challenge in 
quantitatively or semi-quantitatively depicting subcutaneous non-pitting oedema and it was 
for this reason that this project focused solely on establishing gelatine gel mimics for various 
severities of subcutaneous pitting oedema following the relevant literature studies. 
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Mridha et al. conducted two different mechanical tests, which were the mechanical 
impedance test and the mechanical pulse wave propagation test on various concentrations of 
gelatine gels and this has been previously covered in more detail in Section 2.4.2. The 
gelatine gel concentrations of 80%, 84%, 88%, 92% & 96% water content by weight 
represented the different severities of subcutaneous pitting oedema. By conducting these 
mechanical tests, they were able to determine the mechanical behaviour of subcutaneous 
pitting oedema. For mechanical impedance tests, high water content gelatine gels and 
subcutaneous pitting oedema tissues had lower mechanical impedance compared to 
subcutaneous non-pitting oedema, which exhibited higher mechanical impedance (Mridha 
and Odman, 1985). Conversely, for the mechanical pulse wave propagation tests, the 
propagation velocity of mechanical pulse waves was found to be lower in subcutaneous 
pitting oedema than for normal tissues and higher in subcutaneous non-pitting oedema 
(Mridha et al., 1992). 
For normal, ‘healthy’ skin, the gelatine gel concentration was 67% water content by weight. 
This was based on a study by Caspers et al. where an in vivo Raman microspectroscopy 
technique was used to non-invasively determine the water content in healthy skin below the 
stratum corneum to be around 67%, with the value varying slightly depending on anatomical 
region (Caspers et al., 2000). 
Based on these studies, four gelatine gel concentrations were used in this thesis and are 
presented in Table 8. The mild-severe oedema characterisation is based on the Mridha et al. 
studies (Mridha and Odman, 1985; Mridha et al., 1992). The lowest water content gel has the 
highest stiffness, whilst the highest water content gel has the lowest stiffness. 
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Table 8 Composition of gelatine powder and water. 
 
Gelatine powder 
(g) 
 
Water 
(mL) 
Gelatine gel 
(water content 
by weight) 
Subcutaneous mimic 
20 58 67% Normal 
10 45 80% Mild subcutaneous pitting oedema 
5 37 88% Moderate subcutaneous pitting oedema 
5 120 96% Severe subcutaneous pitting oedema 
 
3.2.2.2 Preparation technique of gelatine gels 
Several factors such as gel preparation, curing duration, cooling and measurement 
temperatures can influence the mechanical properties of gelatine gels (Markidou et al., 2005). 
Therefore, each gel concentration was prepared in a consistent manner that involved using an 
electronic stirrer to mix a mass of gelatine powder along with the requisite volume of distilled 
boiling water until all gel powder had dissolved. Several homogeneous mixtures were made 
for the four gelatine gel concentrations (see Table 8). The gel solution was left to cool for 1 
hour, before it was cured at 5°C for 4–5 hours. 
All tests were carried out within 2 hours using the same batch of samples. 
3.2.3 Perma-Gel
®
 as muscle mimic 
As previously discussed in Section 2.4.3, Perma-Gel
®
 (Perma-Gel, Inc., Albany, OR, USA) is 
an ideal muscle mimic. Perma-Gel
®
 which is similar to ballistic gelatine, is used as muscle 
mimic (Caron-Laramee and Brouillette, 2014). Furthermore, synthetic thermoplastic 
materials such as Perma-Gel
®
 are stable at room temperature and can be stored for long 
periods of time (Moy et al., 2011). 
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Perma-Gel
®
 was obtained as a test block form (445 mm × 292 mm × 127 mm) from a third 
party distributor (MidwayUSA, Columbia, USA). The Perma-Gel
®
 was cut in small 
specimens to fit the mechanical clamps. 
3.2.4 Classification of the various in vitro skin models 
A diagram of the representative in vitro skin model comprising the three layers is shown in 
Fig. 16.  
 
Figure 16 Diagram of the representative in vitro skin model showing the skin as the top layer, with gelatine 
gel as a second layer and Perma-Gel
®
 as the third layer. 
The skin model was secured in mechanical clamps and the mechanical clamps are shown in 
Fig. 17. 
 
Figure 17 The mechanical clamp (a) top view of the assembled clamp (b) side view of the assembled clamp and (c) 
individual components of the clamp. 
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The in vitro skin models have been categorised according to anatomical site, gelatine gel 
concentration and Perma-Gel
®
 and are presented in Table 9. The classification of skin model 
names i.e. Model 1A, Model 2A will be used for the remainder of the work carried out in 
later chapters of this thesis. 
Table 9 The categories of two anatomical sites of neonatal porcine skin at various gelatine gel 
concentrations and Perma-Gel
®
. A = Abdominal skin and B = Back skin. 
 
Types of Skin Model 
 
Classification 
Abdominal skin with 67% gel concentration and Perma-Gel
®
 Model 1A 
Abdominal skin with 80% gel concentration and Perma-Gel
®
 Model 2A 
Abdominal skin with 88% gel concentration and Perma-Gel
®
 Model 3A 
Abdominal skin with 96% gel concentration and Perma-Gel
®
 Model 4A 
Back skin with 67% gel concentration and Perma-Gel
®
 Model 1B 
Back skin with 80% gel concentration and Perma-Gel
®
 Model 2B 
Back skin with 88% gel concentration and Perma-Gel
®
 Model 3B 
Back skin with 96% gel concentration and Perma-Gel
®
 Model 4B 
 
3.2.5 Micromechanical characterisation of the layers of the skin model 
A general overview of the indentation technique is mentioned along with the theory. In 
addition, the experimental approach is also detailed in this section. 
3.2.5.1 Dynamic indentation principles 
Indentation or depth-sensing instrumentation is a technique for determining localised 
mechanical properties of materials. With indentation, a prescribed load is applied to an 
indenter in contact with a specimen. As the load is applied, the depth of penetration is 
measured. The area of contact at full load is determined by the depth of the impression and 
indenter geometry (Oliver and Pharr, 1992). A schematic of a typical load-displacement 
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curve is shown in Fig. 18. It also involves small scale mechanical testing, which presents 
several advantages in the characterisation of biological materials. One of which is the small 
volume of material required for testing, thereby minimal sample preparation is required. 
Furthermore, with instrumented indentation it is possible to map out the spatial differences of 
properties in the sample and is a key requirement for characterising biological material (Hay, 
2011). Typically, quasi-static indentation is used for testing biological tissues (Ebenstein and 
Pruitt, 2006). However, there are a number of challenges including difficulties in accurately 
detecting sample surface (Akhtar et al., 2015). 
 
Figure 18 A schematic representation of a typical load versus indenter displacement curve. Pmax and hmax 
are the load and displacement at highest load respectively and a is the radius of the contact circle. hf is the 
final depth of the contact impression after unloading and S is the initial unloading stiffness. (Figure 
reproduced from (Oliver and Pharr, 1992)). 
In this thesis, dynamic indentation has been utilised with a 100 m flat punch tip, therefore 
resulting in micron resolution. Dynamic instrumented indentation provides a simple way to 
accurately measure the mechanical properties of soft biological material like skin and gelatine 
gels (Hay and Cherneva, 2013). Furthermore, indentation is used a lot for skin and has 
advantages over tensile testing. In addition, tips of this geometry (100 m flat punch tip) are 
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typically used to improve surface detection with compliant materials, hence, micro-sized tips 
for indentation. For the characterisation of time-dependent behaviour, dynamic indentation 
has its advantages over quasi-static indentation because it significantly reduces the testing 
time through the measurement of properties over a range of frequencies rather than extended 
time (Odegard et al., 2005). 
3.2.5.2 Theory 
With the Keysight Technologies DCM-II head, as shown in Fig. 19, it is possible to perform 
dynamic (oscillatory) indentation and determine the complex shear modulus (G*), which 
exhibits real and imaginary components and gives the shear storage modulus (G´), which 
depicts the energy stored and viscous or the shear loss modulus (G˝), which depicts the 
energy dissipated as heat. Therefore, the relationship between the elastic and viscous 
properties of the material is shown in Equation 4: 
G* = G´ + i G˝         Equation 4 
 
Figure 19 A schematic of the DCM-II head. (Figure reproduced from (Hay, 2012)). 
The theory is covered in greater detail in Hay (2011) and Hay and Cherneva (2013). In brief, 
by indenting samples with a flat-ended cylindrical punch, the relationship between the shear 
63 
  
modulus (G´), Poisson’s ratio () , elastic contact stiffness (S) and punch diameter (D) can be 
determined using the analysis developed by Sneddon, (1965) as shown in Equation 5: 
𝐺´ =  𝑆(1−𝑣)
2𝐷
         Equation 5 
The influence of contact damping, C on the viscous properties, G˝ is given by the following 
equation: 
𝐺˝ =  𝐶𝜔(1−𝑣)
2𝐷
         Equation 6 
The contact stiffness, S, must be obtained by subtracting the instrument stiffness, Ki from the 
total measured stiffness, Ks and is given by the following equation: 
𝑆 = 𝐾𝑠 − 𝐾𝑖          Equation 7 
Likewise, the contact damping, C must be obtained by subtracting the instrument damping, 
Ci from the total measured damping, Cs and is given by the following equation: 
𝐶𝜔 = 𝐶𝑠𝜔 − 𝐶𝑖𝜔        Equation 8 
By oscillating the indenter electromagnetically, the stiffness and damping are obtained. To 
begin with, the same conditions (e.g. same position, frequency and oscillation amplitude) that 
are used to measure the stiffness and damping of the head only are subsequently used for 
testing. The indenter head is moved down towards the sample until contact is made. During 
this period, a pre-compression is applied so that the indenter maintains total contact with the 
sample surface. The indenter is then vibrated at a fixed frequency and oscillation amplitude. 
Therefore, at the initial oscillation cycle, the indenter head is calibrated in situ. The stiffness 
and damping inputs from the head can then be deducted from the measured signal in order to 
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find the contact only response. Afterwards, the second oscillation cycle acquires the material 
properties (Akhtar et al., 2015). 
3.2.5.3 Experimental setup 
All indentation experiments were carried out on gelatine gels, Perma-Gel
®
 and fresh full 
thickness skin samples. The tissue was hydrated in PBS solution. Indentation tests were 
conducted using a Keysight indenter G200 (Keysight Technologies, Chandler, AZ, USA) 
instrument with an ultra-low load dynamic contact module indentation head (DCM-II 
actuator). The indentations were performed at ambient temperature (24.3–27.2ºC), using a 
100 m flat punch indenter tip (Synton-MDP Ltd, Nidau, Switzerland). A custom sample 
holder was designed in to which the gelatine gel samples were placed. The well in the sample 
holder was 1 cm
2
 and 4 mm deep. 
For the experiments conducted in this thesis, a pre-compression of 5 m for the gelatine gels 
and Perma-Gel
®
 were selected, whilst 8 m was used for the skin samples. The indenter was 
fully in contact with the sample surface. The indenter was then vibrated at a frequency of 110 
Hz (the resonant frequency of the indenter) and with an oscillation amplitude of 500 nm. To 
obtain the response of the contact only, the stiffness and damping contributions from the 
indenter are subtracted from the measured signal. This means that the second oscillation 
sequence acquires the material properties. 10 different sites were tested on each sample, with 
100 m spacing between each indent on the sample. The tip of the indenter head was cleaned 
by indenting a piece of double-sided Scotch tape positioned on an adjacent sample puck 
before repositioning on a new area on the sample following each indent. 
A Poisson's ratio, , of 0.5 was chosen because skin is regarded as fully incompressible 
(Bhushan et al., 2010) and this value was used to calculate the elastic modulus, E, which was 
subsequently, determined using the formula in Equation 9. 
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𝐺´ =  
𝐸
2(1+𝑣)
         Equation 9 
G´, G˝ and the loss factor, tan () given in Equation 10 were calculated for each indentation. 
tan(𝛿) =  
𝐺´
𝐺˝
         Equation 10 
The surface detection relies on a phase shift of the displacement measurement, as presented 
in Fig. 20. As a standard for accurate surface detection, the method reported by Akhtar et al. 
was used. With this method, the phase shift is monitored over several data points in order to 
eliminate random spikes which were found to occur in some instances over short time 
intervals such as 2 data points and thus resulting in an erroneous surface detection. Once the 
surface detection condition had been met over a predefined number of data points, the initial 
contact was determined from the first point in that sequence. 
 
Figure 20 Profile of phase angle as a function of time that is used for accurate surface detection of 67% 
gelatine gel. Point SD is the surface detection, which starts with a gradient increase in the phase angle. 
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3.3   The Microneedle Arrays 
This section provides details about the types of microneedles used in this thesis, the material 
they were made from, their manufacturing process and design. These specific medical grade 
microneedles were sourced because of their intended use on human subjects. 
3.3.1 Polyetheretherketone microneedle arrays 
Custom manufactured polyetheretherketone (PEEK) microneedle arrays (Laser 
Micromachining Ltd, St Asaph, UK) were used for the early experimental analysis. These 
were hollow microneedles as shown in Fig. 21 and were manufactured using laser etching or 
laser finishing following injection moulding to a height, width and 1 mm interspacing 
between the microneedles. 
 
Figure 21 Medical grade PEEK microneedles, where (a) drawing including dimensions and (b) image of the array. 
(a) 
(b) 
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The PEEK microneedles were 9 × 9 arrays consisting of 81 individual needles on 15 mm × 
15 mm base and 0.65 m in height. These medical grade microneedles were provided by 
Renephra Ltd. 
3.3.2 Polymethylmethacrylate microneedle arrays 
Dense polymethylmethacrylate (PMMA) microneedle arrays (10x technology, IL, USA) were 
used for all subsequent experiments reported in this thesis. Microneedles embossing mould 
and embossing machine was used to manufacture the microneedle array to a specific height, 
width and regular interspacing between the microneedles. Fig. 22 shows the PMMA 
microneedles, which is marginally larger than a £1 coin. 
 
 
 
Figure 22 Medical grade Design 2 PMMA microneedle array, where (a) drawing including dimensions and (b) as 
compared to a £1 coin (Renephra, 2015). 
(a) 
(b) 
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The full specifications for the PMMA microneedles are presented in Table 10. These 
microneedles are medical grade and have been used in in vivo patient tests since 2014 by 
Renephra Ltd. 
Table 10 PMMA microneedles specification. 
 
Type 
 
Height 
(m) 
 
Disc size 
diameter 
(mm) 
 
Needles 
per unit 
area 
(mm
2
) 
 
 
Base 
(m) 
 
Centre-to-
centre 
spacing 
(m) 
 
No. of 
needles 
per 
array 
Design 1 356 15.8 6.7 177 386 1316 
Design 2 552 30.1 7.7 160 360 >6000 
 
3.3.3 Scanning Electron Microscopy of microneedle arrays 
Consideration was given to microneedle integrity to determine the number of times it could 
be used on tissue. Scanning Electron Microscopy (SEM) images of microneedles were 
recorded using a Hitachi S-4800 FE-SEM at 3 kV with 1.5 kV deceleration (Tokyo, Japan). 
The PEEK or PMMA samples were fixed onto the aluminium stubs with carbon tabs. The 
samples were gold coated using a sputter-coater (EMITECH K550X) prior to imaging. 
Impact tests with microneedles on tissue were carried out once and SEM images were taken. 
Further impact tests were repeated five times using the same microneedle and SEM images 
taken. 
3.4   The Microneedle Applicators 
This section details the two types of microneedle applicators used for microneedle applications to 
the skin model. All impact tests were conducted at ambient temperature, which was ideal for 
maintaining the stability of the gelatine gels used in the models. 
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3.4.1 Impact applicator system 
The governing principles of a dropped weight impact-testing rig have been detailed in this 
section and the experimental setup described extensively in Sections 3.4.1.3. and 3.4.1.4. 
3.4.1.1 Determination of the dropping heights 
The dropping heights were calculated by inputting values for velocity in the simple motion 
equation, where v is velocity, g is acceleration due to gravity and h is the dropping height. 
𝑣 =  √2 𝑔 ℎ           Equation 11 
Table 11 shows the equivalent dropping heights for the velocities calculated from Equation 
11. Each dropping height was marked along the length of the drop tower guide. 
Table 11 Velocity as a function of dropping height. 
Velocity (ms
-1
) 1 2 3 4 5 
Dropping height (m) 0.05 0.20 0.46 0.82 1.27 
 
3.4.1.2 Theory 
Impact acceleration occurs whenever there is an abrupt change in velocity, such as an 
instantaneous deceleration in a car crash or the sudden halt of a falling lift down a shaft. As a 
consequence, impact forces are usually in milliseconds and human tolerance to them is 
determined by the mechanical strength of body tissues (Glaister, 1975). Therefore, the 
perforation potential of microneedles in skin during a given impact is related to the amount of 
work done or energy absorbed by the tissue. 
During impact, some compression of the tissue occurs and there may also be a rebound of the 
drop mass as residual energy is dissipated, however, for simplicity purposes, rebound is 
ignored in this theory. Furthermore, there is an elastic potential energy (Equation 12), which 
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is the stored energy the drop mass (m) possesses due to its position in a stressed elastic 
system. Conversely, because the drop mass is released from a known height it also has 
potential energy, which is the energy stored up in the drop mass as a result of its position in a 
gravitational field (Equation 13). 
𝐸𝑙𝑎𝑠𝑡𝑖𝑐 𝑃𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙 𝐸𝑛𝑒𝑟𝑔𝑦 =  
1
2
 𝑘 𝑥2     Equation 12 
𝑃𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙 𝑒𝑛𝑒𝑟𝑔𝑦 = 𝑚 𝑔 ℎ       Equation 13 
The spring potential energy is obtained from Equations 12 and 13, and is given by Equation 
14, where x is the compression distance and k is the spring constant. 
𝑚 𝑔 ℎ =  
1
2
 𝑘 𝑥2        Equation 14 
By rearranging Equation 14, the compression distance (x) is given by Equation 15 
𝑥 =  √
2 𝑚 𝑔 ℎ
𝑘
         Equation 15 
Fig. 23 illustrates the relationship between the elastic potential energy and the potential 
energy due to gravitational fields using a simple spring. 
 
Figure 23 Schematic of the potential energy due to gravity and the energy stored up in a spring energy indicating the 
compression distance (x). 
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Using Hooke’s Law in Equation 16 to establish a relationship between force (F) and 
compression distance (x). 
 𝐹 = 𝑘 𝑥         Equation 16 
Substituting the compression distance (x) in Equation 15 into Equation 16 gives the 
expression 
𝐹 = 𝑘 𝑥 =  √2 𝑚 𝑔 ℎ 𝑘       Equation 17 
The velocity for microneedle perforation of skin can be derived from the conservation of 
energy principle because the potential energy is converted into kinetic energy. 
𝐾𝑖𝑛𝑒𝑡𝑖𝑐 𝑒𝑛𝑒𝑟𝑔𝑦 =  
1
2
 𝑚 𝑣2       Equation 18 
Equating the kinetic energy and the potential energy gives the expression in Equation 19 
1
2
 𝑚 𝑣2 = 𝑚 𝑔 ℎ        Equation 19 
Making the velocity (v) the subject of the formula gives 
𝑣 =  √2 𝑔 ℎ         Equation 20 
The force can be obtained by substituting Equation 20 into Equation 17 
𝐹 = 𝑣 √𝑚 𝑘         Equation 21 
Based on the interpretation of Equations 12–21, the following conclusions were drawn: 
 A low mass object will produce a lower magnitude of force compared to a large mass 
object. 
 An increase in the force will result in an increase in velocity. 
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 Increasing the dropping heights will result in an increase in velocity. There is 
contribution from the acceleration due to gravity as the drop mass is released from 
rest. 
 The mass of the object influences the impact energy; a small mass will release less 
energy, whilst a large mass will expend more energy. 
3.4.1.3 First generation impact applicator 
The early dropped weight impact testing rig comprised a drop tower of height 1.86 m, with a 
drop tower guide of height 1.78 m, a piezoelectric accelerometer of 10.96 mV/g sensitivity 
(Unit Type A/126/S, Serial No. 035, Birchall Instruments) connected to a power supply, 
which was connected to a digital oscilloscope (Part No. 54641A, Agilent Technologies) along 
with the proprietary Agilent IntuiLink software (Version 3.1). The accelerometer was 
fastened to one end of the 36 g drop mass and the microneedle array fixed to the free end of 
the drop mass using superglue. The experimental setup is shown in Fig. 24. 
The early impact tests were conducted on only skin and gelatine gels. Five repeats of the 
impact tests were performed on eight different skin models i.e. back skin with four gelatine 
gel concentrations and abdominal skin with four gelatine gel concentrations. The acceleration 
is captured on the oscilloscope as voltage–time plots, which is then converted to an 
acceleration–time plot using the accelerometer sensitivity before it is eventually converted to 
a velocity–time plot. 
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Figure 24 Schematic diagram of the early dropped weight impact-testing rig. 
3.4.1.4 Improved impact applicator 
The improved impact test setup included the addition of a force transducer, power units and a 
beam detector to the early impact applicator system. 
The setup used a piezoelectric accelerometer with 10.71 mV/g sensitivity (Model 3225F-1, 
Dytran Instruments, Inc., CA, USA) and a piezoelectric force transducer with 22.4 mV/N 
sensitivity (Model 1022V, Dytran Instruments, Inc., CA, USA). Both the accelerometer and 
the force transducer were connected to their respective amplifiers (Model 4105C, Dytran 
Instruments, Inc., CA, USA), which had a frequency response of 0.1–100 000 Hz gain ×1 
used for velocities 1–2 ms-1 and 0.1–50 000 Hz gain ×10 used for velocities 3–5 ms-1. This 
was then connected to a digital oscilloscope (54641A, Keysight Technologies, Berkshire, 
UK) and utilised with Keysight IntuiLink software (Version 3.1). The sampling rate was 20 
kHz. The accelerometer was connected to the top of the custom-made drop mass, whilst the 
force transducer was fastened to its bottom end. Two 630–650 nm wavelength (red) with a 
power output <1mW laser diode modules (PL-Series, Hero Electronics, Dunstable, UK) were 
attached to two drill holes on the lower part of the drop tower guide so that a break in signal, 
caused when the drop mass is released, was captured by a beam detector, thus activating the 
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external trigger on the oscilloscope. Subsequently, the force and acceleration outputs were 
captured on the oscilloscope. The experimental setup is shown in Fig. 25. 
 
 
 
 
Figure 25 The improved impact applicator, where (a) is the schematic diagram and (b) includes 
complimentary pictures of the setup. 
The relevant dropping heights in Table 11 were marked along the length of the drop tower 
guide. The opening in the drop tower guide as shown in Fig. 25b allowed for the movement 
(a) 
(b) 
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of the cables fastened to the accelerometer and force transducer. The drop mass along with 
the accelerometer and force transducer were positioned at the appropriate dropping height 
and held in place with the aid of a flat-head screwdriver via the opening along the length of 
the drop tower guide. The screwdriver was removed, thus releasing the drop mass along with 
the accelerometer and force transducer to impact the microneedles placed on the skin model 
at the bottom of the drop tower guide. 
For this research work, five repeats of impact tests using the improved impact applicator were 
conducted on individual samples of skin for Models 1A–4B i.e. five repeats of individual 
samples of skin Model 1A or five repeats of individual samples of skin Model 2A etc. (see 
Table 9 in Section 3.2.4 for skin model classification). The acceleration and the force are 
captured on the oscilloscope as voltage–time plots, which are then converted to acceleration–
time plots and force–time plots using the sensitivities of the accelerometer and force 
transducer respectively. The acceleration–time plot is then converted to a velocity–time plot. 
3.4.1.5 Calibration of the impact applicator 
The results of tests utilising a loadcell or a force transducer is dependent on the accuracy of 
the loadcell and how it is used. A simple and accurate measure of loadcell evaluation is to 
compare the output of the loadcell against a reference mass. For the calibration tests, a mass 
of 5 kg was mounted onto the loadcell and the results captured on the PC as a force–time 
graph. Then, the second law of motion was used to work out the mass registered by the 
loadcell, which was equivalent to the mass of the known weight. 
A vibration calibrator (Bruel & Kjaer, Type 4294, Serial No. 1683419) was used to check the 
accuracy of the accelerometer. The vibration calibrator produces an acceleration of 10 ms
-2
 
equivalent to an acceleration level of 140 dB re 1 × 10
-6
 ms
-2
, at a frequency of 159 Hz (1 
radian). The accelerometer was fixed to the vibrating surface of the calibrator using beeswax. 
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The calibration signal was then used to check the measurement chain from the accelerometer 
to the display in order to confirm that it was at the correct calibration level. 
3.4.2 Clinical applicator system 
For their in vivo patient tests, Renephra used a clinical applicator for microneedle perforated 
skin. The clinical applicator was also used for some of the in vitro work presented in this 
thesis. The perforation tests using the clinical applicator was conducted at ambient 
temperature, which was ideal for maintaining the stability of the gelatine gels used in the skin 
models. The clinical applicator setup is detailed in this section. 
3.4.2.1 Clinical applicator mechanism 
A schematic of the clinical applicator, which is based on a spring and hammer-driven 
mechanism, is shown in Fig. 26. 
 
Figure 26 Diagram of Renephra’s clinical applicator. (a) Side view of the applicator. (b) top view of the 
applicator and (c) the internal components of the applicator. (Courtesy Renephra Ltd). 
In order to use the clinical applicator, the patch button shown in Fig. 25c was placed onto the 
microneedles resting on the skin model. Prior to use, the applicator was first cocked into 
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position by lifting the lever. The cocked lever returned on the spring and was ready for use. 
The applicator was then pressed onto the patch button and this triggered the hammer, which 
was launched to impact the patch button, thereby making contact with the microneedles on 
the skin model lying beneath the patch button. 
3.4.2.2 Determination of the clinical applicator force 
Although the clinical applicator has been used for in vivo patient tests by Renephra, the 
device does not measure the insertion force. Hence, in order to determine the force produced 
by the clinical applicator, the clamped skin model was fastened onto a 20 kg loadcell 
(CZL635 micro loadcell, Active Robots, Somerset, UK). The loadcell was connected to a 
data acquisition tool (i100 instruNet network device, GW Instruments, Inc., Massachusetts, 
USA). The instruNet was used to process the loadcell data output and was also connected to 
a PC setup so as to obtain the graphical output. During testing, the microneedle array was 
placed onto the skin model with the patch button placed directly onto the microneedle array. 
The clinical applicator was cocked into position and then pressed onto the patch button until 
the trigger was released. The force produced by the applicator was detected by the loadcell 
and the data captured on the instruNet/PC setup. The diagram of the clinical applicator 
system is shown in Fig. 27. 
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Figure 27 Schematic diagram of the clinical applicator setup. 
However, it was found following initial tests that the clinical applicator failed to trigger and 
launch the hammer onto the patch button on the skin model shown in Fig. 19. Therefore, the 
patch button had to be placed onto an elevated profile of the skin model. The elevated profile 
of the skin model was achieved by using double the amount of Perma-Gel
®
, as shown in Fig. 
28. The elevated profile of the skin did not influence the outcome of the interaction between 
the microneedles and skin as determined from the methylene blue and H&E stained images. 
Four repeats of clinical applicator tests were conducted on individual samples of skin for 
Models 1A–4B i.e. four repeats on individual samples of skin Model 1A or four repeats on 
individual samples of skin Model 2A etc. 
 
Figure 28 Diagram of the elevated profile of the skin model. 
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3.5   Imaging Techniques for Assessing Microneedle Perforation 
of Skin 
Various imaging techniques were used to assess the depth and extent of the deformation 
resulting from microneedle perforation of skin. This section details the specific imaging 
techniques. 
3.5.1 Visual examination and penetration efficiency calculation of 
microneedle perforated skin 
Methylene blue staining is used to detect microneedle perforations of skin. The staining of 
tissues occurs because the methylene blue dye binds itself to the proteins that are found in 
tissue (Jones et al., 2008). The image of methylene blue staining indicates successful breach 
of the stratum corneum and the creation of microchannels on skin. Typically, the 
hydrophobic nature of the stratum corneum cannot absorb the hydrophilic low molecular 
weight of the methylene blue solution, however, once the stratum corneum has been 
disrupted by microneedle assault, the methylene blue diffuses through the skin (Li et al., 
2009). 
For all experiments, a 2% weight to volume solution was prepared for methylene blue dye. 
The microneedle treated tissue was soaked in methylene blue solution for 30 mins for the 
purpose of detecting microchannels created following penetration tests. The tissue was 
removed from the methylene blue solution and the tissue surface wiped down with ethanol so 
that any microchannels were detected. Methylene blue stained skin samples were imaged 
with Nikon digital camera D5100 (Surrey, UK), as shown in Fig. 29. 
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Figure 29 Methylene blue stained images of 9 × 9 PEEK microneedle array on abdominal skin model at 67% 
gelatine gel concentration, where (a) 5 ms
-1
, (b) 4 ms
-1
 and (c) 3 ms
-1
. 
In order to determine the Penetration Efficiency (PE) from the methylene blue stained 
images, a method similar to that of van der Maaden et al. was used (van der Maaden et al., 
2014). PE can be defined as the percentage of the number of blue spots from the methylene 
blue staining of microchannels created by a microneedle array on the stratum corneum, 
divided by the total number of microneedles on the array. 
The size of the microneedle array for Design 1 microneedles was 15.8 mm in diameter and 
the density of the microneedles was 1316. Therefore, PE is given by the formula in Equation 
22. 
𝑃 𝐸 =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑙𝑢𝑒 𝑠𝑝𝑜𝑡𝑠
1316
 × 100%      Equation 22 
where 1316 represents the total number of microneedles on a 15.8 mm diameter microneedle 
disc. 
In contrast, the size of the microneedle array for Design 2 microneedles was 30.1 mm in 
diameter and the density of microneedles > 6000, therefore, it proved challenging to quantify 
PE following methylene blue staining for the entire disc. As a consequence, for quantitative 
analysis, a central region of 5 × 5 mm was cropped for each image and used for determining 
the PE. The revised formula for calculating PE is given in Equation 23. 
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𝑃 𝐸 =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑙𝑢𝑒 𝑠𝑝𝑜𝑡𝑠
193
 × 100%      Equation 23 
where 193 represents the expected number of microneedles for a 25 mm
2
 area of the sample 
given that there are 7.7 microneedles per unit mm
2
 as presented in Table 10. 
3.5.2 Histology examination of the microneedle perforated skin 
After impact testing, the tissue was prepared for cryosectioning by freezing in Optimal 
Cutting Temperature resin (Sakura Fintek Europe B.V, Alphen aan den Rijn, The 
Netherlands) and then snap frozen in super-cooled isopentane (Graham et al., 2011). The 
perforated skin was snap frozen immediately following removal of the microneedles to 
minimise skin retraction as well as maintain the sample’s integrity. The tissue was then 
sectioned to fit in a cryomold. 
For this project, a standard process used in dermatology for skin histology was used based on 
an established protocol (Watson, 2013). Histology evaluation using H&E staining was used 
to define the layers of skin and for the purpose of this study was useful in assessing the depth 
of the microchannels created and the extent of the deformation within skin. The perforated 
tissue was sectioned using a Leica CM1850 cryostat (Milton Keynes, UK). The thickness of 
the cryosections was optimised via trial and error, therefore, it was determined that a 
thickness of 12 m was appropriate. The sectioned tissue was stained with H&E using a 
standard protocol, which is summarised here: the sectioned tissue was fixed in 4% 
paraformaldehyde for 10 mins, rehydrated in distilled water for 2 mins, immersed in 
haematoxylin for 3 mins before running tap water over it for 5 mins. The glass slide was 
placed in 1% hydrochloric acid (HCl)/70% industrial methylated spirit (IMS) acid/alcohol for 
10 seconds before running tap water over it for a further 5 mins. The glass slide was then 
immersed in eosin for 1 minute, rinsed in distilled water for 1 min, rinsed in 70% IMS for 1 
min and then rinsed in 95% IMS for another minute. The sectioned tissue was rehydrated at 
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100% IMS for 4 mins, then cleared in Histo-Clear (National Diagnostics, Atlanta, GA, USA)  
and mounted in Depex mounting medium (Electron Microscopy Sciences, Washington, PA, 
USA). 
The stained tissue was imaged with a Nikon Eclipse Ci microscope (Surrey, UK). Fig. 30a 
shows the H&E staining of a section of skin that has not undergone hair removal treatment. 
The image shows an intact stratum corneum as well as epidermis and dermis. The image in 
Fig. 30b is of a section of skin that has been pre-treated with hair removal agent. The image 
also shows an intact stratum corneum as well as epidermis and dermis and therefore 
demonstrates that the tissue has borne no adverse effects from the application of the 
chemical. 
 
Figure 30 Inspection technique of the perforated tissue using H&E staining, where (a) is the untreated 
sectioned tissue showing the three histological layers of skin and (b) is the sectioned tissue already treated 
with the hair removal agent. Scale bar represents 100 m. 
Throughout this thesis, the following colour coded arrows on the H&E stained images shown 
in Fig. 31 have been used to denote the disruptions through the stratum corneum, epidermis 
and dermis.  
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Figure 31 Labelling of the H&E stained images, where (a) blue arrow indicates disruption to the stratum 
corneum, (b) red arrow indicates that the breach is contained within the epidermis, (c) black arrow 
indicates that breach has extended into the dermis and (d) key describing the colour coded arrows. Scale 
bar represents 100 m. 
The improvements on the conventional methods of measurement from histological images 
are to utilise a custom image analysis routine for determining breach area. 
3.5.3 Quantitative image analysis using Image SXM software 
A custom routine was written in Image SXM (Heilbronner and Barrett, 2014) for semi-
automated analysis of the histology images to determine the breach area within the skin 
following microneedle application. The optical microscopy images were found to vary in 
contrast, brightness and colour balance and hence a histogram of pixel values was used to 
determine the optimum threshold in order to highlight the pixels above the epidermal layer. 
For images in which the epidermal layer had not been breached, it was found that combining 
the red and blue colour channels of the images produced the most reliable discrimination of 
the edge of the epidermal layer. For images in which the epidermal layer was breached, it was 
found that the green channel gave the most reliable discrimination. Automatic detection of a 
breach was not possible with the routine; hence the most appropriate mode was selected for 
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each image. Only those images in which the epidermal layer was clearly discriminated from 
the rest of the image could be analysed to determine the breach area. For these images, the 
extent of the microneedle puncture was marked by clicking on the two points (Fig. 32a) that 
delineate the puncture at the upper surface of the epidermal layer (Fig. 32b). The area of the 
puncture was measured and logged (Fig. 32c). Subsequently, the next image was loaded and 
displayed ready for user input. 
 
Figure 32 Quantitative image analysis results using ImageSXM of back skin model. (a) Grayscale of 
histology image. (b) Red pixel saturation of the histology image. (c) Quantification of the breach area. 
Scale bar represents 100 m. 
Over 500 images were analysed for the quantification of the breach areas, as more than 30 
images of impact tests with the Design 2 microneedles on eight skin models i.e. Models 1A–
4B selected at random were assessed. Additionally, more than 30 images of Design 1 
microneedles penetration of Model 3B selected at random were analysed. 
3.5.3.1 Assessment of microneedle perforation depth 
ImageJ (Version 1.48, National Institutes of Health) (Abramoff et al., 2004) was used to 
assess the perforation depth of the histology image as shown in Figs 33a and 33b. Similarly, 
approximately 30 images of impact tests with Design 2 microneedles on eight skin models 
i.e. Models 1A–4B and Design 1 microneedles on Model 3B selected at random were 
assessed. The user-defined line was drawn from the stratum corneum to the maximum point 
of penetration in the skin, which was either located within the epidermis or the dermis. 
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Figure 33 Image analysis results of the perforation depth of Model 3B using ImageJ for impact tests with 
(a) Design 2 microneedles and (b) Design 1 microneedles. Scale bar represents 100 m.  
3.5.3.2 Breach area classification 
To better analyse the outcome of the image analysis, the breach areas were placed into three 
groups comprising 0 < breach area < 10 000 m2, which indicates that the perforation has 
travelled through the stratum corneum and just interfaces with the epidermis; 10 000 < breach 
area < 20 000 m2, which indicates that there is a significant level of deformation within the 
epidermis and 20 000 < breach area < 50 000 m2, which indicates that the perforation has 
gone beyond the epidermis into the dermis. Examples of the three groups have been 
illustrated in Fig. 34. The breach area was measured in the way specified in order to 
determine the extent of the perforation and if the perforation varied due to contributions from 
gelatine gels with its different stiffness. 
 
Figure 34 The H&E images illustrate breach area groupings. The area shaded in black represents the 
breach area size, where (a) 0 < breach area < 10 000 m2 small deformation within the epidermis (b) 10 
000 < breach area < 20 000 m2 large deformation within the epidermis and (c) 20 000 < breach area < 50 
000 m2 deformation within the dermis. Scale bar represents 100 m. 
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As stated in the literature review regarding the histology process being time consuming, 
labour intensive and resulting in slight inaccuracies of the measurements of the 
microchannels due to skin retraction caused by the removal of the microneedles before 
staining (Donnelly et al., 2010; Loizidou et al., 2016), using 3D imaging techniques could 
lead to improved accuracies of measuring the deformations in microneedle treated skin. 
Furthermore, the microneedles could be imaged with the skin in situ. 
3.6   Statistical Analysis 
Statistical analysis for the determination of differences in the measured properties between 
and within groups was accomplished using a single factor analysis of variance (ANOVA) 
utilising Microsoft Excel Data Analysis ToolPak. 
All data were presented as a mean value with its standard deviation indicated (Mean ± SD). 
For all the tests in this thesis, the following notations for probability were used: 
p > 0.05 – not significant (ns) 
p ≤ 0.05 – statistically significant (*) 
p ≤ 0.01 – statistically significant (**) 
p ≤ 0.001 – statistically significant (***) 
p ≤ 0.0001 – statistically significant (****) 
3.7   Summary 
The chapter has detailed the experimental approach for determining the biomechanical 
interaction between skin and microneedles. This was based on the outcome of the literature 
review, which described neonatal porcine skin as an ideal substitute for human skin and for 
its close biomechanical properties to human skin. It also demonstrated the significance of a 
representative underlying substrate in the skin model. Moreover, it highlighted the 
importance of tissue preservation in maintaining the integrity of the sample, as this could 
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influence the outcome of the experimental analysis. For microneedle application studies of 
skin, the challenge to effective microneedle penetration is to bypass the inherent elasticity of 
the stratum corneum. Previous studies indicated that insertion velocity and insertion force 
influence perforation of the stratum corneum with microneedles. Furthermore, the 
introduction of microneedles in skin to any depth requires the assistance of external pressure 
using a microneedle delivery apparatus.  
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Chapter 4 
4. Results 
4.1   Introduction 
In this chapter, the results from all the experimental work will be presented. In Section 4.2, 
the results obtained from the dynamic nanoindentation tests to determine the mechanical 
properties of each of the different layers that make up the in vitro skin model are presented. 
In Section 4.3, the results obtained from the preliminary studies of microneedles on skin 
using the impact applicator during the early stage of its development are detailed. In Section 
4.4, data obtained using the fully developed impact applicator on the in vitro skin models are 
presented. Results from studies using clinical applicator on in vitro skin models are presented 
in Section 4.5. The section concludes with a comparison between the performance of the 
impact and clinical applicators (Section 4.6). 
4.2   Micromechanical Characterisation of Skin’s Sub-layers 
The outcome of indentation tests on abdominal skin, back skin, 67%, 80%, 88% gelatine gels 
and Perma-Gel
®
 are presented in this section. 
4.2.1 Indentation tests on abdominal and back skin samples 
Fig. 35 shows the storage modulus, loss modulus and loss factor for abdominal and back skin 
samples following 38 successful indentations. It was found that for the abdominal skin 
samples, the loss modulus (G˝) dominates over the storage modulus (G´). In contrast, for 
back skin, the storage modulus dominates over the loss modulus (Fig. 35b). Back skin 
exhibited a much higher elastic modulus component compared to abdominal skin. For the 
viscous component, back skin was higher than abdominal skin. Abdominal skin was found to 
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have a higher damping capacity, as determined from the loss factor in Fig. 35c. The storage 
and loss factor results were statistically significant, whilst there was no statistically 
significant difference between the samples for the loss modulus. 
 
Figure 35 Micromechanical properties of neonatal porcine abdominal and back skin, with the number of 
indentations (n) listed above each bar chart. (a) Storage modulus, G´ (b) loss modulus, G˝ and (c) loss 
factor. Error bars depict SD. 
As shown in Fig. 36, the back skin samples (45.89 ± 9.61 kPa), produced a higher elastic 
modulus compared to the abdominal skin samples (24.49 ± 5.47 kPa). The variation between 
groups for abdominal and back skin groups was found to be statistically significant. 
**** 
ns 
**** 
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Figure 36 Elastic modulus of neonatal porcine abdominal and back skin following micromechanical tests, 
with the number of indentations (n) listed above each bar chart. Error bars depict SD. 
4.2.2 Indentation tests on gelatine gel samples 
Fig. 37 presents the mechanical properties for each of the gelatine gels following 40 
successful indentations. The storage modulus (G´) dominates over the loss modulus (G˝) for 
each of the gelatine gels (Figs 37a & 37b). The gelatine gel with the lowest water content 
(67%) had the highest elastic component, whilst the gelatine gel with the highest water 
content (88%) had the lowest elastic component. Similarly, the gelatine gel with the lowest 
water content (67%) had the highest viscous component, whilst the gelatine gel with the 
highest water content (88%) had the lowest viscous component. The gelatine gel at 88% 
concentration was found to have the highest damping capacity, as determined from the loss 
factor in Fig. 37c. Unfortunately, it was challenging conducting tests on 96% gelatine gel 
concentration because of the high water content in the gel. The gel was too compliant to test 
with the indenter and thus produced spurious results. Hence, no data for this gel concentration 
were obtained. The storage modulus, loss modulus and loss factor between groups for the 
gelatine gels was statistically significant. 
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Figure 37 Micromechanical properties of gelatine gels for 67%, 80% and 88% water content, with the 
number of indentations (n) listed above each bar chart. (a) Storage modulus, G´ (b) loss modulus, G˝ and 
(c) loss factor. Error bars depict SD. 
Fig. 38 shows the elastic modulus for the gelatine gels. The comparison between repetitions 
showed close agreement for each of the samples of the different gelatine gels. Predictably, the 
gelatine gel with the highest water content (88%) had the lowest elastic modulus. The 
variation between groups for gelatine gels was found to be statistically significant. 
**** 
**** 
**** 
92 
  
  
Figure 38 Elastic modulus of the different gelatine gels following micromechanical tests, with the number 
of indentations (n) listed above each bar chart. Error bars depict SD. 
Fig. 39 presents an image of the residual impression in the gelatine gel following indentation. 
These appear to be more pronounced in the gelatine gel with 67% water content. 
 
Figure 39 Optical images showing the residual impression left visible in the gelatine gels following 
indentation with water content of (a) 67%, (b) 80% and (c) 88%. 
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4.2.3 Indentation tests on Perma-Gel
®
 samples 
Fig. 40 presents the mechanical properties determined for Perma-Gel
®
. Similar to the gelatine 
gels, the storage modulus (G´) dominates over the loss modulus (G˝). Perma-Gel® exhibited a 
higher elastic component compared to its viscous component. The damping capacity was 
determined from the loss factor in Fig. 40c. 
 
Figure 40 Micromechanical properties of Perma-Gel
®
, with the number of indentations (n) listed above 
each bar chart. (a) Storage modulus, G´, (b) loss modulus, G˝ and (c) loss factor. Error bars depict SD. 
The data obtained from a typical indentation experiment on Perma-Gel
®
 are shown in Fig. 41. 
The comparison between repetitions showed close agreement for each of the samples used in 
the indentation tests. 
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Figure 41 Elastic modulus of Perma-Gel
® following micromechanical tests, with the number of 
indentations (n) listed above the bar chart. Error bar depicts SD. 
Fig. 42 shows an optical image of a sample of Perma-Gel
®
 following indentation tests and 
unlike the gelatine gels no residual impression was observed under the optical microscope. 
 
Figure 42 Optical image of Perma-Gel
®
 following indentation test. 
4.2.4 Summary of the micromechanical properties of the sub-layers of the 
skin model 
The summary of the average micromechanical properties of four individual samples of 
abdominal skin, back skin, three different gelatine gels of varying water content and Perma-
Gel
®
 is presented in Table 12. Of all the sub-layers in the skin model, it was found that 
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Perma-Gel
®
 had the highest elastic component, whilst the 88% gelatine gel had the lowest 
elastic component. Back skin had the highest viscous component, whilst 88% gelatine gel had 
the lowest viscous component. Abdominal skin exhibited the highest damping capacity, 
whilst Perma-Gel
®
 had the lowest damping capacity. 
Table 12 Micromechanical properties of the different layers of the skin model (Mean ± SD). 
Material 
 
Storage 
Modulus  
(kPa) 
 
 
Loss Modulus 
(kPa) 
Loss Factor 
 
Elastic 
Modulus  
(kPa) 
 
 
Abdominal skin 
 
8.16 ± 1.82 9.96 ± 3.88 1.11 ± 0.26 24.49 ± 5.47 
 
Back skin 
 
15.3 ± 3.20 10.71 ± 2.74 0.70 ± 0.06 45.89 ± 9.61 
 
67% (w/v) gel 
 
21.04 ± 2.08 3.77 ± 0.24 0.18 ± 0.01 63.11 ± 6.23 
 
80% (w/v) gel 
 
11.52 ± 1.05 2.01 ± 0.16 0.17 ± 0.01 34.56 ± 3.16 
 
88% (w/v) gel 
 
3.77 ± 0.55 0.94 ± 0.23 0.26 ± 0.07 11.30 ± 1.64 
 
Perma-Gel
®
 
 
26.91 ± 0.89 2.66 ± 0.81 0.10 ± 0.02 80.73 ± 2.67 
 
An increase in water content in the gelatine gels resulted in a subsequent reduction in the 
magnitude of the respective elastic modulus, which is depicted in a linear relationship shown 
in Fig. 43. G´ and G˝ both decreased with increasing water content. The damping factor also 
decreased with increasing water content. Interestingly, the normal tissue fluid mimic (67%) 
had higher mechanical properties compared to either abdominal or back skin.  
96 
  
 
Figure 43 Linear relationship between elastic modulus and gel water content following micromechanical 
tests. Error bars depict SD.  
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4.3   Development of the Impact Applicator 
This section details the preliminary tests using the impact applicator. Initially tests were 
performed to determine the relationship between force and velocity and afterwards further 
tests were conducted using microneedles. 
4.3.1 Preliminary tests using the impact applicator 
Prior to conducting impact tests on the full skin model, impact tests were performed on 
Perma-Gel
®
 only and on microneedles resting on Perma-Gel
®
 in order to establish the 
relationship between force and velocity in relation to how a material or combination of 
materials responds to impact load and the velocity at which the load is introduced to it. 
Several impact tests were carried out on Perma-Gel
®
 block at five different velocities 
calculated from dropping heights (see Table 11) using three different aluminium drop masses 
weighing 36 g, 17 g and 7 g. The trends for the three different drop masses are shown in Fig. 
44. A linear relationship between velocity and force for each of the three drop masses was 
observed, as the velocity increased, the force increased. 
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Figure 44 Linear plots of velocity as a function of force for impact tests of Perma-Gel
®
 using various drop 
masses, (a) 36 g (b) 17 g and (c) 7g. 
Additional testing was conducted by placing Design 1 microneedles on Perma-Gel
®
. Fig. 45 
shows the relationship between velocity and force. The linear relationship shows that as 
velocity increases, the force also increases. Furthermore, more than twice the force was 
observed for impact tests of microneedles on Perma-Gel
®
 as compared to on Perma-Gel
®
 
only. 
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Figure 45 Linear plots of velocity as a function of force for impact tests with Design 1 microneedles on 
clamped Perma-Gel
®
 using various drop masses weighing, (a) 36 g (b) 17 g and (c) 7g. 
4.3.2 Skin penetration tests using PEEK microneedles 
A pilot study of impact tests using the impact applicator on full thickness skin on different 
gelatine gels was carried out using PEEK microneedles, which have been used for in vivo 
studies on patients and the results are detailed in this section. Visual examination of the 
microneedles was performed in order to determine how often the microneedles could be used 
for impact tests on the skin models. 
4.3.2.1 SEM imaging of PEEK microneedles following multiple applications 
SEM imaging of PEEK microneedles were taken before and after they were applied to the 
skin and the images are presented in Fig. 46. The images show the profile of the needle tips. 
The figure also shows that the uneven profile of the microneedles was consistent for both 
images, indicating no change of shape to the tip and surrounding areas. The microneedles 
remained intact after impact tests on tissue and therefore were suitable for repeated use. 
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Figure 46 Comparison of SEM images for PEEK microneedles before and after impact tests. (a) before 
test and (b) after five applications. 
4.3.2.2 The effects of differences in skin properties 
The structural difference between the two skin regions examined is that abdominal tissue is 
thinner (0.79 ± 0.21 mm) as compared to tissue from the back region (2.73 ± 0.35 mm). Fig. 
47 presents the methylene blue stains of microchannels created in abdominal and back skin 
models at various gelatine gel concentrations. There appears to be greater damage to back 
skin as compared to abdominal skin. 
 
Figure 47 Methylene blue stained images of microchannels created by PEEK microneedles at a velocity of 
5 ms
-1
 on abdominal skin model, where (a) 67%, (b) 80%, (c) 88%, (d) 96% gel water content and back 
skin model, where (e) 67%, (f) 80%, (g) 88%, (h) 96% gel water content. 
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4.3.2.3 Contributions from the subcutaneous mimic 
Fig. 48 shows that the intensity of the methylene blue stain appears to increase with 
increasing water content in the gelatine gels. Fig. 48e also shows a significant reduction in 
the number of perforations on the stratum corneum, where there was an absence of a bed of 
gelatine gel to act as underlying substrate. 
 
Figure 48 Methylene blue stained images of the microchannels created by PEEK microneedles on 
abdominal skin model comprising different amounts of water content in its gelatine gels at a velocity of 5 
ms
-1
, where (a) 67%, (b) 80%, (c) 88%, (d) 96% and (e) no gelatine gel as an underlying substrate. 
Again, it was noted that for back skin, the quality of penetration appeared to improve with 
increasing water content in the gelatine gels (see Fig. 49). At 88% gelatine gel concentration 
however, no penetration was observed due to tissue damage, as shown in Fig. 49c. It was 
unclear, if the tissue damage was due to the impact of the microneedles or caused by existing 
bruising on the skin. 
102 
  
 
Figure 49 Methylene blue stained images of the microchannels created by PEEK microneedles on back 
skin model comprising different amounts of water content in its gelatine gels at a velocity of 5 ms
-1
, where 
(a) 67%, (b) 80%, (c) 88% and (d) 96%. 
Representative histology images of back skin model at 88% gelatine gel water content are 
shown in Fig. 50. Most of the perforations are contained within the epidermis, with the 
disruption extending into the dermis for two of the images. Although, successful breach of 
the epidermis occurred with PEEK microneedles for back skin model, it was challenging to 
consistently reproduce these perforations. 
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Figure 50 H&E images of back skin model with 88% water content in its gelatine gel at a velocity of 5 ms
-
1
. Red arrows indicate that the breach is contained within the epidermis and the black arrows indicate 
that the breach has extended into the dermis. Scale bar represents 100 m. 
4.3.2.4 Impact velocity 
No penetration was achieved on the back skin model with 67% water content gelatine gel at 
velocities of 1–3 ms-1 following methylene blue staining. At velocities of 4–5 ms-1, however 
there was perforation. For the abdominal skin model containing 67% water content in its 
gelatine gel, penetration was achieved at velocities of between 3–5 ms-1. It was noted that 
even when the microneedle remained in tissue for two minutes following impact, it had no 
bearing on the quality of penetration. 
4.3.3 Summary of the development of the impact applicator 
Microneedle application on skin was achieved using an early development impact applicator. 
The parameters for penetration were a drop mass of 36 g, 3–5 ms-1 velocity on abdominal 
skin models and 4–5 ms-1 velocity on back skin models. The challenges with reproducible 
back skin perforations using PEEK microneedles meant that a different design of polymer 
microneedles were utilised for the work with the improved impact applicator.  
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4.4   Impact Applicator Studies 
Reproducibly perforating the stratum corneum, epidermis and dermis was challenging with 
PEEK microneedles and therefore they were not used for further tests in this thesis to 
evaluate microneedles interaction with skin. The results however did provide velocity and 
force parameters, which were used as a basis for subsequent tests involving skin Models 1A–
4B (see Table 9 in Section 3.2.4 for skin model classification) and PMMA microneedles (see 
Table 10 in Section 3.3.2 for PMMA microneedles details). Both designs of PMMA 
microneedles were medical grade. 
Design 1 and 2 microneedles have been used for in vivo tests with patients (Renephra, 2015) 
and were the microneedles used for the bulk of the work carried out in this thesis. Moreover, 
Renephra conducted in vivo studies using these PMMA microneedles and the results from 
this thesis would complement and enhance their work, as the in vitro tests could be performed 
indiscriminately on neonatal porcine skin. Visual examination using SEM imaging was 
carried out on Design 2 microneedles in order to determine the frequency of use during 
testing. These tests were only conducted on Design 2 microneedles and not on Design 1 
microneedles since the former arrays were used more extensively in testing. Furthermore, 
Design 2 microneedles were also used by Renephra for most of the clinical studies. 
4.4.1 Visual examination of Design 2 microneedles using SEM imaging 
SEM images of the Design 2 microneedles are shown in Fig. 51. With these microneedles it 
was found that with a single impact test on tissue, the needle tips had deformed (Fig. 51b). 
When five tests were carried out using the same microneedle array on five different skin 
models, the tips had broken off in some rows of needles as shown in Fig. 51c. To standardise 
testing as far as possible, Design 1 and 2 microneedles were only used once. 
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Figure 51  Comparison of SEM images for Design 2 PMMA microneedles before and after impact tests. 
(a) before test, (b) after single application and (c) after five applications. 
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4.4.2 Penetration efficiency 
The images in Fig. 52 and 53 illustrate the effects of varying the water content in gelatine 
gels in the abdominal and back skin models respectively. It would appear that majority of the 
microneedles on the array created microchannels in each skin model. In addition, Fig. 52a–d 
appears to show that the intensity of methylene blue dye reduced with increasing water 
content in the gelatine gels. 
 
Figure 52 Inspection technique of impact applicator tests on Models 1A–4A for penetration efficiency 
with methylene blue staining where the whole disc provides visual confirmation of penetration and the 
cropped image, which is the selection highlighted in red is 5 × 5 mm in size and was used for calculating 
penetration efficiency for (a) 67%, (b) 80%, (c) 88% and (d) 96% of water content in the gelatine gels. 
The diameter of the microneedle disc is 30.1 mm. 
Fig. 53a–d also appears to show that majority of the microneedles on the disc caused 
perforations on the stratum corneum. Although by comparing Figs 52 and 53, it is observed 
that there appears to be more perforations on abdominal skin models (Models 1A–4A) as 
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compared to back skin models (Models 1B–4B). It should also be noted that there is a 
physiological difference between abdominal and back skin, as full thickness abdominal tissue 
(≈ 0.79 mm) is thinner as compared to full thickness back tissue (≈ 2.43 mm). For human 
abdominal skin, the thickness varies from 1.71 ± 0.27 mm in children to 2.15 ± 0.42 mm in 
adults (Lo Presti et al., 2012), which is similar to the thickness of neonatal porcine back skin. 
 
Figure 53 Inspection technique of impact applicator tests on Models 1B–4B for penetration efficiency 
with methylene blue staining where the whole disc provides visual confirmation of penetration and the 
cropped image, which is the selection highlighted in red is 5 × 5 mm in size and was used for calculating 
penetration efficiency for (a) 67%, (b) 80%, (c) 88% and (d) 96% of water content in the gelatine gels. 
The diameter of the microneedle disc is 30.1 mm. 
Again, visual quantification of the entire methylene blue stained image was challenging using 
imaging software, which was due to the densely populated number of individual 
microneedles on Design 2 (> 6000 on array). The cropped area of 5 × 5 mm were selected 
from the centre of the images (Figs 52 & 53) and assessed to determine penetration efficiency 
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for abdominal and back skin models. The results of the penetration efficiency are presented in 
Fig. 54. As expected, 100 % penetration efficiency was not achieved (van der Maaden et al., 
2014). There was no significant difference between abdominal and back skin samples. 
 
Figure 54 Penetration efficiency determined from the methylene blue images for impact applicator tests 
on 3 samples each of Models 1A–4B. Error bars depict SD. 
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4.4.3 The effects of differences in skin properties 
Although the methylene blue staining provided quick visual confirmation that the majority of 
the microneedles had successfully penetrated the stratum corneum, the H&E images provided 
additional details in terms of the deformation extent. In addition, the H&E images also 
showed that not all perforations observed actually propagated through the stratum corneum to 
the epidermis or dermis. The H&E images in Fig. 55a–b show that both the abdominal and 
back tissue respond in a similar way to microneedle application with the deformation 
extending into the epidermis. However, the deformation in Models 1A & 2A was observed 
deep in the layers, whilst the deformation within Models 1B & 2B was predominantly 
contained within the epidermis. Fig. 55c shows the comparison between Models 3A and 3B, 
which is 88% water content in the gelatine gels. At this gelatine gel concentration, there 
appears to be a more significant deformation through the layers for Model 3A as compared to 
Model 3B. The comparison between Models 4A & 4B, which is depicted in Fig. 55d shows 
that the abdominal and back tissue exhibited a similar response to microneedle application as 
significant deformations were observed through the skin, extending into the dermis. 
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Figure 55 Comparison of perforation depths (H&E staining) using the impact applicator for abdominal 
and back skin models with respect to altering the water content in gelatine gels. Red arrows indicate that 
the breach is contained within the epidermis and the black arrows indicate that the breach has extended 
into the dermis. Scale bar represents 100 m and the diameter of Design 2 microneedle disc is 30.1 mm.  
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4.4.4 The role of the subcutaneous mimic property on microneedle 
performance 
The depth of penetration for each of the skin models is shown in Fig. 56. For Models 1A–4A 
(Fig. 56a), the depth of penetration increased with gel water content (from Models 1A to 3A) 
but was lowest for Model 4A at its highest gel water content. For the back skin models, the 
depth of penetration was lower at each gel concentration relative to the abdominal skin 
models except for Model 4B. The values for Model 3B with 88% gel water content were 
lower following the trends observed with qualitative assessment of the H&E images 
mentioned in Section 4.4.3 and insertion force data in Section 4.4.6. 
Generally, the perforation depth for abdominal skin models was marginally greater than back 
skin models as shown in Fig. 56, with Model 4A the exception. For the mean breach areas in 
Fig. 57 however, there was no evident trend between abdominal and back skin models. 
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Figure 56 Perforation depth data for impact applicator tests using 36 g drop mass at a velocity of 3 ms
-1
, 
where (a) abdominal skin models and (b) back skin models, with the number of images (n) in each group 
listed above each box and whisker plot. 
The overall trends in the breach area for Models 1A–4B are shown in Fig. 57 and are similar 
to those for penetration depth (shown in Fig. 56). In Fig. 57a, the mean breach area for 
Models 1A–4A increased with gel water content but reduced for Model 4A at its highest gel 
water content. In Fig. 57b, the mean breach area for Models 1B–4B, the depth of penetration 
was slightly higher at each gel concentration relative to the abdominal skin models except for 
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Model 4B. The values for Model 3B with 88% gel water content were much lower following 
the trends observed with the insertion force data. There appears to be a relationship between 
perforation depth and breach area as indicated, with the mean trends being similar for 
perforation depth (Fig. 56) and breach area (Fig. 57). 
  
 
Figure 57 Breach area data for impact applicator tests using 36 g drop mass at a velocity of 3 ms
-1
, where 
(a) abdominal skin models and (b) back skin models, with the number of images (n) in each group listed 
above each box and whisker plot. 
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For the abdominal skin models, over 60% of the measured perforations were 0 < breach area 
< 10 000 m2 for Model 1A, which is the model with the lowest water content gel (Fig. 58a). 
There was over 70% for Model 3B in this category, which had a higher water content gel 
(Fig. 58b). The frequency of the breach area reduced at > 10 000 m2 for all skin models, 
Therefore, the majority of microneedles interaction with skin occurs at the stratum corneum–
epidermal interface (as defined in Section 3.5.3.2). A contrast between abdominal skin model 
compared to back skin model was that perforations occurred in each breach area category, 
whilst there was no breach areas observed in some categories for back skin model. Generally, 
as epidermal breach occurs at 10 000 < breach area < 20 000 m2 (as previously described in 
Section 3.5.3.2), therefore, it can be said that both anatomical regions appear to be ideal sites 
for microneedle application for fluid extraction on neonatal porcine skin, whilst the breach 
areas in excess of 10 000 m2 could indicate penetration effectiveness. 
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Figure 58 Frequency distribution of the breach area for impact applicator tests on (a) abdominal skin 
models and (b) back skin models. 
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4.4.5 Impact applicator force and velocity 
As mentioned in the literature, the introduction of microneedles in biological tissue to any 
depth requires the assistance of external pressure to penetrate skin. This required assistance 
can be achieved using a microneedle delivery apparatus. Work by Bouwstra et al. suggests 
that the optimal method for microneedle application requires velocities in excess of 2 ms
-1
 
(Bouwstra et al., 2009). Firstly, the challenge to effective microneedle penetration is to 
bypass the inherent elasticity of the stratum corneum (Bal et al., 2008). Secondly, the 
appropriate insertion velocity and insertion force to achieve penetration of the stratum 
corneum with microneedles is necessary (Donnelly et al., 2011). 
Typical force and velocity plots obtained with Design 2 microneedles are shown in Fig. 59. 
Due to the high velocity from the impact test setup, it was difficult to precisely determine the 
exact moment that the microneedles penetrated through the skin. However, due to the 
characteristics of the plots shown in Fig. 59a and 59b, the insertion force and insertion 
velocity could be inferred. 
The insertion force, which was 37.1 N and the insertion velocity, which was 2.5 ms
-1
 were 
obtained from the force–time see Fig. 59a. The maximum force reached was 107 N. 
Accounting for some elastic recovery of skin and to ensure that the microneedles were fully 
embedded in the skin (Lara et al., 2012), the microneedles were left in the skin for 
approximately 2 mins prior to removal for subsequent imaging, so as to minimise skin 
retraction following removal of microneedles (Donnelly et al., 2010; Loizidou et al., 2016). 
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Figure 59 Impact tests of Design 2 microneedles on Model 2B, where (a) force–time plot and (b) the 
description of points along the force–time curve. The impact occurred at 0.9 ms, where the velocity was 
approximately 2.5 ms
-1
, the force was 37.1 N and the maximum force reached was 107 N. The data 
suggest that the initial insertion occurred at 0.9 ms. Hence, at this point the velocity was approximately 
2.5 ms
-1
, the force was 37.1 N and the maximum velocity and force reached were 3 ms
-1
 and 107 N 
respectively. In the absence of any microneedles, a smooth force-time plot up to the maximum load would 
be expected for a drop mass impacting on a tissue sample (Burgin and Aspden, 2007). 
The insertion force which was inferred from the force-time plots (Fig. 59a) did not vary with 
gel water content for the skin models, but was approximately 10 N higher for most of the 
back skin models as compared to the abdominal skin models (Fig. 60a). Fig. 60b shows the 
variation of the maximum force across the different abdominal skin models and as can be 
seen decreased progressively with increasing water content of the subcutaneous mimic. This 
was found to be related to the elastic modulus of these gels (Fig. 60c). For back skin models, 
the maximum force was relatively constant for most of the gel water content except for 
Model 3B, which contained 88% gel water content (Model 1B/67% - 102 N, Model 2B/80% - 
100 N, Model 3B/88% - 46 N, Model 4B/96% - 102 N). Furthermore, histological 
examinations of perforation depths and breach area also showed a small depth and area for 
Model 3B as compared to Models 1B, 2B and 4B, which indicate that the size of the force is 
commensurate with the size of the deformation. For Models 1A and 1B, which contained 
67% gel water content, there was no difference in the maximum force with the two different 
types of skin i.e. the thicker and stiffer back skin did not require a larger insertion force. The 
difference in the force values for the two different anatomical skin models was more 
pronounced at higher water contents in the subcutaneous mimic. 
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Figure 60 Force data for impact applicator tests, where n = 5 for each skin model (a) insertion force data 
for abdominal and back skin models, (b) variation of the maximum force as a function of gel water 
content in abdominal skin Models 1A–4A and (c) maximum force for Models 1A–4A vs elastic modulus of 
the gelatine gels. Error bars depict SD. 
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4.4.6 The effects of microneedle geometry on skin penetration 
Neonatal porcine back skin bears similar thickness to human skin (Lo Presti et al., 2012) as 
compared to abdominal skin. Further, neonatal porcine back skin has similar mechanical 
properties to human skin (Groves, 2011) and was chosen for tests involving the two designs 
of PMMA microneedles. A high water content gel was selected for all the tests comparing the 
two microneedle designs on back skin. This was because of the relevance to oedema to this 
project (Section 1.2). Hence, the 88% gelatine gel was selected as the 96% gelatine gel was 
too compliant. Thus, skin Model 3B was used for these tests. This section compares impact 
applicator tests for Design 1 (1316 microneedles on the array/356 m length) with Design 2 
(> 6000 microneedles on the array/552 m length) microneedles using this model. 
4.4.6.1 Microneedle penetration on skin Model 3B 
This section details the results of impact tests using Design 1 and Design 2 microneedles on 
skin Model 3B. 
4.4.6.1.1 Comparison between visual examination and perforation depth 
Representative methylene blue and histology images of impact applicator tests on Model 3B 
using Design 1 and 2 microneedles are presented in Fig. 61. As shown in Figs 61a–b, the 
methylene blue staining confirmed the successful perforation of the stratum corneum, whilst 
the histology showed the depth of perforation through the layers. In Fig. 61a, image analysis 
using ImageJ showed that 80% of Design 2 microneedles perforated the stratum corneum of 
Model 3B compared to 55% of Design 1 microneedles in Fig. 61b. The H&E images show 
comparable levels of deformation within the layers. 
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Figure 61 Design 1 and 2 microneedles comparison on perforation quality (methylene blue staining) and 
perforation depth (H&E staining) for impact applicator tests on Model 3B. (a) Design 2 (b) Design 1. The 
diameter of Design 2 microneedle disc is 30.1 mm. The diameter of Design 1 microneedle disc is 15.8 mm. 
Red arrows indicate that the breach is contained within the epidermis. Scale bar represents 100 m. 
The depth of penetration in Model 3B for Design 1 and 2 microneedles is shown in Fig. 62. 
The greatest perforation depth was 351 m for Design 1 microneedles as compared to 288 
m for Design 2 microneedles. In addition, the mean penetration depth is greater for Design 1 
microneedles as compared to Design 2 microneedles. 
  
Figure 62 Perforation depth data for impact applicator tests comparing results of Design 1 and 2 
microneedles on Model 3B, with the number of images (n) in each group listed above each box and 
whisker plot. 
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4.4.6.1.2 Histological examination of breach area 
The results of the breach area on model 3B for Design 1 and 2 microneedles are shown in 
Fig. 63. The percentage frequency of perforations shows that the highest number of 
perforations occurred between 0 < breach area < 10 000 m2 range and the lowest number of 
perforations occurred between 40 000 < breach area < 50 000 m2 range. The frequency chart 
shows that there is a decline in the frequency of perforations at increased breach area. The 
chart also highlighted a higher proportion of breach area (10 000 m2) for Design 2 
microneedles as compared to Design 1 microneedles. 
The general trend for the frequency distribution of deformation within Model 3B, showed 
that Design 2 microneedles produced the greatest deformation area at 0 < breach area < 10 
000 m2, however, at categories > 10 000 m2, Design 1 microneedles created greater breach 
areas. 
 
Figure 63 Frequency distribution for impact tests at 3 ms
-1
 using a 36 g drop mass on Design 1 and 2 
microneedles on Model 3B. 
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4.4.6.2 Impact force and velocity for skin Model 3B 
This section presents the force and velocity outcome of Design 1 microneedles on skin Model 
3B. Later in the section, the force and velocity outputs are compared to the results of Design 
2 microneedles. 
4.4.6.2.1 Variation of the velocity and force 
Penetration of the stratum corneum was assessed qualitatively from the methylene blue 
images shown in Fig. 64. Following visual examination, a greater concentration of 
methylene blue dye was observed on Model 3B after the application of Design 1 
microneedles using 36 g and 17 g drop masses at velocities of 5 and 4 ms
-1
. At 3 ms
-1
, a 
significant proportion of the microneedles penetrated the stratum corneum with the 36 g 
drop mass shown in Fig. 64a. However, at the same velocity penetration appeared lower 
with the 17 g drop mass shown in Fig. 64b. At 2 ms
-1
, the intensity of methylene blue 
staining was further reduced with the 36 g drop mass shown in Fig. 64a but minimal 
staining was observed at this velocity with the 17 g drop mass shown in Fig. 64b. These 
images demonstrated that the microneedle arrays successfully perforated Model 3B at 
velocities ≥ 3 ms-1 with the highest drop mass used in this study, which could be useful 
details in the development of Renephra’s applicator. The quality of penetration in terms of 
perforations on the stratum corneum and intensity of the methylene blue dye decreased with 
the lower drop mass weights. 
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Figure 64 Example images of methylene blue stained skin model 3B following impact tests at various 
velocities with (a) 36 g drop mass (b) 17 g drop mass. Diameter of Design 1 microneedle disc is 15.8 mm. 
Microneedles are designed to effectively penetrate the stratum corneum without causing any 
damage to the dermal layer (Kim et al., 2012). Hence, histological staining was used to 
examine the penetration profile, complementing the methylene blue assessment. In some 
cases, only minute breaches in the epidermal layer were found as shown in Fig. 65. 
Although under all the tested parameters some damage to the stratum corneum layer was 
consistent and repeatable, epidermal breach (illustrated in Fig. 30) was not consistent when 
the velocity was < 3 ms
-1
 or with drop masses 7 g and 17 g. 
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Figure 65 Histology images of skin following microneedle application at a constant velocity (2 ms
-1
), using 
Design 1 microneedles under various loads (a) 36 g (b) 17 g (c) 7 g. Blue arrows indicate disruption to the 
stratum corneum and the red arrows indicate that the breach is within the epidermis. Scale bar 
represents 100 m. 
A comparison between the methylene blue and histology images are shown in Fig. 66. By 
comparing the methylene blue stained images in Figs 66a and 66d and the histological 
cross-sections in Figs 66b–c and 66e–f, a more holistic insight into the interaction between 
microneedles and skin was obtained. The methylene blue stains confirmed successful 
perforation of the stratum corneum with a sizeable quantity of microneedles at 2 ms
-1
 using 
the 36 g drop mass (Fig 66d). The histology images however in Figs 66e–f showed that 
there was minimal disruption to the stratum corneum. In contrast, there was substantial 
breach to the epidermal layer at 3 ms
-1
 as shown in Figs 66b–c. 
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Figure 66 The influence of velocity on perforation quality (methylene blue staining) and perforation 
depth (H&E staining), with the impact applicator at 3 ms
-1
 (a) methylene blue stained image (b) and (c) 
example histology images. The influence of velocity on perforation quality (methylene blue staining) and 
perforation depth (H&E staining), with the impact applicator at 2 ms
-1
 (d) methylene blue stained image 
(e) and (f) example histology images. Blue arrows indicate disruption to the stratum corneum and the red 
arrows indicate that the breach is contained within the epidermis. Scale bar represents 100 m and 
diameter of Design 1 microneedle disc is 15.8 mm. 
4.4.6.2.2 Graphical output 
Fig. 67 shows the force and velocity graphs for impact tests on Model 3B at 5 ms
-1
, using a 
drop mass load of 36 g with Design 1 microneedles. The insertion force, which was 17.5 N 
and the insertion velocity, which was 4.96 ms
-1
 were obtained from the force–time plot 
shown in Fig. 67a. The maximum force reached was 84.4 N. Design 2 microneedles 
remained in skin for around 2 mins before removal for staining and imaging in order to 
account for skin’s elastic recovery. 
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Figure 67 Impact tests of Design 1 microneedles on Model 3B, where (a) force–time plot and (b) the 
description of points along the force–time curve. The impact occurred at 0.13 ms, where the velocity was 
approximately 4.96 ms
-1
, the force was 17.5 N and the maximum force reached was 84.4 N. The data 
suggest that the initial insertion occurred at 0.13 ms. Hence, at this point the velocity was approximately 
4.96 ms
-1
, the force was 17.5 N and the maximum velocity and force reached were 5 ms
-1
 and 84.4 N 
respectively. 
The maximum force value was 90.67 ± 10.68 N (n = 5) at 5 ms
-1
 velocity, 49.83 ± 15.74 N (n 
= 5) at 4 ms
-1
 and 42.93 ± 11.08 N (n = 5) at 3 ms
-1
. The insertion force values were around 
27.13 ± 11.05 N at 4.96 ms
-1
 insertion velocity, 13.40 ± 3.70 N at 3.83 ms
-1
, 9.33 ± 2.76 at 
2.96 ms
-1
. At 1–2 ms-1, it was challenging to determine insertion force values and maximum 
force values using the impact applicator. 
The insertion force for Design 1 microneedles was 9.33 ± 2.76 N (n = 5) as compared to that 
of Design 2, which was 23.50 ± 4.97 N (n = 5). Therefore, Design 1 microneedles required a 
lower insertion force for microneedle application on Model 3B as compared to Design 2 
microneedles. The maximum force for Design 1 microneedles was 42.93 ± 11.08 N, whilst 
that of Design 2 was greater at 46.24 ± 8.57 N. The insertion velocity for Design 1 
microneedles was 2.96 ms
-1
 as compared to Design 2 microneedles, which was 2.64 ms
-1
. 
4.4.7 Summary of impact applicator studies 
Reproducible microneedle penetration of skin was achieved with the improved impact 
applicator using Design 1 and 2 microneedles. Methylene blue staining confirmed breach of 
the stratum corneum, however, H&E staining provided details of the extent of the breach 
through the layers. 100% penetration was not achieved for both skin models, with the size of 
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perforations larger in abdominal skin as compared to back skin. PE for abdominal skin 
models decreased with increasing fluid content in the subcutaneous layer. Furthermore, the 
insertion force was relatively constant for both skin models, however, the maximum force 
acting on back skin did not vary with fluid content in the subcutaneous layer except for 
Model 3B. 
Design 1 microneedles produced larger perforation depths as compared to Design 2 
microneedles, therefore highlighting the role that microneedle geometry plays in skin 
penetration studies. It was also noted that the size of the deformation is related to the 
magnitude of the force, thus a small force results in a small deformation and a high force in a 
large deformation. Majority of the deformation through the layers of skin occurs past the 
stratum corneum bordering the epidermis, with the frequency of perforations reducing at 
higher breach areas.  
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4.5   Clinical Applicator Studies 
As previously mentioned clinical applicator tests were conducted so as to compare with 
experimental results in vitro using the impact applicator. Furthermore, as the clinical 
applicator was used for in vivo studies carried out by Renephra, it was necessary to 
understand the penetration effectiveness and efficiency using both methods of application. 
Due to the fact that the position of the loadcell in the impact and clinical setup differed, 
impact tests using the force transducer and loadcell was conducted in order to establish 
whether the results from the two experimental setups (Fig. 24 and Fig. 26) were comparable. 
In order to achieve this, the clinical applicator’s loadcell was fastened to the mechanical 
clamps and placed at the bottom of the drop tower guide; the setup was similar to the impact 
applicator setup in Fig. 24. The tests (n = 7) were conducted on only Perma-Gel
®
 placed in 
the clamps. The mean force transducer force output was 24.41 ± 0.76 N. By comparison, the 
clinical applicator (n = 7), yielded a mean loadcell force output of 29.80 ± 6.90 N. Statistical 
analysis (Student’s t-Test) was conducted in order to determine if there was any statistically 
significant difference between the force transducer (impact applicator setup) and loadcell 
(clinical applicator setup) force outputs. The outcome of the t-Tests produced p = 0.063 for 
the tests conducted on Perma-Gel
®
. Hence, there was no statistically significant difference 
between both data sets. 
4.5.1 Penetration efficiency 
Visual examination of abdominal skin models in Fig. 68 shows that successful perforation of 
the stratum corneum occurred. Ideally, an even spread of perforations across the circular 
impression created by the microneedles on the stratum corneum is expected. The skin model 
setup, however, resulted in a raised profile of the skin (see Fig. 27), therefore, the entire disc 
of Design 2 microneedles was not flush against skin before the clinical applicator was 
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utilised. This setup resulted in some instances, in partial perforation on the stratum corneum 
as shown in Figs 68b and 68d.  
 
Figure 68 Inspection technique of clinical applicator tests on Models 1A–4A for penetration efficiency 
with methylene blue staining where the whole disc provides visual confirmation of penetration and the 
cropped image, which is the selection highlighted in red is 5 × 5 mm in size and was used for calculating 
penetration efficiency for (a) 67%, (b) 80%, (c) 88% and (d) 96% of water content in the gelatine gels. 
The diameter of Design 2 microneedle disc is 30.1 mm. 
Fig. 69 also confirms the successful disruption to the stratum corneum. By comparing Figs 68 
and 69, it was observed that the intensity of the methylene blue dye appeared to be greater in 
back skin models (Models 1B–4B) as compared to abdominal skin models (Models 1A–4A). 
As already mentioned, the variation in perforation density in different regions of the same 
skin as shown in Figs 69b, 69c and 69d is due to the skin setup. The central region was still 
cropped for PE analysis as majority of the perforations covered at least two-thirds of skin for 
abdominal tissue. Although this was not the case with back tissue, however for consistency 
and comparison purposes, the reduced number of perforations on back skin was an important 
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result, as it may have been due to the clinical applicator performance or a combination of the 
clinical applicator performance on the thicker back skin. 
 
Figure 69 Inspection technique of clinical applicator tests on Models 1B–4B for penetration efficiency 
with methylene blue staining where the whole disc provides visual confirmation of penetration and the 
cropped image, which is the selection highlighted in red is 5 × 5 mm in size and was used for calculating 
penetration efficiency for (a) 67%, (b) 80%, (c) 88% and (d) 96% of water content in the gelatine gels. 
The diameter of Design 2 microneedle disc is 30.1 mm. 
In order to validate the visual observations of perforation density and assess PE, a cropped 
central location of the perforations on abdominal and back skin models were analysed using 
imaging techniques. PE results are presented in Fig. 70 and show that it decreased with 
increasing water content for abdominal (Models 1A–4A) and back skin (Models 1B–4B). 
Again as expected, 100 % penetration efficiency was not achieved. 
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Figure 70 Penetration efficiency determined from the methylene blue images for clinical applicator tests 
on 3 samples each of Models 1A–4B. Error bars depict SD.  
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4.5.2 The effects of differences in skin properties 
The H&E stained images are presented in Fig. 71. There was significant deformation within 
all of the abdominal skin models (Models 1A–4A), with the extent of the perforations 
propagating deep into the dermis. For back skin models (Models 1B–4B) however, the 
deformation was predominantly within the epidermis and just interfacing with the dermis. 
The application of Design 2 microneedles using the clinical applicator on abdominal skin 
models caused greater deformation as compared to back skin models. 
There was no obvious relationship between PE from methylene blue images and perforation 
depth from H&E stained images. The H&E stained images indicated that the microneedles 
interacted differently through the layers of abdominal and back skin models. The perforation 
profile of the back skin model was narrower and barely interfaced with the dermal layer, 
whilst the perforation profile of the abdominal skin was wider and extended into the dermis. 
This contrasts the PE determined from the methylene blue stained images, which showed that 
PE decreased with increasing gel water content for both skin models. 
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Figure 71 Comparison of perforation depths (H&E staining) using the clinical applicator for abdominal 
and back skin models with respect to altering the water content in gelatine gels. Red arrows indicate that 
the breach is contained within the epidermis and the black arrows indicate that the breach has extended 
into the dermis. Scale bar represents 100 m and diameter of Design 2 microneedle disc is 30.1 mm.   
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4.5.3 The role of the subcutaneous mimic property on microneedle 
performance 
The methylene blue stained images in Fig. 68 showed that by varying the gel water content in 
the subcutaneous mimic, the perforation density appears consistent for Models 2A–4A, the 
exception being Model 1A, which seemed to be more densely perforated. A similar trend was 
observed for back skin models (Models 1B and 4B differed). Conversely, the H&E images in 
Fig. 71a–d showed that with the increase in the gel water content in the subcutaneous mimic, 
the needles fully opened up the epidermis and the dermis in the abdominal skin model. This 
trend was not apparent in back skin models, as the deformation appeared narrower and in 
some instances extended into the dermis (Fig. 71a–c). 
In terms of penetration depth for each skin model, which is shown in Fig. 72, there was no 
apparent trend for varying the gel water content in the subcutaneous mimic. For abdominal 
skin models presented in Fig. 72a, the mean penetration depth increases with increased gel 
water content. For the back skin models, the depth of penetration did not follow this trend and 
showed an increase in penetration depth from Model 1B to 2B, followed by a decline from 
Model 2B to 3B and then an increase from Model 3B to 4B. 
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Figure 72 Perforation depth data for clinical applicator tests, where (a) abdominal skin models and (b) 
back skin models, with the number of images (n) in each group listed above each box and whisker plot. 
For the results of the breach area shown in Fig. 73, there was no significant difference for 
abdominal skin models 1A–4A (Fig. 73a). As shown in 73b, the mean breach area for Models 
1B–4B was lower at each gel concentration relative to the abdominal skin models. For PE 
comparison with the mean breach area, the trend differed for abdominal skin models but was 
similar to the perforation depth results for back skin models. Therefore, for back skin model, 
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there is a relationship between perforation depth and the size of the deformation within the 
layers (Figs 72b & 73b). 
 
 
Figure 73 Breach area data for clinical applicator tests, where (a) abdominal skin models and (b) back 
skin models, with the number of images (n) in each group listed above each box and whisker plot. 
As shown in Fig. 74, the frequency of perforations reduced as the breach area increased, 
which suggests that not every microneedle is deeply embedded in the skin, indicating that 
majority of the microneedles interaction with skin occurs at the stratum corneum layer. 
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There was a higher incidence of perforations in the abdominal skin models as compared to 
the back skin models. Model 1A (Fig. 74a) & 1B (Fig. 74b) had the highest frequencies for 
breach area, where the gel water content in the subcutaneous mimic is for normal skin. 
Again, perforations occurred in each breach area category for the abdominal skin models, 
whilst there was no breach area observed in some categories for the back skin model. There 
was no obvious correlation between perforation areas and variation of the gel water content 
in the subcutaneous mimic. As expected, there were very few perforations at the larger 
sizes. 
 
 
Figure 74 Frequency distribution of the breach area for clinical applicator tests on (a) abdominal skin 
models and (b) back skin models.  
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4.5.4 Clinical applicator force 
The force results obtained from clinical applicator studies on skin Models 1A–4B are detailed 
in this section. 
An example force–time plot is shown in Fig. 75a. The insertion force was 61.8 N and the 
maximum force achieved was 80.8 N. In order to account for elastic recovery of skin, the 
microneedles remained embedded in skin for approximately 2 mins before removal and the 
skin prepared for staining and imaging. 
 
Figure 75 The force–time plot for clinical applicator tests of Design 2 microneedles on Model 1A. The 
impact occurred at 4.62 s, where the force was 61.8 N and the maximum force reached was 80.8 N. The 
data suggests that the initial insertion occurred at 4.62 s. Hence, at this point the force was 61.8 N and the 
maximum force reached 80.8 N. 
Fig. 76a details the insertion force for the abdominal and back skin models. The trend shows 
that the insertion force increases at higher gel water content in the subcutaneous mimic of the 
skin models for all skin models. The insertion force for Models 4A and 4B are higher than for 
all other skin models. The insertion force was low for Model 1A as compared to the other 
skin models considering that this model contains the lowest gel water content in its 
subcutaneous mimic and therefore, has a higher elastic modulus. In addition, the insertion 
force is influenced by skin site, with the back skin models requiring greater insertion force as 
compared to the abdominal skin models, with the exception being Models 4A and 4B, where 
the insertion force values are in close agreement. Fig. 76b shows the variation of the 
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maximum force across the different abdominal skin models and as can be seen is an almost 
constant value with increasing water content of the subcutaneous mimic, except for Model 
4A, which is greater. A similar trend was observed with back skin models. There was no 
relationship between gel water content and elastic modulus and a trend could not be 
determined, as error bars for the maximum force were high (Fig. 76c). A similar trend was 
also observed with back skin models. 
 
Figure 76 Force data for clinical applicator tests, where n = 4 for each skin model (a) insertion force data 
for the abdominal and back skin models, (b) maximum force–gel water content for Models 1A–4A and (c) 
maximum force for Models 1A–4A vs elastic modulus of the gelatine gels.  
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4.5.5 The effects of microneedle geometry on skin penetration 
This section compares clinical applicator studies for Design 1 (1316 microneedles on the 
array/356 m length) with Design 2 (> 6000 microneedles on the array/552 m length) 
microneedles on Model 3B. 
4.5.5.1 Microneedle penetration on skin Model 3B 
Microneedle perforation of skin Model 3B is detailed here using Design 1 and 2 
microneedles. 
4.5.5.1.1 Comparison between visual examination and perforation depth 
The results of clinical applicator tests using Design 1 and 2 microneedles on Model 3B are 
presented in Fig. 77. Methylene blue staining in Figs 77a and 77b showed the disruptions to 
the stratum corneum, whilst histology showed the extent of the deformation through the 
layers. In Fig. 77a, image analysis using ImageJ to assess PE showed that 56% of Design 2 
microneedles perforated the stratum corneum of Model 3B as compared to 64% of Design 1 
microneedles in Fig. 77b. The H&E images showed greater deformation within the layers for 
Design 1 microneedles as compared to Design 2 microneedles. 
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Figure 77 Clinical applicator studies for the comparison of Design 1 and 2 microneedles on perforation 
confirmation (methylene blue staining) and perforation depth (H&E staining), on Model 3B. (a) Design 2 
and (b) Design 1. The diameter of Design 1 microneedle disc is 15.8 mm. The diameter of Design 2 
microneedle disc is 30.1 mm, Red arrows indicate that the breach is contained within the epidermis and 
the black arrows indicate that the breach has extended into the dermis. Scale bar represents 100 m. 
The penetration depth in Model 3B for Design 1 and 2 microneedles is shown in Fig. 78. The 
greatest perforation depth was 360 m for Design 2 microneedles as compared to 311 m for 
Design 1 microneedles. In addition, the mean penetration depth was similar for both types of 
microneedles.  
 
Figure 78 Perforation depth data for clinical applicator tests comparing results of Design 1 and 2 
microneedles on Model 3B, with the number of images (n) in each group listed above each box and 
whisker plot. 
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4.5.5.1.2 Histological examination of breach area 
The general trend for the frequency distribution of deformation within Model 3B presented in 
Fig. 79 showed that Design 2 microneedles produced the highest frequency of deformations 
at 0 < breach area < 10 000 m2. At categories > 10 000 m2 however Design 1 microneedles 
created greater breach areas. 
 
Figure 79 Frequency distribution for clinical applicator studies using Design 1 and 2 microneedles on 
Model 3B. 
4.5.5.2 Clinical applicator force on skin Model 3B 
The insertion force for Design 1 microneedles was 66.70 ± 3.11 N (n = 4) as compared to that 
of Design 2, which was 68.00 ± 8.77 N (n = 4). Therefore, Design 1 microneedles required a 
similar magnitude of insertion force for microneedle application on skin Model 3B as 
compared to Design 2 microneedles. The maximum force for Design 1 microneedles was 
91.00 ± 2.83 N, whilst that of Design 2 was lower at 77.30 ± 15.55 N. 
4.5.6 Summary of clinical applicator studies 
The results of the clinical applicator studies showed that reproducible microneedle 
penetration of skin occurred for all the skin models using Design 1 and 2 microneedles. 
Visual examination of methylene blue images for the clinical applicator showed that the 
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intensity of the methylene blue dye appeared greater on abdominal skin models as compared 
to back skin models. PE for the clinical applicator was between 39–80%, indicating that not 
all the microneedles perforated skin. 
The insertion force increased with increasing water content in the gelatine gels for both 
abdominal and back skin models, with the insertion force on back skin greater than the 
insertion force on abdominal skin. This result showed that altering the fluid content in the 
subcutaneous layer had an effect on the insertion force. The maximum force on the skin 
models was relatively constant for both abdominal and back skin models, with no particular 
trend observed. 
In addition, the performance of the clinical applicator was affected by microneedle geometry, 
as it produced poorer perforation results with Design 1 microneedles as compared to Design 2 
microneedles, with a higher proportion of the perforations occurring in the region of ≤ 10 000 
m2 breach area. 
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4.6   Comparison between Impact and Clinical Applicator Studies 
Impact and clinical applicators were used to insert microneedles into abdominal and back 
skin models. The force and velocity were obtained from the impact applicator, whilst only the 
force was obtained from the clinical applicator. The impact applicator was developed for in 
vitro tests on neonatal porcine skin, whilst the clinical applicator has been used for in vivo 
tests on patients by Renephra. Therefore, it was necessary to perform in vitro tests with the 
clinical applicator and compare the results to the results of the impact applicator tests. This 
section compares the effect of the impact and clinical applicators on the microneedle treated 
skin models. 
4.6.1 Penetration efficiency 
With respect to PE, it can be seen in Fig. 80 that the impact applicator produces a better result 
for Design 2 microneedle application to abdominal skin models as compared to the clinical 
applicator. It also appears that the clinical applicator plateaus around 50% PE for Models 
2A–4A. The results also show that for the impact applicator, PE reduces with increased water 
content in the subcutaneous mimic.  
 
Figure 80 Penetration efficiency as determined from the methylene blue images for impact and clinical 
applicator tests on abdominal skin models (Model 1A–4A). 
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The PE data for back skin models is presented in Fig. 81 and showed that for impact 
applicator tests, an increase in gel water content in the subcutaneous mimic leads to higher 
PE values, which was not the case for abdominal skin models. In contrast, for the clinical 
applicator however, an increase in gel water content leads to a decline in PE. 
 
Figure 81 Penetration efficiency determined from the methylene blue images for impact and clinical 
applicator tests on back skin models (Model 1B–4B).  
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4.6.2 The effects of differences in skin properties 
The images in Fig. 82 present a comparison of the methylene blue and H&E staining for 
impact and clinical applicator tests on abdominal skin models (Models 1A–4A). Fig. 82a 
appears to show a greater intensity in the methylene blue dye for the clinical applicator tests 
as compared to the impact applicator tests. Furthermore, the microneedle perforations 
travelled beyond the epidermis into the dermis. The H&E images for the impact applicator 
showed that most of the disruption through the layers was contained within the epidermis, 
with exception to the last image. 
In Fig. 82b–d, the intensity of the methylene blue dye appeared to be greater for the clinical 
applicator as compared to the impact applicator. For the impact applicator, the H&E images 
showed that the deformation was contained mainly within the epidermis, barely interfacing 
with the dermis as the gel water content increased. The deformation within Model 4A in Fig. 
82d extended more into the dermis. On the other hand, the H&E images for the clinical 
applicator showed that the microneedle perforations extended into the dermis. 
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Figure 82 Impact and clinical applicators interaction with abdominal skin models by varying the gel 
water content to determine that perforation is achieved (methylene blue staining) and perforation depth 
(H&E staining) using Design 2 microneedles. (a) 67% (b) 80% (c) 88% and (d) 96% gel water content. 
Red arrows indicate that the breach is contained within the epidermis and the black arrows indicate that 
the breach has extended into the dermis. Scale bar represents 100 m and diameter of Design 2 
microneedle disc is 30.1 mm.  
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In Fig. 83a, the intensity of the methylene blue dye appears deeper for the clinical applicator 
as compared to the impact applicator. The disruptions through the layers for both applicators 
were predominantly contained within the epidermis, except with the second image for the 
impact applicator and the third image for the clinical applicator. As shown in Fig. 83b, the 
methylene blue stained images was comparable for both applicators and so were the 
deformations caused by microneedle interference through the layers in the H&E images. Fig. 
83c showed that the intensity of the blue dye for the clinical applicator was greater than that 
of the impact applicator. In Fig. 83d, the methylene blue stained images showed similar dye 
intensity for both applicators. It was also found that for the clinical applicator, not all the 
microneedles on the array perforated the stratum corneum, although more than 50% 
perforations were seen on the stratum corneum.  
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Figure 83 Impact and clinical applicators interaction with back skin models by varying the gel water 
content to determine that perforation is achieved (methylene blue staining) and perforation depth (H&E 
staining) using Design 2 microneedles. (a) 67% (b) 80% (c) 88% and (d) 96% gel water content. Red 
arrows indicate that the breach is contained within the epidermis and the black arrows indicate that the 
breach has extended into the dermis. Scale bar represents 100 m and diameter of the microneedle disc is 
30.1 mm.  
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4.6.3 The role of the subcutaneous mimic property on microneedle 
performance 
The impact applicator produced the highest perforation depth in the abdominal skin model 
(Model 2A), as shown in Fig. 84. Conversely, the smallest perforation depth was produced by 
the clinical applicator on Model 2A. Generally, the impact applicator produced higher values 
for mean perforation depths across all abdominal skin models. 
 
Figure 84 Perforation depth data for impact and clinical applicator tests comparison on abdominal skin 
models, where 1A–4A refers to Models 1A–4A, with the number of images (n) in each group listed above 
each box and whisker plot. 
In Fig. 85, there was no significant difference between the impact and clinical applicator on 
back skin Models 1B–4B. Therefore, it is likely that the thicker and higher elastic modulus of 
the back skin model could be a contributory factor. 
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Figure 85 Perforation depth data for impact and clinical applicator tests comparison on back skin 
models, where 1B–4B refers to Models 1B–4B, with the number of images (n) in each group listed above 
each box and whisker plot.  
In terms of the breach area, the overall trends seen on the skin models showed that there was 
no significant difference between impact and clinical applicator performance on abdominal 
skin models as shown in Fig. 86. 
 
Figure 86 Breach area data comparison between impact and clinical applicator tests on abdominal skin 
models, with the number of images (n) in each group listed above each box and whisker plot. 
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There was no significant difference in breach area between the impact and clinical applicator 
performance on back skin models as shown in Fig. 87. 
 
Figure 87 Breach area data comparison between impact and clinical applicator tests on back skin models, 
with the number of images (n) in each group listed above each box and whisker plot. 
Histogram distribution of the breach area is shown in Fig. 88. The impact applicator produced 
greater breach area frequency as compared to the clinical applicator for the abdominal skin 
model. For the back skin models however, the clinical applicator performed better than the 
impact applicator.  
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Figure 88 Frequency distribution for impact and clinical applicator studies using Design 2 microneedles 
on (a) abdominal skin models and (b) back skin models.  
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4.6.4 The effects of microneedle geometry on skin penetration 
This section details the comparison between the impact and clinical applicators on Design 1 
and 2 microneedles using skin Model 3B. 
4.6.4.1 Comparison between visual examination and perforation depth 
The images in Fig. 89 compare perforation success using methylene blue staining and 
perforation depth using H&E staining for Design 1 and 2 microneedles on Model 3B. For 
Design 1 microneedles, the clinical applicator caused more disruptions to the stratum as 
majority of the microneedles perforated this layer as compared to the impact applicator. The 
H&E images show that the deformation was contained within the epidermis for the impact 
applicator and that the breach size was narrower. In contrast, for the clinical applicator, the 
deformation extended deep into the dermal layer in some instances and slightly interfaced 
with the dermis (Fig. 89a). 
For Design 2 microneedles, shown in Fig. 89b, the intensity of the methylene blue dye was 
greater for the clinical applicator treatment as compared to the impact applicator. The H&E 
stained images showed that the breach was contained within the epidermis for both 
applicators. 
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Figure 89 Impact and clinical applicator studies for the comparison of Design 1 and 2 microneedles on 
perforation confirmation (methylene blue staining) and perforation depth (H&E staining), on Model 3B. 
(a) Design 1 and (b) Design 2. The diameter of Design 1 microneedle disc is 15.8 mm. The diameter of 
Design 2 microneedle disc is 30.1 mm. Red arrows indicate that the breach is contained within the 
epidermis and the black arrows indicate that the breach has extended into the dermis. Scale bar 
represents 100 m.  
For the clinical applicator, the image analysis using ImageJ showed that 64% of Design 1 
microneedles perforated the stratum corneum of Model 3B as compared to the impact 
applicator treatment, yielding 55% perforations. Furthermore, for the impact applicator, 80% 
of Design 2 microneedles perforated the stratum corneum as compared to 56% perforation by 
the clinical applicator treatment. 
156 
  
The perforation depth due to impact and clinical applicator treatment is shown in Fig. 90. The 
trend shows that the mean perforation depth is relatively close in value for the impact and 
clinical applicators. The impact applicator appears to produce a consistent performance in 
skin irrespective of microneedle geometry as compared to the clinical applicator which 
appeared to be more affected by microneedle geometry. This is because with similar 
magnitude of force, the clinical applicator produced a smaller perforation depth for Design 1 
microneedles as compared to Design 2 microneedles. In contrast, the impact applicator 
produced a higher perforation depth at a relatively low force for Design 1 microneedles as 
compared to Design 2 microneedles. The impact applicator insertion force was also lower 
than the clinical applicator insertion force, which indicates that at a higher insertion force 
comparable to the clinical applicator insertion force, greater perforation depths could be 
achieved, since it has already been demonstrated that the magnitude of force is commensurate 
with the size of the deformation. 
 
Figure 90 Perforation depth data for impact and clinical applicator tests comparing results of Design 1 
and 2 microneedles on Model 3B, with the number of images (n) in each group listed above each box and 
whisker plot. 
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4.6.4.2 Histological examination of breach area 
For Design 2 microneedles, the clinical applicator produced a greater breach area as 
compared to the impact applicator at ≤ 10 000 m2 as shown in Fig. 91. As expected, there 
were less perforation areas for larger breach area categories. 
 
Figure 91 Frequency distribution for impact and clinical applicator studies using Design 2 microneedles.  
0
20
40
60
80
10000 20000 30000 40000 50000
F
re
q
u
en
cy
 (
%
) 
Breach Area (m2) 
Impact (Design 1) Clinical (Design 1)
Impact (Design 2) Clinical (Design 2)
10000 20000 30000 40000 50000 0 
** 
158 
  
4.6.5 Impact and clinical applicator force 
For the impact applicator, the insertion force for Design 1 microneedles was 9.33 ± 2.76 N (n 
= 5) as compared to that of the clinical applicator, which was 66.70 ± 3.11 N (n = 4). For 
Design 2 microneedles, the insertion force was 23.50 ± 4.97 N for the impact applicator and 
68.00 ± 8.77 N for the clinical applicator. The maximum force for Design 1 microneedles 
was 46.24 ± 8.57 N for the impact applicator and it was 91.00 ± 2.83 N for the clinical 
applicator. For Design 2 microneedles, the maximum force was 42.93 ± 11.08 N for the 
impact applicator as compared to 77.30 ± 15.55 N for the clinical applicator. 
The insertion force comparison between the impact and clinical applicators for tests on all the 
skin models provide an interesting insight into the influence of skin’s properties with respect 
to microneedle application. Fig. 92a shows a constant insertion force value for skin Models 
1A–4A for the impact applicator and an increase in insertion force values for the clinical 
applicator with increased water content in the subcutaneous mimic. A similar trend was also 
observed for back skin model in Fig. 92b, except that Model 3B exhibited the lowest 
insertion force produced by the impact applicator. 
159 
  
 
Figure 92 Force data comparison between the impact and clinical applicator tests on (a) abdominal skin 
models and (b) back skin models. 
4.6.6 Summary of the comparison between impact and clinical applicator 
studies 
Impact and clinical applicator studies of microneedle penetration of skin were reproducible as 
detailed in previous sections. 100% penetration was not achieved on all skin models for the 
clinical applicator and this was also observed with the impact applicator studies as well as 
mentioned in the literature. Furthermore, PE reduced with increasing fluid content in the 
subcutaneous layer for the clinical applicator as compared to the impact applicator. 
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For both applicators, the mean breach area for all skin models increased with an increase 
fluid content of the subcutaneous layer. 
Microneedle geometry also highlighted how each applicator influenced skin penetration with 
the impact applicator demonstrating that the magnitude of force played a major role in the 
size of the deformation through the layers. Whilst the clinical applicator showed that with a 
similar magnitude of force on both Design 1 and 2 microneedles, Design 2 microneedles 
produced higher perforation depths in skin.  
Finally, in terms of insertion force, for the impact applicator, abdominal and back skin was 
relatively constant. However, for the clinical applicator the insertion force increased with 
increasing fluid content in its subcutaneous layer. 
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Chapter 5 
5. Discussion 
5.1   Introduction 
The results presented in Chapter 4 demonstrate that the micromechanical properties of the 
skin model with respect to anatomical region and altering the fluid content in the 
subcutaneous layer influence the effectiveness of microneedle perforation of skin. In the 
body, subcutaneous adipose tissue contributes to skin deformation during loading and load 
transfer from skin to deeper layers (Geerligs et al., 2010b). To date, the role of subcutaneous 
tissue on microneedle performance has largely been ignored due to incomplete in vitro skin 
models. Therefore, the work carried out in this thesis using a representative skin model shows 
the importance of the role of the subcutaneous layer for determining microneedle 
performance. Furthermore, although skin thickness is related to elastic modulus because the 
thinner abdominal skin produces a lower elastic modulus as compared to the thicker back 
skin with a higher elastic modulus, nonetheless, contributions from the subcutaneous layer, 
particularly the compliant 96% gel water content yielded comparable maximum force values 
for both abdominal and back skin models using the clinical applicator. This result however 
was not observed with the impact applicator. Additionally, microneedle geometry and 
microneedle applicator also contributed to microneedle performance in skin. The study found 
that microneedle penetration of skin was reproducible and repeatable, however the extent of 
the deformation through the layers varied according to microneedle geometry and 
microneedle applicator. Further, the mechanical properties of the various layers was 
quantified and related to microneedle performance. Insertion force, insertion velocity and 
maximum force values were obtained for the impact and clinical applicators as these 
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influenced effective microneedle penetration of skin. The findings from these studies are now 
discussed in further detail and as it relates to previous findings reported in the literature. 
5.2   Micromechanical Characterisation of Skin’s Sub-layers 
The mechanical behaviour of skin varies due to various factors including age (Daly and 
Odland, 1979; Leveque et al., 1980), pathology such as scleroderma, polyfibromatosis 
(Pierard and Lapiere, 1977), species (e.g. human, porcine or murine) and anatomical site. 
Data reported in the literature also varies depending on test conditions (e.g. in vivo or in vitro) 
and test type e.g. indentation (Pailler-Mattei et al., 2007b), suction (Diridollou et al., 2000) or 
tension (Manschot and Brakkee, 1986). 
The micromechanical tests using the nanoindentation setup allowed for the characterisation 
of the different layers of the skin model and thereby comparison with values reported in the 
literature for skin’s subcutaneous and muscle tissue. The difference in elastic modulus for 
abdominal skin compared to back skin was consistent with published data (Zak et al., 2011). 
The storage modulus (elastic properties) was greater than the loss modulus (viscous 
properties) for both abdominal and back skin. This result was consistent with the work 
carried out utilising nanoindentation testing on murine skin (Kendall et al., 2007). The 
importance of a full thickness skin sample in the skin model was reinforced by Zahouani et 
al. who showed that the dermis made a significant contribution to skin because of its load 
bearing capabilities (Zahouani et al., 2009). Furthermore, it is easier to penetrate the human 
epidermis without the dermal layer (Li et al., 2015), which would not be an ideal way to 
demonstrate successful microneedle interaction with skin. For the work carried out in this 
thesis, unlike in some studies, a full thickness skin sample comprising the stratum corneum, 
epidermis and dermis as well as subcutaneous layers represented by gelatine gels and Perma-
Gel
®
 as muscle mimic were used. The mechanical tests on three concentrations of gelatine 
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gels (67%, 80% and 88%) showed that the elastic modulus decreased with increased fluid 
content in the gelatine gels matching trends reported by Mridha and Odman (1985) and 
Mridha et al. The storage modulus was significantly greater than the loss modulus for the 
gelatine gels. In the literature, for subcutaneous tissue, G´ of 7.5 kPa for porcine tissue was 
reported (Geerligs et al., 2008). For the work in this thesis, G´ ranged from 3.8–21 kPa, 
which was also comparable with the literature given the much higher frequency that was 
utilised during testing i.e. 110 Hz for this study as compared to approximately 1.6 Hz in the 
rheology study by Geerligs et al. The tests on Perma-Gel
®
 yielded a mean G´ of 29.9 ± 0.9 
kPa, which matched values reported in the literature for the shear modulus of muscle (Pailler-
Mattei et al., 2008). 
As already reported, skin site, test method and test condition influence the outcome of skin’s 
mechanical characterisation. The study by Zahouani et al. also demonstrated the similarity in 
stiffness between dermal equivalents and volar forearm (Pailler-Mattéi and Zahouani, 2006; 
Pailler-Mattei et al., 2008; Zahouani et al., 2009), which suggests that during in vivo tests, the 
mechanical contribution from the dermis is prominent. Ex vivo tests on the stratum corneum 
layer only, yielded a low elastic modulus (Pailler-Mattei et al., 2007b). This single layer of 
tissue is not ideal for microneedle penetration studies as the key mechanical strength 
provided by the dermis is absent. Uniaxial tensile tests confirmed that back tissue was stiffer 
and has a higher elastic modulus than abdominal tissue (Zak et al., 2011), which was also 
demonstrated in this study. The values of the elastic modulus in the Zak et al. study using 
tensile testing techniques were between 100–200 times greater than results obtained from the 
dynamic nanoindentation tests carried out in this thesis. The disparity in mechanical property 
data reported for various biomechanical studies in the literature highlights complexities due 
to different tissue types and testing methodologies. 
164 
  
Another noteworthy observation was that the range of elastic modulus obtained lay within the 
range of mechanical properties of previous studies listed in Table 3 (Section 2.3.1.2) and 
Table 4 (Section 2.3.2), with particular reference to the values from Groves (2011) and 
Zahouani et al. in vivo studies. Therefore, the micromechanical properties of skin in this 
study were comparable to the results of the in vivo studies. 
As previously mentioned in the literature review in Chapter 2 (Section 2.3.1.2, Table 2), 
Crichton et al. demonstrated the effects of varying the indentation probe diameter and its 
influence on the elastic modulus of murine ear skin. They found that the elastic modulus 
increased with the smaller probe diameters and decreased with the larger probe diameters 
(Crichton et al., 2013). Kendall et al. previously found a similar trend in a nanoindentation 
study of murine skin using two different probe diameters (Kendall et al., 2007). Crichton et 
al. also stated that the mechanical behaviour of mice skin was comparable to human skin and 
cited indentation tests carried out by Geerligs et al. on frozen human tissue (Geerligs et al., 
2011). Geerligs et al. used an ex vivo abdominal human tissue and reported that the elastic 
modulus of the stratum corneum (2.6 ± 0.6 MPa) was greater than the epidermis (1.1 ± 0.2 
MPa). They also showed that a reduction in the stiffness of the viable epidermis causes an 
increase in indentation depth. 
Another study by Kocchar et al., which focused on microneedle tests on soft tissue, also used 
rat skin and argued that for microneedle penetration studies, rat skin behaved similar to 
human skin (Kochhar et al., 2013b). Groves et al. demonstrated in their study involving ex 
vivo murine and human skin that under low loads, the extension in human skin was 
significantly greater as compared to murine skin and careful consideration should be taken 
when using murine skin as a biomechanically representative model of human skin (Groves et 
al., 2013). Ding et al. also found mouse skin to be thinner but more flexible than human skin 
(Ding et al., 2009). 
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Furthermore, Li et al. in their study of microneedle interaction with skin showed that the 
epidermal thickness of rat skin (≈ 15 m) was very different to human skin (≈ 100–200 m), 
which made it easier to strain rat skin following microneedle application (Li et al., 2015). 
They also found that it was easier to deeply penetrate rat skin due to its thinner epidermis. 
Therefore, rat skin may not be a suitable soft tissue model for microneedle application 
studies. Moreover, the work in this thesis using neonatal porcine skin has shown that the 
thickness of abdominal skin (≈ 0.79 mm) and back skin (≈ 2.43 mm) does contribute to 
microneedle performance, therefore, microneedle perforation of abdominal skin occurred 
more readily and is an ideal site for microneedle application. The micromechanical tests 
highlighted the difference in elastic modulus for the back skin (45.89 ± 9.61 kPa), which was 
almost twice that of abdominal skin (24.49 ± 5.47 kPa). The depth of penetration was 
typically lower in the back skin at lower gel water content i.e. Models 1B and 2B relative to 
the abdominal skin (Fig. 56 Section 4.4.4). In addition, the elastic component (G´) and 
viscous component (G˝) was also lower for abdominal skin compared to back skin. 
Furthermore, neonatal porcine skin exhibits close biomechanical properties to human skin 
(Shergold et al., 2006; Cilurzo et al., 2007) as well as similar histological, physiological and 
immunological properties (Avon and Wood, 2005). Therefore, if access to human tissue is 
challenging, then neonatal porcine skin can be used as a suitable substitute. 
The variation of the elastic modulus in soft tissue demonstrated in several studies also 
highlighted the extremely variable nature of biological material in general. 
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5.3   Impact Applicator Studies  
A number of different methods have been employed in the literature to apply microneedles to 
skin. Dermaroller
®
 (Badran et al., 2009), syringe applicators (Haq et al., 2009), actuator 
driven applicator (Bouwstra et al., 2009) and an electrically driven applicator (Verbaan et al., 
2008) have all been used for microneedle application to skin. The more commonly used 
microneedle applicators are the spring-driven applicators; however, some studies have shown 
that the impact applicator setup is a more suitable option for microneedle application in soft 
tissue as compared to manual application (Burgin and Aspden, 2007). Furthermore, van der 
Maaden et al. used an impact applicator for reproducible perforation of skin (van der Maaden 
et al., 2014). 
In this thesis, impact applicator studies support the assertion in the literature that reproducible 
microneedle perforation of both abdominal and back skin models are achievable at velocities 
in excess of 2 ms
-1
. As a consequence, attempts have been made to relate the force, velocity, 
mechanical properties of the skin model layers, microneedle geometry to microneedle 
penetration results. Therefore, the findings of impact applicator tests on all skin models are 
discussed in this section. 
5.3.1 Visual examination of microneedles using SEM imaging 
SEM images showed that PEEK microneedles remained intact after five applications during 
impact tests on skin, whilst the tips of Design 2 PMMA microneedles deformed after single 
application and completely fractured following five applications. The elastic modulus for 
PEEK is 4.1 GPa (Victrex, 2014) and 1.7 GPa for PMMA (Ianches, 2015), which suggests 
that PEEK microneedles were more robust in its design because of its higher elastic modulus 
and due to its construction had design integrity. Furthermore, in the polymer family, PEEK 
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also has the highest fracture toughness, a value of 2.73–4.30 MPa√m (Granta, 2003), which 
also explains why it exhibits superior design integrity. 
Design 2 PMMA microneedle tips were sharper than PEEK microneedle tips. Therefore, 
these design intricacies could explain why PEEK microneedles produced poor perforation 
results as compared to Design 1 and Design 2 PMMA microneedles. The tip sharpness of the 
PMMA microneedles as compared to the PEEK microneedles may have influenced the 
integrity of the needles during multiple uses i.e. a small diameter tip is more likely to deform 
after a single insertion than a blunter, larger diameter tip. In addition, Renephra’s clinical 
trials by Ebah (2012) using PEEK microneedles also reported that the design of the 
microneedles may have hindered its performance in skin in vivo. 
5.3.2 Penetration efficiency 
Visual examination using methylene blue staining and histological examination using H&E 
images showed that with Design 1 and 2 PMMA microneedles, 100% penetration was not 
observed. These results were consistent with findings from other researchers who had less 
densely populated arrays i.e. 16–576 microneedles on the array (van der Maaden et al., 2014; 
van der Maaden et al., 2015) as compared to Design 1 microneedles (1316 microneedles on 
the array) and Design 2 microneedles (> 6000 microneedles on the array) used in this study. 
Furthermore, the PE determined from methylene blue staining varied from 43–93% for the 
regions analysed. For this reason, the expected frequency of microneedle breaches i.e. with 
clearly visible breaches every 360 µm were not seen during the analysis of H&E images. In 
addition, this may also be attributable to the substantial irregular surface topography of skin 
(see Figs 95 and 96 in the Appendix). Moreover, there may be unavoidable issues due to the 
tissue sectioning process (see Fig. 97 in the Appendix). 
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PE as determined in other studies has largely relied on methylene blue or Trypan blue 
staining to assess penetration efficiency (Park et al., 2005; Verbaan et al., 2008; Haq et al., 
2009; Kochhar et al., 2013b; Olatunji et al., 2013; van der Maaden et al., 2014; Qiu et al., 
2015; van der Maaden et al., 2015), however as shown in Fig. 66, a combination of 
methylene blue staining with histology is required to fully assess the extent of microneedle 
penetration of skin. In the study by van der Maaden et al., the stratum corneum was stripped 
from the skin in order to effectively determine that the perforations had propagated through to 
the epidermis (van der Maaden et al., 2014). As already established the methylene blue 
staining only confirms disruption to the stratum corneum layer and not perforation depth, 
which is why it should not be considered as a technique for measuring successful epidermal 
penetration. Microneedle penetration success should be defined as the complete breach of the 
stratum corneum that extends to the epidermal layers. This is because in this study, there have 
been instances where some microneedles on the array have only caused dents in the stratum 
corneum, thus creating a temporary pocket that carries the methylene blue solution. This 
would be observed as successful methylene blue staining through visual examination, 
however, there is no breach in skin. van der Maaden et al. also noted a similar occurrence in 
their study, as some of the dye solution was stored in dents in the stratum corneum. A further 
observation was that not every microneedle on the array seemed to fully penetrate through to 
the epidermis; however, the majority of the microneedles did deform the stratum corneum 
layer, as shown in Figs 66d–f. This phenomenon was also observed in other methylene blue 
or Trypan blue stained image studies, where every single microneedle on the arrays did not 
perforate the stratum corneum (Haq et al., 2009; Qiu et al., 2015; Xiang et al., 2015). 
Moreover, emerging technologies within biomedical research such as OCT and XMT could 
also be utilised in providing this detail. 
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5.3.3 The effects of differences in skin properties 
There are currently only a few studies which have explored how microneedles performance is 
influenced by the physiological and mechanical properties of skin. In this thesis, it was 
observed that microneedle perforation occurred more readily in the thinner abdominal skin as 
compared to the thicker back skin. This occurrence was similar to the study by Al-Qallaf and 
Das (2008), who demonstrated that increasing drug permeability in skin with microneedles 
varied due to differences in epidermal thickness between Caucasian and Korean groups. The 
thicker epidermis found in the Korean group exhibited lower skin permeability as compared 
to the thinner epidermis in the Caucasian group, which had higher skin permeability (Al-
Qallaf and Das, 2008). As already noted that neonatal porcine back skin bears similar 
thickness (Lo Presti et al., 2012) and has a comparable mechanical property to human skin 
(Groves, 2011), therefore, the outcome of studies on neonatal back skin provides details of 
how microneedles could interact in human skin. In addition to skin thickness, Verbaan et al. 
postulated that age and skin region due to the variation in the elasticity of skin makes 
microneedle perforation of skin less reproducible (Verbaan et al., 2008). Furthermore, 
Olatunji et al. showed computationally that the insertion force for microneedles was 
significantly higher for aged human skin as compared to younger skin (Olatunji et al., 2013). 
As fluid overload and oedema are conditions common to elderly patients suffering from heart 
or kidney failure (McMurray and Stewart, 2000), it is therefore important to address the 
likely effects of microneedle application to ageing skin. Although no study was carried out on 
ageing skin in this thesis, contributions from insertion force and insertion velocity could play 
a role in the postulations by Verbaan et al. and Olatunji et al. regarding the reproducibility of 
microneedle perforations in ageing skin. According to Kelchen et al. for their in vivo 
comparison study between elderly and young subjects, manual application of microneedle 
created microchannels in skin for both subjects. The difference noted was the time taken for 
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microchannel closure, which was longer in elderly subjects as compared to young subjects 
(Kelchen et al., 2016). Furthermore, ageing skin is thinner due to epidermal thinning 
(Kelchen et al., 2016) as compared to younger skin; hence, the structural differences between 
ageing and young skin could influence microneedle performance. This thesis demonstrated 
that structural differences between abdominal and back skin resulted in different outcomes, 
with more deformation occurring in abdominal skin as compared to back skin. Likewise, the 
thicker back skin required a higher insertion force as compared to the thinner abdominal skin. 
The difference between the insertion force of abdominal and back skin indicates that 
microneedle penetration of skin is influenced by the difference in thickness at different 
anatomical sites. 
Another factor for microneedle performance in different skin regions could be due to 
variation in skin topography. Skin has a natural undulation, which varies in size and depth 
(see Figs 94 and 95 in the Appendix). This could explain why some of the microneedles 
perforated deeper into skin in some regions as compared to other regions. The histology 
images also illustrated 2D profiles of skin’s topography, with some cross-sections having 
flatter ridges as compared to other cross-sections having more pronounced ridges. 
There are certain disadvantages associated with the analysis of histology images. This is 
because only a small portion of the tissue can be sectioned during histology, which means 
that useful information is lost with the tissue that is discarded. Furthermore, it involves time-
consuming fixing, sectioning and staining steps. Coulman et al. demonstrated that 
histological measurements of microneedle penetration led to an overestimation (Birchall et 
al., 2005; Coulman et al., 2010). This error is also compounded by the introduction of slight 
inaccuracies due to skin retraction caused by the removal of the microneedles before staining 
(Donnelly et al., 2010; Loizidou et al., 2016). Despite these limitations, using histology for 
the light microscopic assessment of skin biopsies is still regarded as the benchmark in 
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dermatology (Holme et al., 2014; Newton et al., 2015). In order to improve on conventional 
methods of measurement from histological images, a custom image analysis routine was used 
for all measurements of breach area from histology images. 
5.3.4 The role of the subcutaneous mimic property on microneedle 
performance 
As mentioned previously in Section 2.6.5, several microneedle in vitro studies have used skin 
models with underlying substrates that do not provide a true representation of the mechanical 
characteristics of skin’s underlying layers (Park et al., 2005; Verbaan et al., 2007; Badran et 
al., 2009; Yan et al., 2010; Donnelly et al., 2011; Kochhar et al., 2013a; Kochhar et al., 
2013b; Olatunji et al., 2013). Hence, the additional novelty of the approach outlined in this 
thesis was that microneedle tests were performed on a more representative in vitro skin model 
that incorporated a subcutaneous tissue layer and muscle mimic that were comparable in 
mechanical behaviour to skin’s underlying layers. Early on, the role of gelatine gels as an 
underlying substrate for skin in the study involving PEEK microneedles showed that 
penetration was marginal when skin was not placed on a gelatine gel bed. Typically, the 
human anatomy contains organs, muscles, fat and is supported by a skeleton, which gives 
skin support. Understandably, the lack of a gelatine gel bed reinforces the requirement for the 
in vitro tissue to have a representative layer that can mimic the subcutaneous layers of skin.   
For methylene blue staining utilising Design 2 microneedles with back skin models, it was 
observed that penetration quality improved with increasing water content in the gelatine gels. 
As noted by Mridha et al. gelatine gels with high water content have low mechanical 
impedance and this phenomenon could explain the improved penetration of skin with high 
water content gelatine gels following microneedle application. Although skin tension with 
respect to oedema was not measured during experimental investigation, contributions from 
the subcutaneous layer cannot be ignored as, the influence of the lowest stiffness gelatine gels 
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was prominent for skin Models 4A and 4B, where the deformation in abdominal and back 
skin were significant in terms of their large breach sizes. Typically, the stiffer back tissue 
contained most of the deformation within the epidermis for Models 1B, 2B and 3B. It was 
also noted that the thinner abdominal tissue produced deeper breach sizes that extended into 
the dermis with increased fluid content in the gelatine gels. 
Overall, it was found that for abdominal skin model, increased fluid content in the gelatine 
gels resulted in larger deformations in terms of breach area. Therefore, manipulating the 
water content in the gelatine gels compromised the integrity of the skin model. Additionally, 
it was found that the mechanical performance of abdominal skin model was influenced by the 
mechanical contribution from the gelatine gel layer, as an increase in water content affected 
its interaction with microneedles. Moreover, as abdominal tissue is thinner and has a lower 
elastic modulus, it offers all the right components to make it easy for microneedles to bypass 
its skin barrier and cause deformation. This could mean that microneedles could cause greater 
deformation in patients with oedematous tissues or epidermal thinning associated with ageing 
(Kelchen et al., 2016). The histograms presented in Section 4.4.4 showed that there were 
more perforations for a breach size of 10 000–20 000 m2 in the abdominal skin relative to 
the back skin. This could also be related to the thickness of the abdominal skin, which means 
that it has a reduced ability to resist the disruptive influence of microneedle assault as 
compared to back skin. 
5.3.5 Impact applicator force and velocity 
The impact applicator used for the work carried out in this thesis allowed for both force and 
velocity to be varied. This was in contrast to other studies which have tended to use a fixed 
force (van der Maaden et al., 2014) or only considered the application velocity (Verbaan et 
al., 2008; Ding et al., 2009).  
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At higher drop mass loads and higher velocities, as shown in Figs 64a–b, the intensity of the 
methylene blue dye increased for Design 1 microneedle penetration on the stratum corneum 
of skin Model 3B. Verbaan et al. used intensity of Trypan blue dye as an assessment of 
perforation effectiveness in their study. In addition, they also quantified their Trypan blue 
intensity tests by conducting separate transepidermal water loss (TEWL) studies on samples 
of microneedle perforated tissues without dye staining. TEWL is a standardised way of 
measuring the changes in skin barrier properties (Treffel et al., 1994; Rosado et al., 2005) and 
can be used as an additional indicator of stratum corneum disruption (Haq et al., 2009). Their 
TEWL results were consistent with the results obtained from their visual observation studies 
using Trypan blue (Verbaan et al., 2007). The methylene blue staining results also 
highlighted the influence of force and velocity on the quality and consistency of 
incorporation of the high-density Design 1 microneedles into Model 3B. Furthermore, the 
quality of perforation through skin improved at a higher velocity of 3 ms
-1
 as compared to 2 
ms
-1
. This observation was in line with the study by Donnelly et al., which concluded that 
perforation of skin could occur at high velocities and low loads (Donnelly et al., 2010). 
Furthermore, van der Maaden et al. achieved perforation of skin at 3 ms
-1
 and at a force in the 
range of 3.43–22.1 N (van der Maaden et al., 2014). The insertion force, which is indicated in 
Figs 59 and 67, is likely to be the point at which the force exerted on the microneedles causes 
piercing of the skin, as described by Olatunji et al. (Olatunji et al., 2013). Therefore, the 
optimal parameters of insertion velocity and insertion force for reproducible and predictable 
penetration of skin Model 3B using Design 1 microneedles were 2.96 ms
-1
 and 9.33 ± 2.76 N 
respectively. 
There was some correlation between insertion force and the extent of the deformation in skin, 
as the size of the insertion force used for microneedle application was commensurate with the 
size of the deformation. This was particularly evident in skin Model 3B, whereby a low 
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insertion force resulted in a small breach size as compared to the breach size observed in 
Models 1B, 2B and 4B (Fig. 55c). The insertion force using Design 2 microneedles on Model 
3B was 23.50 ± 4.97 N, which was lower than the insertion forces of 37.52–40.72 N on 
Models 1B, 2B and 4B (Fig. 67a). These skin models produced higher breach areas as 
compared to Model 3B (Fig. 55). This also suggests that the size of the insertion force is 
important for ideal microneedle interaction within skin. Furthermore, Donnelly et al., used a 
spring-driven applicator of varying forces (4.4–16.4 N/array) to demonstrate that increasing 
the insertion force led to a significant enhancement in the depth of microneedle penetration 
into skin (Donnelly et al., 2010). 
In comparison to back skin models, a lower insertion force and insertion velocity was 
required for microneedle penetration of abdominal skin models. It has already been 
established that the elastic modulus as well as the elastic and viscous effects for back skin is 
higher than for abdominal skin, therefore, it is for this reason that the stiffer back skin 
requires a higher insertion force as compared to the less stiff abdominal skin. The insertion 
force values were not overly influenced by the subcutaneous mimic properties in any of the 
abdominal skin models because as the fluid content increased in the gelatine gels, the 
insertion force remained relatively constant. The maximum force however increased with 
increasing water content in the gelatine gels, which indicates the prominent role played by the 
subcutaneous mimic in microneedle interaction with skin. This would indicate that at greater 
force values, the integrity of the gelatine gels becomes compromised and disintegrates, 
unable to withstand the force. It was noted that the maximum force measured by the force 
transducer decreased by approximately 37% from Model 1A containing 67% gel water 
content to Model 4A containing 96% gel water content. Although PE decreased marginally 
with gel water content, the average depth size and breach area increased with gel water 
content. Also noteworthy, was the reduction in these parameters with Model 4A containing 
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96% gel water content. It appears that the high compliance of the subcutaneous mimic in this 
model seems to result in poorer microneedle interaction with skin, the histogram data 
however (Fig. 58a) shows that the distribution of small (< 10,000 µm) and large breach areas 
(> 20,000 µm) is comparable to Models 2A and 3A containing 80% and 88% gel water 
content respectively. 
The maximum force did not decrease for back skin models as in the case of abdominal skin 
models with increasing compliance of the subcutaneous mimic. Again, this can be related to 
the relative stiffness and thickness of back skin. The overall trends for average depth size and 
breach area matched those found in abdominal skin. The key difference between abdominal 
and back skin was the average data reported for Model 3B containing 88% gel water content. 
The histogram data for back skin models (Fig. 58b), however, also demonstrates that the 
overall trends are relatively consistent in terms of microneedle performance as compared to 
gel water content. The inherent issues with histological assessment of microneedle 
perforation of skin cannot be ignored as contributory factors for some of the disparities. 
5.3.6 The effects of microneedle geometry on skin penetration 
The stratum corneum is the stiffest layer in skin and the least extendable under applied load 
(De Rigal and Leveque, 1985; Hendriks, 2001). It is also the first surface that comes into 
contact with microneedles. Thus, the stratum corneum remains a barrier against the 
application of microneedles (Prausnitz, 2001). PEEK and PMMA microneedles successfully 
bypassed the stratum corneum, with the deformation extending into the epidermis. The 
reproducible perforation of skin was an issue with PEEK microneedles and may have been 
due to its method of manufacture, laser machining, as its original design was for sharper tips. 
For the PMMA microneedles however, reproducible and repeatable perforation of skin 
occurred for both abdominal and back skin models due to consistency of tip sharpness 
attributable to its microfabrication process. 
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For the work in this thesis, the microneedle tip diameters were of similar construction and its 
size was ≈ 10 m for Design 1 and 2 PMMA microneedles. The variation in needle length 
was 356 m for Design 1 microneedles and 552 m for Design 2 microneedles. In terms of 
needle density, it was 1316 for Design 1 microneedles and > 6000 for Design 2. The 
difference in interspacing was 386 m for Design 1 microneedles and 360 m for Design 2 
microneedles. 
Design 1 microneedles penetrated through the stratum corneum to the epidermal layer and in 
some instances caused deformation to the dermal layer. The objective of microneedle 
penetration studies is to achieve epidermal breach, since this layer contains few nerve endings 
or blood vessels. It was noted by Henry (1998) that even though microneedles are long 
enough to penetrate the dermis, they are however short and narrow enough to avoid 
stimulating dermal nerves (Henry et al., 1998). Although the histological images in Fig. 61 
did not show any significant difference between Design 1 and 2 microneedles interaction 
with skin, the insertion force for Design 2 microneedles was more than twice the magnitude 
required for Design 1 microneedles. Therefore, this increase in insertion force for the more 
densely populated, longer length Design 2 microneedles (> 6000) as compared to the less 
densely populated, shorter length Design 1 microneedles (1316) demonstrates that 
microneedle geometry plays a role in the force outputs for microneedle interaction with skin. 
Liu et al. also showed that insertion force varies with microneedle geometry (Liu et al., 
2016). Furthermore, Loizidou et al. demonstrated that design elements such as microneedle 
length, interspacing, base diameter that affect microneedle geometry are critical parameters 
that influence skin penetration (Loizidou et al., 2016). The differences in interspacing 
between individual microneedles for Design 1 microneedles (386 m) and Design 2 
microneedles (360 m) as well as differences in needle density for Design 2 microneedles (> 
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6000), which is approximately four times that of Design 1 microneedles (1316) were factors 
in determining how both microneedles behaved in skin. 
For Model 3B, Design 2 microneedles produced a greater number of perforations ≤ 10 000 
m2 however, Design 1 microneedles produced perforations in skin at all measurement 
ranges, whilst there were some ranges where no perforations were recorded for Design 2 
microneedles. This observation suggests that despite the lower insertion force of the Design 1 
microneedles as compared to Design 2 microneedles, Design 1 microneedles were completely 
embedded in skin at its highest perforation depth of 351 m (Fig. 62). However, the insertion 
force per microneedle highlights that almost two times the insertion force per microneedle is 
acting on Design 1 microneedles (0.007 N/microneedle) as compared to Design 2 
microneedles (0.004 N/microneedle). This was further corroborated by other studies in which 
microneedle perforation depth improves with insertion force (Donnelly et al., 2010) and 
insertion velocity (Crichton et al., 2010). 
Another design difference between Design 1 and 2 microneedles is the height, where Design 
1 microneedles were 356 m in height as compared to Design 2 microneedles height of 552 
m. As already mentioned in Section 5.3.2, following microneedle interaction with skin, the 
skin is initially indented before perforation of the stratum corneum occurs. Consequently, 
several studies have reported that microneedle perforation depth varies widely from 10–80% 
of the length of the microneedle (Coulman et al., 2010; Donnelly et al., 2010; Kalluri et al., 
2011). This could perhaps explain the observation in this study why Design 2 microneedles 
did not penetrate as deeply into skin. 
Verbaan et al. demonstrated using the same design of microneedles, which were a 4 × 4 array 
of lengths 300 m, 550 m, 700 m and 900 m that TEWL increased with the increasing 
length of the microneedle. The 900 m microneedle produced the best TEWL results. The 
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only variable with their microneedles was its length, as needle density and interspacing were 
the same. This made it possible in determining that increased microneedle length resulted in 
increased perforation of skin (Verbaan et al., 2007). On the other hand, Yan et al. conducted 
several tests on a wide number of microneedle lengths with various needle densities. In their 
study, they found that the longer microneedle length (650 m) with needle density of 400 or 
900 resulted in increased skin perforation as compared to the shorter microneedle length (≤ 
300 m) with needle density of 11 900 (Yan et al., 2010). Moreover, Romgens et al. further 
stated that the length of the microneedle also influenced the perforation depth, in contrast to 
the interspacing between individual microneedles on an array and that microneedles with a 
tip diameter of < 15 m insert microneedles to a desired perforation depth (Romgens et al., 
2014). In this thesis, PMMA microneedle tip diameters were of similar construction, 
however, there were variations in needle length, needle density and interspacing. These 
differences further influenced microneedles performance in Model 3B, with Design 1 
microneedles producing larger perforation depths and breach areas as compared to Design 2 
microneedles. 
Due to the significant differences in microneedle length, needle density and interspacing 
between Design 1 and Design 2 microneedles, it is difficult to separate out the effects of each 
of these variables. However, as stated in this section, length and the number of needles on the 
array appears to have the greatest effect on microneedle performance. It was beyond the 
scope of the thesis to investigate each of these effects separately. Testing was only conducted 
on those arrays being utilised by Renephra for clinical trials. 
Overall, for the desired application it would seem that Design 1 microneedle is most suitable 
because it produced more consistent deformations within skin following successfully 
bypassing the stratum corneum layer and PE ≥ 30%.  
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5.4   Clinical Applicator Studies 
Clinical applicator induced microneedle tests were conducted on abdominal and back skin 
models using Design 1 and 2 microneedles. Therefore, the findings of the clinical applicator 
tests are discussed in this section. 
5.4.1 Penetration efficiency 
In order for the hammer mechanism to be launched when the clinical applicator was used, the 
microneedles were placed flush on the raised profile of skin, which ensured that the hammer 
mechanism of the clinical applicator depressed the microneedles into skin. The PE 
determined from methylene blue staining varied from 39–80% for the regions analysed. 
Although the raised profile of skin may have contributed to the reduced number of 
perforations observed, however, as already noted from previous studies that not every 
microneedle on the array will perforate skin, this reduced frequency means that breaches 
were not observed for every 360 µm of interspacing on the array during assessment of the 
H&E images. Moreover, a further reason why not every microneedle perforated skin may be 
due to the irregular surface topography of skin. 
5.4.2 The effects of differences in skin properties 
The deformation created within the abdominal skin model was wider and extended into the 
dermis as compared to the back skin model, where the deformation was narrow and on 
occasion also stretched into the dermis. This may be attributed to physiological differences 
between abdominal tissue and back tissue, as abdominal tissue is thinner than back tissue. 
In addition to physiological differences between abdominal and back skin, the difference in 
their mechanical characteristics could also explain the ease with which microneedle insertion 
instigated by the clinical applicator caused significant deformation in abdominal tissue as 
compared to back tissue. Furthermore, back tissue has a higher elastic modulus as compared 
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to abdominal tissue (Zak et al., 2011). Similarly, in this thesis, the elastic modulus of back 
skin was higher than abdominal skin as reported in Section 5.2. Moreover, in the literature, it 
was mentioned that the difference in skin thickness was found to affect its viscoelastic 
characteristics (Nguyen and Banga, 2015), as a full thickness skin sample was found to be 
more elastic and more resistant to microneedle insertion force (Nguyen and Banga, 2015). 
The mechanism of the clinical applicator required manual pressure to be applied on the 
microneedles in addition to the clinical applicator force. Therefore, this added manual 
pressure may have also contributed to the extent of the deformation within the thinner 
abdominal tissue as compared to the thicker back tissue. There was also a difference in 
insertion force for abdominal and back skin models, with a higher insertion force required for 
back skin and a lower insertion force required for abdominal skin. This suggests that insertion 
force varies according to skin site, even though a similar magnitude of maximum force was 
applied on both skin models. 
5.4.3 The role of the subcutaneous mimic property on microneedle 
performance 
The mean penetration depth increased with increasing water content in the subcutaneous 
mimic, which were similar to the results of the impact applicator studies. The breach area 
increased with increasing water content in gelatine gels for abdominal skin, however, at the 
most compliant gel water content (96%), it reduced. This trend was not observed for back 
skin model and therefore, a plausible explanation for this outcome would be that back skin is 
stiffer and thicker. 
The median values of breach areas for the abdominal skin model was around 10 000 m2 as 
compared to the back skin model, which was circa 5000 m2 for Models 1B and 3B. There 
appeared to be no obvious trend for the effects of the influence of the subcutaneous mimic. It 
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was noted however, that in terms of the length of the microneedle embedded in skin that at 
least 50–60% of the microneedle length breached skin’s layers, which was in accordance with 
trends observed (Coulman et al., 2010; Donnelly et al., 2010; Kalluri et al., 2011), 
irrespective of fluid content in the subcutaneous layer 
5.4.4 Clinical applicator force 
There was an increase in insertion force with increased gel water content for abdominal and 
back skin models. This trend was also observed for the maximum force on both skin models. 
Although, there were no successful micromechanical tests conducted on the 96% gelatine gel 
because of its extremely high water content, logically, it can be assumed that it would have 
exhibited the lowest elastic modulus of the gelatine gels. Likewise, it can also be stated that at 
the lower water content gelatine gel such as 67%, its higher elastic modulus would require a 
higher insertion force. As reported by Cheung et al. a high elastic component (G´) indicates 
that the skin will be more resistant to microneedle insertion (Cheung et al., 2014). It was 
found that the insertion force was lowest on Model 1A, containing the lowest water content 
gelatine gel and could be due to the elastic modulus of skin being lower than that of the 67% 
gelatine gel. Furthermore, as skin is the first surface that experiences the effects of the 
clinical applicator force could explain why a low insertion force was required for the 
microneedle to perforate skin for Model 1A. Therefore, the contributions from varying the 
water content in the gelatine gels is more pronounced in terms of how the clinical applicator 
insertion force is applied on the microneedle. Therefore for Model 4A, the highest insertion 
force recorded may have been as a result of the compliant nature of the 96% gelatine gel 
which led to the clinical applicator probably interfacing with the Perma-Gel
®
. A similar trend 
was also observed for back skin models. 
In the study by Donnelly et al., it was reported that microneedle penetration could occur at a 
relatively low insertion force of 4.4 N/array (0.49 N/microneedle) using a spring-driven 
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applicator. The clinical applicator used in this study is also spring-driven; however, the 
addition of a hammer in its design means that it performs differently to a solely spring-driven 
applicator. The clinical applicator produced an insertion force of ≈68 N/array (0.011 
N/microneedles) for Design 2 microneedles on skin Model 3B. Furthermore, other 
microneedle applicator types that are not spring-driven yielded low insertion forces (Olatunji 
et al., 2013; van der Maaden et al., 2014; Qiu et al., 2015). For example, in the study by 
Olatunji et al. their applicator device produced an insertion force of 0.03 N/microneedle, 
which is in the same order of magnitude as the clinical applicator insertion force. Although 
Donnelly et al. reported a low insertion force, their insertion force per microneedle was 
considerably greater than the insertion force utilised in this study. 
5.4.5 The effects of microneedle geometry on skin penetration 
Visual assessment of methylene blue images showed comparable microneedle performance 
on the stratum corneum for Design 1 and 2 microneedles. The analysis of H&E images 
indicated that Design 1 microneedles were completely embedded in Model 3B at a 
perforation depth of 311 m considering the microneedle length is 356 m (Fig. 78). Hence 
the deformations were more significant as compared to those caused by Design 2 
microneedles, which had a perforation depth of 360 m, approximately 65% of its length 
travelled within skin. This may have been as a result of the number of microneedles on the 
array for Design 2 microneedles as compared to less densely populated Design 1 
microneedles. 
The insertion force applied on Design 1 and 2 microneedles were of similar magnitude, 
which meant that the same amount of force was acting on the less densely populated Design 1 
microneedles (0.051 N/microneedles) as compared to the more densely populated Design 2 
microneedles (0.011 N/microneedles). As already stated in Section 5.3.5, several studies have 
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been conducted in the literature with respect to microneedle length and its influence on 
perforation depth. Furthermore, according to Kochhar et al., a decrease in the number of 
microneedles on an array and increased spacing, produced an incremental force per needle 
and a higher percentage of microneedle penetration (Kochhar et al., 2013b), which was 
consistent with the findings in this section on the variation of microneedle length. The 
general conclusion from the literature is that variables such as needle density, interspacing 
and needle length contribute significantly to perforation depth. Therefore, for the work in this 
study, it was observed that the size of the deformations caused in skin was not commensurate 
with the size of the insertion force imposed upon the microneedles by the clinical applicator 
as compared to the impact applicator. 
For the clinical trials, an understanding of the role of microneedle length is important for in 
vivo work. Nguyen and Banga showed that as the microneedle length increased, drug delivery 
increased and was as a result of microneedle treatment duration and equilibration time 
(Nguyen and Banga, 2015). Although this implies that the microneedles travelled deeper into 
skin, however, consideration must be given to the duration that the microneedles were left in 
skin as this could explain the improved drug delivery in their study. This is because the 
duration of the microneedles in skin results in more time for the drug to have diffused into 
skin and not necessarily improved microneedle penetration of skin. Gupta et al. demonstrated 
that extremely long microneedle projections (1500 m) can cause pain comparable to that of 
a hypodermic needle in patients (Gupta et al., 2011). This observation was also consistent 
with previous literature that indicated that for the design of the microneedle, the length of the 
microneedle projection was the most important aspect in the measurement of pain (Gill et al., 
2008). Furthermore, clinical trials using the clinical applicator on Design 2 microneedles 
produced minimal pain and bleeding in patients (Renephra, 2015). 
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In terms of breach areas, Design 2 microneedles produced a higher number of perforations in 
the breach area category where the stratum corneum was fully bypassed and the deformation 
extended into the epidermis. At breach areas greater than this, Design 1 microneedles 
performed considerably better than Design 2 microneedles. Therefore, as there is a higher 
insertion force per microneedle acting on Design 1 microneedles as compared to Design 2 
microneedles would explain the greater deformation produced by Design 1 microneedles as 
compared to Design 2 microneedles. This result demonstrates that the clinical applicator is 
affected by microneedle geometry and therefore, the clinical applicator should be used on 
Design 2 microneedles. 
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5.5   Comparison between Impact and Clinical Applicator Studies 
Two types of microneedle applicators were used to insert microneedles into the abdominal 
and back skin models for the work in this thesis. The microneedle applicators employed 
different mechanisms for operation; the impact applicator depended on impact acceleration to 
drive the microneedles into skin, whilst the clinical applicator design was based on a spring 
and hammer mechanism. Therefore, it was important to assess microneedles interaction with 
the skin models by comparing the results from both applicators. The impact applicator setup 
allowed for measurements of insertion force and insertion velocity, whilst only measurements 
of insertion force were obtained from the clinical applicator setup. A comparison of impact 
and clinical applicator tests are discussed in this section. 
5.5.1 Penetration efficiency 
PE can be defined as the percentage of the number of blue spots from the methylene blue 
staining of microchannels created by a microneedle array on the stratum corneum, divided by 
the total number of microneedles on the array. It was found that 100% penetration was not 
observed using both applicators and these results were consistent with findings from other 
researchers using different designs of applicators (Kolli and Banga, 2008; van der Maaden et 
al., 2014; Xiang et al., 2015). PE varied from 43–93% for the regions analysed using the 
impact applicator to 39–80% for the regions analysed using the clinical applicator, thus, these 
ranges are similar. The results in study were better as the arrays used were more densely 
populated. Likewise, for both applicators it was not possible to observe microneedle 
perforations every 360 µm during the analysis of H&E images. 
Furthermore, for the impact applicator, PE reduced for abdominal skin models and increased 
for back skin models with increasing water content in the subcutaneous mimic. Conversely, 
for the clinical applicator, PE reduced for both skin models with increasing water content in 
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the subcutaneous mimic. It would appear that with the clinical applicator, compliance of the 
subcutaneous layer had a profound effect on PE even in the stiffer and thicker back skin. 
Therefore, PE did not reduce drastically with compliance in back skin with the impact 
applicator as it did with the clinical applicator. These differences in the outcome of applicator 
performance may have been due to the physical act of pressing the applicator onto the 
microneedles on skin in order to use the clinical applicator. This approach introduces some 
variability associated with the initial manual pressure applied on the microneedles. For the 
impact applicator however, as the drop mass is released, there is no added intervention to 
facilitate microneedle application to skin. 
5.5.2 The effects of differences in skin properties 
With the impact applicator, the size of the deformation increased with increased water 
content for abdominal skin. However, with the clinical applicator the size was considerably 
larger and was contained in the dermis for all abdominal skin models. For the back skin 
model, the deformations were predominantly contained within the epidermis for both 
applicators. This highlights the role that the physiological differences between abdominal 
tissue and back tissue play in applicator induced microneedle interaction with skin, as larger 
deformations were found within the thinner abdominal tissue as compared to back tissue. 
Therefore, for the work carried out in this thesis, it was the abdominal skin models that 
underwent larger deformations in comparison to the back skin models irrespective of 
applicator type. 
5.5.3 The effect of the subcutaneous mimic property on microneedle 
performance 
The average perforation depth in abdominal skin models was higher for the impact applicator 
as compared to the clinical applicator. This suggests that the impact applicator performs 
comparatively better than the clinical applicator on abdominal skin models. For the breach 
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areas, the impact applicator had a higher percentage in the category where the stratum 
corneum is disrupted and extends to the epidermis in the abdominal skin model (Fig. 88a), 
whilst the clinical applicator had a higher percentage of breaches in the category where the 
epidermis is fully opened up. 
There was no obvious trend for perforation depth for back skin models and this indicated that 
there was a higher degree of variability associated with back skin models. The clinical 
applicator had higher percentages of breaches for ≤ 10 000 m2 as compared to the impact 
applicator (Fig. 88b) for the back skin models. This also implies that the clinical applicator is 
able to overcome the elastic modulus of the stiffer back tissue as compared to the impact 
applicator. Although, it must be noted that the clinical applicator produced a higher number 
of smaller perforations in back skin as compared to the impact applicator’s lower frequency 
of larger perforations in back skin. Ideally, larger perforations are preferred, as there are 
higher chances that the perforations have extended beyond the stratum corneum into the 
epidermis, where the fluid bed can be accessed for fluid extraction. 
The analysis of H&E images showed that with the impact applicator larger deformations 
were made as determined by the breach area with increasing fluid content in the abdominal 
skin models. It was therefore established that manipulating the water content in the gelatine 
gels compromised the integrity of the abdominal skin model. In contrast, the size of the 
breach area in the back skin model reduced with increased fluid content in the gelatine gels 
and may be due to a combination of the magnitude of the insertion force per microneedle as 
well as its higher elastic modulus. For the clinical applicator however, smaller breach areas 
were seen in the abdominal skin model across all gelatine gel concentrations for deformations 
contained within the epidermis as compared to back skin model. For deformations that 
extended into the dermis however, larger breach areas were seen in the abdominal skin model 
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as compared to back skin model. These observations have highlighted the influence of 
applicator input in perforation quality, where it appears that the size of the breach area 
produced by the impact applicator is influenced by the mechanical strength of the skin model, 
which was not the case with the clinical applicator. The contrast in applicator performance 
may be due to application technique, for instance, the impact applicator’s drop mass is 
released from a height to make contact with the microneedles and skin model. In the case of 
the clinical applicator, the patch button is placed onto the microneedles and skin model, with 
an initial manual pressure applied onto the patch button before the trigger is released and 
therefore could be a likely explanation for the difference in perforation quality between both 
applicators. Furthermore, the results of clinical applicator studies showed large SD values 
(Fig. 81), which imply the high degree of variability linked to use of the clinical applicator as 
compared to the impact applicator. 
5.5.4 Impact and clinical applicator force 
For the impact applicator, an insertion force of ≈0.005 N/microneedle was required to 
perforate Models 1A–4A. In contrast, for the clinical applicator, an insertion force of 0.006–
0.016 N/microneedle was required for Models 1A–4A. Conversely, for the back skin models, 
a slightly higher insertion force (0.004–0.007 N/microneedle) was required for microneedle 
application using the impact applicator. For the clinical applicator, an insertion force of 
0.009–0.016 N/microneedle was required. It was observed that the clinical applicator’s 
performance was hugely influenced by fluid content in the gelatine gels, as it produced its 
highest insertion force on Models 4A (94. 03 N) and Model 4B (96.05 N). Therefore, it was 
postulated that due to the compliant nature of the 96% gelatine gel concentration, it is 
plausible that the clinical applicator interfaced with the Perma-Gel
®
 layer in the skin model. 
Notably, the Perma-Gel
®
 also had the highest elastic modulus in the skin model, as shown in 
Table 12. 
189 
  
The ability to vary the insertion force and insertion velocity for the impact applicator is a 
significant advantage over the clinical applicator, where the insertion force cannot be varied. 
Furthermore, only a relatively low insertion force and a low insertion velocity as compared to 
the clinical applicator’s comparatively higher insertion force was required to successfully 
penetrate skin irrespective of the level of fluid content in the underlying subcutaneous layer. 
Albeit, this limitation with the design of the clinical applicator has demonstrated how the 
application of an insertion force on biological tissue such as skin is absorbed, since it appears 
that the underlying subcutaneous layer of the gelatine gel at its highest fluid content was 
unable to withstand the clinical applicator’s insertion force. Generally, the clinical 
applicator’s insertion force was higher than the impact applicator’s insertion force and was in 
the order of 2–7 times the force produced by the impact applicator. In this thesis, both devices 
produced reproducible microneedle penetration of both skin models. Therefore, the impact 
applicator at a relatively lower insertion force yielded similar if not better results when 
compared to the outcome of tests involving the clinical applicator. 
The other parameter that contributed to the impact applicator performance was the influence 
of insertion velocity. Most microneedle studies have relied on only insertion force (Park et 
al., 2005; Donnelly et al., 2010; Kochhar et al., 2013b; Olatunji et al., 2013) or only insertion 
velocity (Verbaan et al., 2008; van der Maaden et al., 2014) to assess successful microneedle 
perforation of skin. The novelty of the work carried out in this thesis was the ability to vary 
insertion force and insertion velocity using the impact applicator setup. 
Furthermore, the relatively low insertion force and low insertion velocity using the impact 
applicator system provides an alternative applicator design for Renephra to achieve 
reproducible perforation of skin. 
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5.5.5 The effect of microneedle geometry 
For the impact and clinical applicator, reproducible penetration occurred in abdominal and 
back skin models at all gelatine concentrations with Design 2 microneedles. The clinical 
applicator produced better perforation results with Design 2 microneedles as compared to 
Design 1 microneedles. This could be due to an inherent design feature of the clinical 
applicator, as it has already been demonstrated through the work carried out in this thesis that 
the clinical applicator produced a higher frequency of smaller perforations in skin with 
Design 2 microneedles. This outcome indicates that for the clinical applicator, the length of 
the microneedles is important for effective skin penetration. Hence, as the results have 
shown, the length of the shorter Design 1 microneedles is not adequate for effective skin 
penetration using the clinical applicator. 
Although the magnitude of force produced by the clinical applicator was similar for both 
Design 1 and 2 microneedles, variables such as needle density differed. This difference meant 
that a greater insertion force per microneedle was acting on Design 1 microneedles (0.051 
N/microneedle) as compared to Design 2 microneedles (0.011 N/microneedle). Despite the 
lower force applied to Design 2 microneedles, it still produced better penetration results when 
compared to the penetration results of Design 1 microneedles. Therefore, the result reinforces 
the fact that clinical applicator performance is influenced by microneedle geometry. 
Contrastingly, the impact applicator system was not influenced by microneedle geometry, 
which means that both Design 1 and 2 microneedles can be successfully applied to skin. 
Furthermore, comparing the insertion force per microneedle applied to Design 1 
microneedles by both applicators showed an insertion force of 0.007 N/microneedle for the 
impact applicator as compared to the clinical applicator’s insertion force of 0.051 
N/microneedle. The value of the clinical applicator’s insertion force was more than 7 times 
that of the impact applicator. Despite this difference in insertion force per microneedle, the 
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impact applicator still had a higher perforation depth as compared to the clinical applicator. 
The better perforation depth produced by the impact applicator could also be due to 
contributions from insertion velocity. 
Moreover, the highest perforation depth for Design 1 microneedles (Fig. 90) showed that the 
impact applicator caused 98% of the microneedle length to disrupt skin’s layers as compared 
to the deformation caused by the clinical applicator which only involved 56% of the 
microneedle length. In addition, for Design 2 microneedles, the insertion force per 
microneedle for impact applicator was 0.004 N/microneedle as compared to 0.011 
N/microneedle for the clinical applicator. Again, the value of the clinical applicator insertion 
force per microneedle was more than twice that of the impact applicator. Furthermore, the 
highest perforation depth for Design 2 microneedles (Fig. 90) showed that at this 
comparatively lower insertion force, the impact applicator caused 52% of the microneedle 
length to disrupt skin’s layers. For the clinical applicator however, with more than twice the 
insertion force as compared to the impact applicator only caused deformation in tissue 
utilising 65% of the Design 2 microneedle length. Therefore, the insertion force and the 
geometry of the microneedles (i.e. needle density, interspacing and needle length) influence 
how microneedles interact with skin for the clinical applicator. 
Generally, a higher number of deformations caused by the clinical applicator were found in 
the first category at a measurement range of ≤ 10 000 m2, where the stratum corneum is 
disrupted and the deformation extends into the epidermis. And the more significant 
deformations caused by the impact applicator were located within the epidermis at a 
measurement range of 10 000–20 000 m2. This observation was consistent with the result of 
the perforation depth, which showed that for the highest perforation depth, some of Design 1 
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microneedles were fully embedded in skin for the impact applicator as compared to more 
than half the length of Design 2 microneedles embedded in skin for the clinical applicator. 
Although, it was not possible to test whether or not the nerves were stimulated due to 
microneedle application for either in vitro applicator studies, the literature has already 
established that microneedle projections of 1500 m or more will stimulate the nerves in skin 
and thus cause pain as they reach into the dermis (Gill et al., 2008; Gupta et al., 2011), 
therefore, Design 1 and Design 2 microneedles of length 356 m and 552 m respectively 
were not within the threshold to cause pain. Furthermore, in vivo studies using Design 2 
microneedles inserted into skin with the comparatively higher insertion force of the clinical 
applicator demonstrated that patients experienced minimal pain (Renephra, 2015). 
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5.6   Summary 
Several factors need to be considered for successful microneedle application to skin. 
Parameters such as microneedle geometry, microneedle applicator, insertion force and 
insertion velocity, influence of anatomical site and altering the fluid content in the 
subcutaneous layer of skin were investigated so as to determine effective microneedle 
penetration of skin. 
The work in this thesis demonstrated that reproducible microneedle penetration was achieved 
utilising the impact and clinical applicators. Based on the outcome of individual studies of the 
impact and clinical applicator performance, the results showed that the impact applicator 
produced better penetration results as compared to the clinical applicator, as it produced 
better PE and caused more deformation in skin at a lower insertion force. In addition, a 
disadvantage of the clinical applicator was that its performance was dependent on 
microneedle design. The clinical applicator produced better results for Design 2 microneedles 
as compared to Design 1 microneedles. For the impact applicator however, its performance 
was not microneedle geometry dependent. 
The insertion force was considerably higher for the clinical applicator as compared to the 
impact applicator. Despite the fact that more than twice the insertion force was produced by 
the clinical applicator on Design 2 microneedles as compared to the impact applicator, the 
magnitude of the insertion force was not commensurate with the size of the deformation 
created by the clinical applicator. In the case of the impact applicator, the magnitude of the 
force was commensurate with the size of the resulting deformation in skin. 
The viscoelastic properties of skin contributed to microneedle performance, as thinner 
regions of skin such as abdominal tissue were less resistant to microneedle intervention. 
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Furthermore, the results of impact applicator studies showed that the insertion force applied 
to abdominal tissue was lower as compared to the force applied to back tissue. 
The influence of the subcutaneous mimic was observed in the abdominal skin models 
following impact applicator tests, as the maximum force declined with increasing fluid 
content. Furthermore, a relationship between maximum force and the elastic modulus of the 
gelatine gels of the subcutaneous mimic was also established, because an increase in the 
elastic modulus of the gelatine gels resulted in an increase in maximum force. Hence, for 
microneedle application studies, contributions from the subcutaneous layer of skin should not 
be ignored as it affects parameters such as force, which influence microneedle behaviour in 
skin. 
For effective microneedle application to skin, the impact applicator is a more suitable device 
because it operates at a relatively low insertion force and insertion velocity as compared to 
the clinical applicator. It also produced larger deformations within skin, which is important 
for the success of microneedle technology like the TFR, as fluid can be more readily 
extracted from the larger fissure. Furthermore, the ability to control the force and velocity 
means that the parameters of the impact applicator can be tailored to suit specific patient 
requirements. 
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Chapter 6 
6. Conclusions and Further Work 
6.1   Summary 
Fluid overload or oedema is associated with heart and kidney failure and remains a global 
challenge. Based on work by Renephra, a novel medical device, the TFR utilising 
microneedle technology is under development for the relief of fluid overload. TFR could lead 
to a reduction in the amount of fluid overload or oedema and improved patient prognosis. As 
such, there was a need to understand the mechanical behaviour of skin and how it influences 
the performance of microneedle devices. In order to investigate this, microneedle tests on 
skin were necessary, however, most in vitro and ex vivo experimentation studies used to 
evaluate microneedle performance do not consider the biomechanical properties of skin or 
that of its subcutaneous layers. Therefore, a representative in vitro skin model was developed 
for microneedle application studies. Typically, microneedles are not designed to travel 
beyond the epidermis to the dermis where nerve endings may be stimulated or blood vessels 
damaged. Hence, minimal or no pain or bleeding occurs to the patient following microneedle 
application. Despite significant advances in the field of microneedles, the complexity of the 
mechanical behaviour of skin coupled with the inherent elasticity of the stratum corneum still 
pose a challenge for microneedle application. 
The primary aim of the work carried out in this thesis was to investigate microneedle 
performance in a representative in vitro skin model by establishing the optimal parameters for 
reproducible penetration of skin. Furthermore, by altering the fluid content in the 
subcutaneous layer of the skin model, an understanding of the interaction between the 
biomechanics of the skin layer and microneedles was revealed. Additional parameters such as 
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microneedle geometry, applicator type further established the intricacies associated with 
producing repeatable perforation of skin. 
6.2   Conclusions 
The aims and objectives of this study were achieved using a range of techniques, namely; 
impact applicator tests, clinical applicator tests, micromechanical tests using dynamic 
nanoindentation, methylene blue staining, H&E image analysis and Image SXM custom 
image analysis software. Consequently, the results of the experimental phase of the study 
using the aforementioned techniques and material acquired within the literature led to the 
following conclusions:  
6.2.1    Experimental analysis of the mechanical properties of skin 
Micromechanical tests were conducted on skin samples from the abdominal and back regions 
of neonatal pigs; on three concentrations of the gelatine gels, as the fourth gelatine gel 
concentration was too compliant and on Perma-Gel
®
. Perma-Gel
®
 produced the highest 
elastic modulus, which showed that it made a significant contribution to the other layers in 
the skin model. Of the gelatine gels, the gel with the lowest water content produced the 
highest elastic modulus. Furthermore, the elastic modulus decreased with increasing water 
content in the gelatine gels. This observation demonstrated that excessive fluid in the skin 
model compromised its mechanical integrity. The back region of skin produced a higher 
elastic modulus as compared to the abdominal region. The physical attributes of the back 
region were also different from the abdominal region and could also explain the difference in 
their mechanical properties. For instance, back tissue was thicker and stiffer than abdominal 
tissue. 
Skin is an extremely complex functional system made of three stratified layers that are made 
up of sub-layers. The natural function of skin is to act as a chemical barrier, limiting 
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penetration by foreign substances and preventing loss of water and other fluids. The barrier 
function is located in the stratum corneum. In order to breach the stratum corneum for 
microneedle application, numerous in vitro tests using microneedles were carried out on a 
variation of abdominal and back skin models. The literature review highlighted that 
unrepresentative or even inappropriate experimental skin models had been used previously in 
other studies. The main drawback with the skin models used in the literature was that the 
material used as underlying substrates were not representative of biological material and 
would therefore exhibit a different mechanical behaviour as compared to a biological material 
like tissue fluid or muscle found in skin’s underlying layers. Therefore, the representative in 
vitro skin model used in this thesis comprised neonatal porcine skin, gelatine gels at various 
concentrations to mimic the subcutaneous layer and Perma-Gel
®
 to mimic muscle behaviour 
and to also provide adequate support. Furthermore, for a reasonable evaluation of 
microneedle interaction with skin, it was important to establish this type of representative 
skin model.  
6.2.2    Development of the impact applicator system 
The second objective was to develop an impact applicator system. The literature covered 
numerous designs for a microneedle delivery device such as an electrically driven 
applicator, an actuator driven applicator, a Dermaroller
®
 and syringe applicators etc. For 
reproducible microneedle application to skin, an external force was required. After careful 
consideration of these various designs, it was imperative to develop an impact applicator 
that was suitable for purpose. The literature recommended a velocity in excess of 2 ms
-1
 as a 
reasonable microneedle insertion velocity. Therefore, a dropped weight impact-testing rig 
was developed that could produce velocities in excess of 1 ms
-1
. Furthermore, the force 
could be measured from the drop mass using a force transducer. 
The optimal parameters for reproducible microneedle penetration of skin utilising the 
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impact applicator setup were established in this study for Design 1 microneedles on skin 
Model 3B and it was 3 ms
-1
 velocity with a 36 g drop mass. These parameters were used for 
the rest of the study involving Design 2 microneedles on abdominal and back skin models at 
all gelatine gel concentrations.  
The results of the impact applicator setup demonstrated that the mechanical behaviour of skin 
influences microneedle performance. The microneedle geometry also influenced penetration, 
as the less densely populated Design 1 microneedles caused significant deformation within 
skin’s layers as compared to the more densely populated Design 2 microneedles. 
6.2.3    The clinical applicator system 
The third objective was to carry out a study using the clinical applicator and to compare the 
results with the impact applicator system. The study revealed that both applicators produced 
reproducible microneedle penetration. The impact applicator performed better than the 
clinical applicator because it had better PE, caused more deformation in skin at a relatively 
lower insertion force as compared to the clinical applicator. Moreover, the performance of the 
impact applicator was not affected by microneedle geometry, which was not the case with the 
clinical applicator as it produced poorer perforation results with Design 1 microneedles as 
compared to Design 2 microneedles. The clinical applicator insertion force was about twice 
that of the impact applicator insertion force for Design 2 microneedles and more than seven 
times that of the impact applicator insertion force for Design 1 microneedles. 
Ideally, microneedle application should be contained within the epidermis in order to avoid 
stimulation of nerve endings and blood vessels that may cause pain and bleeding in vivo. 
Therefore, the comparison study identified the impact applicator as the preferred method of 
microneedle application because penetration could be achieved at a relatively low insertion 
force, with the deformations contained within the epidermis. 
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Although, the research in this thesis did not involve ISF extraction, the microneedle 
penetration studies in vitro were important in determining the effects of Design 2 
microneedles perforations across the layers through histology staining and image analysis to 
complement the in vivo work carried out by Renephra Ltd. Their recent studies show that ISF 
was extracted following the application of Design 2 microneedles and negative pressure 
therapy in 56% cases as compared to the use of a hypodermic needle, which gave a 10% 
success rate. The ISF extracted was 800 mL over 4 hours using a 10 × 10 cm surface 
(Renephra, 2015). Mukerjee et al. was arguably the first to successfully demonstrate the 
feasibility of using hollow microneedles and capillary action to extract ISF from skin 
(Mukerjee et al., 2004). Furthermore, Wang et al., (2005) extracted a considerably small 
amount of ISF (1–10 L) for glucose monitoring using solid microneedles and negative 
pressure therapy. 
6.2.4    Quantitative image analysis of microneedle treated skin 
The fourth objective was to conduct extensive image analysis of the perforated skin. The 
evaluation of the microchannels created in the skin following microneedle treatment was 
determined through methylene blue staining, H&E staining and quantitative image analysis. 
The methylene blue dye adhered to the microchannels created in the tissue, the histology 
images showed the depth of microneedle penetration through skin’s sub-layers and image 
analysis provided the size of the deformation area within the H&E stained images.  
Although the methylene blue stained images confirmed successful breach of the stratum 
corneum, it was the H&E stained images that indicated that in some instances not all the 
microneedles had completely bypassed the stratum corneum to fully perforate the epidermis. 
Furthermore, the H&E stained images also revealed those instances where the deformation 
caused by microneedle intervention had travelled beyond the epidermis into the dermis.  
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For a complete analysis of the H&E stained images, it was important to carry out image 
analysis of over 30 images per skin model in order to better determine the effects of the 
microneedle deformation through skin’s layers. Interestingly, the image analysis 
demonstrated that the clinical applicator device is affected by microneedle geometry as 
demonstrated by the differences in magnitude of the deformations caused by Design 1 and 2 
microneedles in Model 3B. 
A pilot study of 3D imaging of microneedle treated skin was conducted using XMT to 
compliment the analysis of H&E images. The results of the XMT analysis showed that it was 
a promising technique for microneedle application to skin. Further details of XMT can be 
found in Section 8.1 of the Appendix. 
Finally, the findings in this project such as the optimal parameters for reproducible 
microneedle penetration of skin, the contribution of skin’s mechanical properties, the effects 
of a variation of the water content in the gelatine gels as a mimic for tissue fluid in the skin 
model, the influence of anatomical site, microneedle geometry and the magnitude of 
deformations caused by microneedle treatment of skin could be used to aid the development 
of Renephra’s microneedle fluid extraction device (TFR). Based on the outcome of the study, 
Renephra could develop an applicator similar to the impact applicator that can measure the 
insertion force and insertion velocity, as it has been demonstrated that the clinical applicator 
produces high forces and is affected by microneedle geometry.  
6.3   Further Work 
The work carried out during this study provides important information related to the 
mechanical behaviour of skin and how it affects microneedle performance. Based on the 
work carried out during this study, there are still many opportunities for further advances 
through research and a few potential studies are mentioned in this section. 
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6.3.1    3D image analysis of microneedle treated skin 
The emergence of micro XMT as an imaging tool for soft tissue could provide the 
opportunity to image a whole sample of microneedle treated tissue, without going down the 
laborious route of H&E staining. The limitation with H&E staining is that it affords only a 
small area for sectioning, with the remaining tissue containing vital information discarded. 
The main drawback of micro XMT imaging of soft tissue is that grayscale colour contrast is 
challenging to decipher. The non-destructive method of examining skin using XMT is a 
promising technique for determining microneedle induced breach in skin. The challenge 
remains that consideration needs to be given to an adequate staining protocol in order to 
achieve good contrast definition between skin’s layers without having to undergo the arduous 
and time-consuming task of having to carry out a significant amount of manual segmentation 
of the images caused by noise in the data or poor contrast. 
Further, development of the staining and image segmentation methods for soft tissue XMT 
may make this a powerful technique for microneedle research. 
6.3.2    Optical Coherence Tomography studies of microneedle application 
to skin 
The primary focus of this thesis was on the in vitro studies of microneedle performance in a 
representative skin model. The data obtained from the work carried out on the representative 
in vitro skin model is useful for improving the microneedle device, however, the in vitro skin 
model still has a limitation in that it cannot in its entirety fully mimic all the mechanical 
characteristics of the in vivo skin such as anisotropy, viscoelasticity, non-linearity, patient 
age, progression of the disease. These factors contribute to the overall behaviour of skin and 
its interaction with microneedles. 
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Therefore, an exhaustive in vivo investigation into microneedles interaction with skin should 
be conducted using techniques like OCT as shown in Fig. 93. The stratum corneum is visible 
in the image; however, it is challenging to determine the epidermal and dermal layers in Fig. 
93b. Therefore, further work is required to ascertain whether OCT can be utilised for in vivo 
studies of microneedle perforated skin. 
 
Figure 93 Optical Coherence Tomography images of skin, where (a) palmar region of skin with no 
microneedle perforations and (b) skin from the inner wrist with microneedles embedded. (Courtesy 
Renephra Ltd). 
6.3.3    Impact applicator 
The results produced by the impact applicator demonstrated that reproducible penetration of 
skin could be achieved at a relatively low force. It was further demonstrated that penetration 
was achieved irrespective of Design 1 or Design 2 microneedles, which is a good indication 
that it can perform well with some changes in microneedle design. As the applicator system 
was a rather large setup that was difficult to move to various locations, it would be 
advantageous for a smaller device to be manufactured in its place. The new device could be 
based on the parameters of the improved impact applicator setup, thus having the ability to 
vary its velocity and force. This device could then be used for further in vitro studies, 
whereby the design of microneedles are restricted to just one variable i.e. varying only the 
interspacing between individual microneedles or only the height of the microneedles. As a 
203 
  
further improvement to the subcutaneous mimic in the in vitro skin model, fluid could be 
injected into a membrane placed within the subcutaneous layer. Furthermore, the device 
could possibly be utilised for in vivo studies. 
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Chapter 8 
8. Appendix 
8.1   3D Image Analysis using XMT 
XMT imaging was performed on skin Model 3A. The staining and wax embedding protocol 
is summarised as follows: full thickness microneedle treated skin was soaked in 
paraformaldehyde for 4 hours and then rehydrated in PBS solution for 5 mins. The tissue was 
then subsequently stained with Lugol’s contrasting agent for 21 hours. After staining, the 
sample was washed three times in water and placed in 70% ethanol for 15 mins, then in 90% 
IMS for 15 mins, followed by 15 mins in 100% ethanol and then 3 xylene washes of 30 mins. 
Finally, it was placed on the processor for wax embedding for 30 mins. 
The skin was then imaged on a Carl Zeiss Xradia MicroXMT-500 system using 4× objective, 
with a source voltage of 45 kV, a source current of 78 A and a power source of 3.5 W. The 
sample was positioned 8 mm from the source and 45 mm from the detector. 
The size of the sample was approximately 2 × 2 mm, 1015 TIFF images were obtained using 
Avizo 8 imaging software (FEI
™
, Oregon, USA). The image stacks were opened in ImageJ 
using the orthogonal selection. The XY view showed the vertical cross-section of the skin 
through the stratum corneum, epidermis and dermis, whilst the XZ view showed the planar 
cross-section of the skin through the dermis. In the case where the XY view showed that 
there was no breach of skin’s layers, no disruption was seen in XZ view. When there was a 
breach, this was observed in the XY view and confirmed by the disruption in the XZ view. A 
single image was analysed following confirmation of the breach in skin as shown in the 
region shaded red in Fig. 94. 
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Figure 94 Breach area selection on XMT image of microneedle treated skin. Scale bar represents 100 m. 
3D reconstruction of the image stacks was carried out using Avizo 8 and prior to 
segmentation, noise in the data was reduced by applying a non local means filter. In some 
areas of the images the contrast was poor and therefore, manual adjustments to the 
segmentation were necessary. This process was labour intensive and improved staining 
techniques is required to ensure that there is better contrast between the layers of skin so as to 
reduce the time spent in manual segmentation of the data. 
Skin Model 3A was used for the 3D image analysis because of the thinner, less stiff 
abdominal skin and the high volume of water content, compliant gelatine gel as determined 
from micromechanical tests. The volume rendered image of Model 3A presented in Fig. 95 
shows the irregular surface topography of the stratum corneum. The lines in the skin are 
highlighted; however, it is challenging to detect any perforations caused by the application of 
microneedles using the impact applicator in the reconstructed image. 
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Figure 95 Volume rendering showing the output of the segmentation process on microneedle treated 
Model 3A, showing the stratum corneum and epidermal layers only. Scale bar represents 100 m. 
In addition, Fig. 96 shows the various orthogonal views of the reconstructed image. The 
different views show that skin is not a flat surface, but consists of many undulations. These 
undulations vary in size and depth. 
 
Figure 96 Volume rendering showing the various orthogonal layouts of the 3D image of the skin, where 
(a) XY, (b) XZ and (c) YZ. Scale bar represents 100 m. 
232 
  
Furthermore, a comparison of the breach area for the XMT image analysis and H&E staining 
is shown in Fig. 97. The stratum corneum, epidermis and dermis are well defined for the 
H&E images (Fig. 97a) and are comparable to the XMT images (Fig. 97b). The H&E stained 
skin appears to be prone to sectioning induced artefacts (Fig 97a), which does not appear to 
be the case for the XMT image (Fig. 97b). The microneedle induced disruption through the 
layers in the XMT image visually appears to be similar to what is observed in the H&E 
images. The delamination to the stratum corneum seen in the H&E images is also observed in 
the XMT images. 7 images were analysed for the XMT and H&E images. The breach area for 
the XMT images was 1921 ± 1682 m2 compared to that of the H&E images, which was 
3417 ± 2178 m2. The breach profiles observed with the two techniques appear comparable 
hence providing validation of the measurements from the H&E images. 
 
Figure 97 Comparison of imaging techniques on Model 3A, where (a) XMT images and (b) H&E images. 
Scale bar represents 100 m. 
This pilot study demonstrates the feasibility of utilising XMT for 3D analysis of microneedle 
perforation of skin.  
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{ = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = } 
{ } 
{ File: Microneedles.p Date: 30 Jul 2015 } 
{ } 
{ Project: Image SXM Author: S D Barrett } 
{ } 
{ } 
{ Routines for analysis of microneedles images } 
{ } 
{ Created in collaboration with: Dr Riaz Akhtar RAkhtar@liv.ac.uk } 
{ University of Liverpool } 
{ } 
{ = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = } 
{ } 
{ Version History } 
{ } 
{ v1 Beta of MNA code tested by Riaz Dec 2014 } 
{ } 
{ v2 Modified to calculate area above epidermal layer Jan 2015 } 
{ } 
{ v3 Modified to handle epidermal layer breach 25 Jun 2015 } 
{ } 
{ = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = } 
{$propagate-units} 
unit Microneedles; 
interface 
uses 
Background, FileUtils, Math, MIASMAutils, SXMcomp; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
function GetMNAver: integer; 
procedure MicroneedleSingle; { analyse a single image } 
procedure MicroneedleAnalysis; { analyse images in folder(s) } 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
implementation 
const 
MNAver = 3; { microneedle analysis algorithm version num } 
var 
MNAsingle: boolean; 
MNAstr: GPCstr; 
TempHistoMag: integer; 
UseThisInfo: InfoPtr; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
function GetMNAver: integer;  
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begin 
GetMNAver := MNAver; { make version available to other routines } 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure PreambleMNA; 
begin 
DoingMIASMA := true; 
DoingMNA := true; 
SuppressLog := true; { keep Session Log clear of clutter } 
SuppressMessages := true; { neater to not update Info window } 
SXMwindow := true; 
AbortAnalysis := false; 
OpeningCellRGBimage := true; 
Measurements := [XYLocM, AreaM]; 
TempHistoMag := HistoMag; 
HistoMag := 1; 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure FilePreambleMNA (Folder: integer); 
begin 
SLogArrayOnReset; 
DiagnosticLog(stringOf('Microneedle Analysis v', MNAver : 1)); 
DiagnosticLog('+'); 
DiagnosticLog('+Load: ' + AbbrevPathName(CellsLoadFolder, true, 50)); 
DiagnosticLog('+Save: ' + AbbrevPathName(CellsSaveFolder, true, 50)); 
DiagnosticLog('+'); 
DiagnosticLog('+'); { spreadsheet tabs } 
DiagnosticLog(stringOf('+', tab, 'Area in sq.μm')); 
DiagnosticLog(stringOf('+', tab, '-------------')); 
RefreshSessionLog; { dummy call to update SLog window } 
SuppressLog := true; { keep Session Log clear of clutter } 
SuppressMessages := true; { neater to not update Info window } 
SXMwindow := true; 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure UpdateMNAinfoWindow (MessageText: GPCstr); 
var 
FilesDoneInThisFolder, FilesDone, FilesToDo: longint; 
begin 
FilesDoneInThisFolder := FileIndexInThisFolder - 1; { index = number in this folder } 
FilesDone := FilesDoneInPrevFolders + FilesDoneInThisFolder; 
FilesToDo := NumFilesInBatch - FilesDone; 
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MNAstr := stringOf('Microneedle Analysis', cr, cr); 
MNAstr := stringOf(MNAstr, 'Analysing image ', FilesDone + 1 : 1, ' of ', NumFilesInBatch : 1, cr); 
MNAstr := MNAstr + cr + MessageText + cr; 
ShowInInfo(MNAstr); 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure MNAdiagnostics; 
begin 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure AnalyseMicroneedles (ImageNum: integer); 
var 
InfoR, InfoB: InfoPtr; 
ScaleBarPixels: integer; 
WinLeftEdge, WinBotEdge, WinRightEdge, dX, dY: integer; 
Bin, LocalMin, FirstMax, FirstMin, LastMax: integer; { SDB 25 Jun 15 } 
SaveSliceStart: integer; { SDB 25 Jun 15 } 
NumFound, xClick4, yClick4: integer; 
DistToClick4, MinDistSoFar: extended; 
i, Damage: integer; 
{ –––––––––––––––––––––––––––––––––––––– } 
procedure MakeLineInScaleBar (x1, x2, y: integer); 
begin 
with Info^ do begin 
KillRoi; 
LX1 := PixelsPerLine + x1; 
LY1 := nLines + y; 
LX2 := PixelsPerLine + x2; 
LY2 := nLines + y; 
RoiType := LineRoi; 
MakeRegion; 
RoiShowing := true; 
end; 
end; 
{ –––––––––––––––––––––––––––––––––––––– } 
procedure SetScaleFromBar; 
const 
SmallxScaleBox = 200; { rectangle in bottom right that contains scale bar } 
SmallyScaleBox = 125; 
LargexScaleBox = 300; { rectangle in bottom right that contains scale bar } 
LargeyScaleBox = 150; 
var 
xScaleBox, yScaleBox: integer; 
y, i, LeftEdge, RightEdge, ScaleBarWidth, ScaleBarSum, ScaleBarNum: integer; 
MNApixPerMicron: real; 
begin 
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RemoveZcalib; { otherwise PlotLineProfile gives odd z values } 
ScaleBarPixels := 100; { default scale 100 pix = 100 μm } 
ScaleBarSum := 0; 
ScaleBarNum := 0; 
if Info^.PixelsPerLine < 800 then begin 
xScaleBox := SmallxScaleBox; 
yScaleBox := SmallyScaleBox; 
end 
else begin 
xScaleBox := LargexScaleBox; { make search region for scale bar a bit bigger } 
yScaleBox := LargeyScaleBox; 
end; 
for y := -yScaleBox to -yScaleBox div 3 do begin 
MakeLineInScaleBar(-xScaleBox, -5, y); { take profile close to bottom right corner } 
ShowPlot := false; 
PlotLineProfile; 
ShowPlot := true; 
RightEdge := 0; 
for i := 1 to xScaleBox - 10 do 
if PlotData^[i] > 250 then { scale bar is usually black = 255 } 
RightEdge := i; 
LeftEdge := xScaleBox; 
for i := xScaleBox - 10 downto 1 do 
if PlotData^[i] > 250 then { scale bar is usually black = 255 } 
LeftEdge := i; 
ScaleBarWidth := RightEdge - LeftEdge; 
if (ScaleBarWidth > 25) and (ScaleBarWidth < 125) then begin 
ScaleBarSum := ScaleBarSum + ScaleBarWidth; 
ScaleBarNum := ScaleBarNum + 1; 
end; 
if ScaleBarNum > 4 then begin 
ScaleBarPixels := round(ScaleBarSum / ScaleBarNum); 
leave; 
end; 
end; 
MNApixPerMicron := ScaleBarPixels / 100; { scale bar always = 100 μm? } 
with Info^ do begin 
xScale := MNApixPerMicron; yScale := xScale; 
xInc := 1 / xScale; yInc := 1 / yScale; 
xSize := PixelsPerLine / xScale; ySize := nLines / yScale; 
xUnit := 'μm'; yUnit := 'μm'; 
SpatiallyCalibrated := true; 
end; 
KillRoi; 
end; 
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{ –––––––––––––––––––––––––––––––––––––– } 
function Get2clicks (var Click: ClickArray): boolean; 
var 
i: integer; 
{ –––––––––––––––––––––––––––––––––––––– } 
procedure DrawCross (mouseLoc: point); { draw cross at mouse loc } 
const 
box = 5; 
begin 
with mouseLoc do begin 
MoveTo(h - box, v); 
LineTo(h + box, v); 
MoveTo(h, v - box); 
LineTo(h, v + box); 
end; 
end; 
{ –––––––––––––––––––––––––––––––––––––– } 
procedure GetClickPos (i: integer); 
var 
mouseLoc: point; 
begin 
WaitForMouse; 
GetMouse(mouseLoc); 
DrawCross(mouseLoc); 
ScreenToOffscreen(mouseLoc); 
Click[i].pt := mouseLoc; 
end; 
{ –––––––––––––––––––––––––––––––––––––– } 
begin 
Get2clicks := false; 
SetPortWindowPort(Info^.wRef); { ensures that click coords are local, ie relative to window } 
SetCursor(ToolCursor[SelectionTool]); { make sure cursor is a cross } 
for i := 1 to 2 do begin 
SuppressMessages := false; 
ClearInfoWindow; 
ShowMessage(stringOf(MNAstr, cr, 'Waiting for click ', i : 1, '...')); 
GetClickPos(i); 
ShowMessage(' '); 
SuppressMessages := true; 
if not PtInRect(Click[i].pt, Info^.PicRect) then begin 
FlushEvents(EveryEvent, 0); { don't act on this click } 
exit; 
end; 
end; 
FlushEvents(EveryEvent, 0); { discard mouse clicks from event buffer } 
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dX := Click[2].pt.h - Click[1].pt.h; 
dY := Click[2].pt.v - Click[1].pt.v; 
Click[4].pt.h := (Click[1].pt.h + Click[2].pt.h) div 2; { centre of line } 
Click[4].pt.v := (Click[1].pt.v + Click[2].pt.v) div 2; 
SuppressBeachBall; { allows cosses to show } 
Get2clicks := true; 
end; 
{ –––––––––––––––––––––––––––––––––––––– } 
procedure TakeOutBaseline; 
{ –––––––––––––––––––––––––––––––––––––– } 
procedure MakeBaseline; 
begin 
with Info^ do begin 
KillRoi; 
LX1 := Click[1].pt.h; 
LY1 := Click[1].pt.v; 
LX2 := Click[2].pt.h; 
LY2 := Click[2].pt.v; 
RoiType := LineRoi; 
MakeRegion; 
RoiShowing := true; 
end; 
end; 
{ –––––––––––––––––––––––––––––––––––––– } 
begin 
Click[1].pt.h := Click[1].pt.h - dX div 2; { extend line from click 1 to click 2 } 
Click[1].pt.v := Click[1].pt.v - dY div 2; 
Click[2].pt.h := Click[2].pt.h + dX div 2; 
Click[2].pt.v := Click[2].pt.v + dY div 2; 
MakeBaseline; 
DoClear; { draw white line to separate damaged tissue from background } 
Click[1].pt.v := Click[1].pt.v - 1; { nudge up and do again } 
Click[2].pt.v := Click[2].pt.v - 1; 
MakeBaseline; 
DoClear; { draw white line to separate damaged tissue from background } 
KillRoi; 
SuppressBeachBall; { allows cosses to show } 
end; 
{ –––––––––––––––––––––––––––––––––––––– } 
begin 
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OrigInfo := Info; 
ResetToColour(R); 
SetScaleFromBar; 
if MNAbreach then begin { SDB 25 Jun 15 } 
ResetToColourBlind(G); 
UseThisInfo := Info; 
end 
else begin 
Info := OrigInfo; 
ResetToColourBlind(R); MedianFilter; Smooth; { prep R channel } 
SOK := DuplicateOffscreen(''); InfoR := Info; 
Info := OrigInfo; 
ResetToColourBlind(B); MedianFilter; Smooth; { prep B channel } 
SOK := DuplicateOffscreen(''); InfoB := Info; 
SOK := DuplicateOffscreen(RemoveSuffix(OrigInfo^.Title)); { use orig title (without suffix) } 
UseThisInfo := Info; { to ensure log displays correctly } 
CurrentMathOp := MinMath; 
RealImageMath := false; 
MathGain := 1.0; 
MathOffset := 0.0; 
DoMath(InfoR^.PicNum, InfoB^.PicNum, UseThisInfo, Info^.PicRect); { min of R and B ch } 
GetRidOfWindow(OrigInfo); 
GetRidOfWindow(InfoR); 
GetRidOfWindow(InfoB); 
Info := UseThisInfo; 
end; 
with Info^ do 
if nLines < ScreenHeight div 2 then ResizeSXMwindow(0) { 200% } 
else if nLines < ScreenHeight then ResizeSXMwindow(1) { 100% } 
else if nLines < ScreenHeight * 2 then ResizeSXMwindow(2) { 50% } 
else ResizeSXMwindow(3); { 33% } 
with Info^ do begin { reposition image } 
WinLeftEdge := rleft + rwidth + 16; 
MoveWindow(wRef, WinLeftEdge, PicBaseTop, false); 
WinBotEdge := PicBaseTop + round(nLines * magnification); 
WinRightEdge := WinLeftEdge + round(PixelsPerLine * magnification); 
DoHistogram; { generate histogram before smoothing it } 
GetSmoothHistogram; 
if PixelsPerLine > nLines then { put Histogram below image } 
MoveWindow(HistoWindow, WinLeftEdge, WinBotEdge + 32, true) 
else { or to right of image if image is 'portrait' } 
MoveWindow(HistoWindow, WinRightEdge + 32, PicBaseTop, true); 
DrawHistogram; 
end; 
if MNAbreach then begin { SDB 25 Jun 15 } 
FirstMax := 0; 
for Bin := 80 downto 1 do { find first local max in smoothed histogram } 
if (Histogram[Bin] > 2000) and (Histogram[Bin] >= Histogram[Bin - 1]) 
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and (Histogram[Bin] >= Histogram[Bin + 1]) then 
FirstMax := Bin; 
for Bin := FirstMax to 250 do { find last local maximum in smoothed histogram } 
if (Histogram[Bin] > 2000) and (Histogram[Bin] >= Histogram[Bin - 1]) 
and (Histogram[Bin] >= Histogram[Bin + 1]) then 
LastMax := Bin; 
for Bin := 250 downto FirstMax do { find first local minimum in smoothed histogram } 
if (Histogram[Bin] <= Histogram[Bin - 1]) and (Histogram[Bin] <= Histogram[Bin + 1]) then 
FirstMin := Bin; 
SliceStart := FirstMin + (LastMax - FirstMin) div 3 - 10; { colour epidermal layer in red } 
end 
else begin 
LocalMin := 0; 
for Bin := 240 downto 80 do { find last local minimum in smoothed histogram } 
if (Histogram[Bin] > 2000) and (Histogram[Bin] <= Histogram[Bin - 1]) 
and (Histogram[Bin] <= Histogram[Bin + 1]) then begin 
LocalMin := Bin; 
end; 
if LocalMin = 0 then begin { if that didn't work because of the smoothing then... } 
GetRectHistogram; { find last local minimum in unsmoothed histogram } 
for Bin := 240 downto 80 do 
if (Histogram[Bin] > 2000) and (Histogram[Bin] <= Histogram[Bin - 1]) 
and (Histogram[Bin] <= Histogram[Bin + 1]) then begin 
LocalMin := Bin; 
end; 
end; 
if LocalMin = 0 then begin 
LocalMin := 150; { histogram had no valley so } 
Beep; { set to something sensible } 
end; 
SliceStart := LocalMin; { colour epidermal layer in red } 
end; 
SliceEnd := 255; 
EnableDensitySlice; 
if not Get2clicks(Click) then begin 
ShowMessage('Microneedle analysis aborted'); 
exit; 
end; 
SaveSliceStart := SliceStart; 
SliceStart := 0; { colour everything but epidermal layer in red } 
SliceEnd := SaveSliceStart; 
ThresholdToForeground := true; { density slice red -> black } 
NonThresholdToBackground := true; { everything else -> white } 
Macro := true; 
ApplyLookupTable; { apply without dlog box } 
Macro := false; 
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TakeOutBaseline; 
DoOpeningWithCount(3); { tidy rough edges of damage } 
CellsIncEdges := false; { ensure objects at edge are ignored } 
DoParticleAnalysisXY(-1, 999, 999999, NumFound); 
Measurements := [AreaM, xyLocM, LengthM]; { make sure Area is displayed in Results } 
if InvertYCoordinates then 
Click[4].pt.v := Info^.nLines - 1 - Click[4].pt.v; { for comparison with xyCenter values } 
xClick4 := round(Click[4].pt.h / OrigInfo^.xScale); 
yClick4 := round(Click[4].pt.v / OrigInfo^.yScale); 
MinDistSoFar := 999999; { find object closest to click 4 } 
for i := 1 to NumFound do begin 
DistToClick4 := (xCenter^[i] - xClick4) * (xCenter^[i] - xClick4) + 
(yCenter^[i] - yClick4) * (yCenter^[i] - yClick4); 
PerimLen^[i] := round(sqrt(DistToClick4)); { for diagnostics } 
if DistToClick4 < MinDistSoFar then begin 
Damage := i; 
MinDistSoFar := DistToClick4; 
end; 
end; 
{ padding gives neater } 
DiagnosticLog(stringOf(tab, mArea^[Damage] : 6 : 0, tab, ' ', tab)); { spreadsheet output } 
RefreshSessionLog; { dummy call to update SLog window } 
Wait(60); { pause to allow user to see result } 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure FilePostambleMNA (Folder: integer); 
begin 
if DoingMNAbatch then 
GetRidOfWindow(UseThisInfo) 
else 
ResetGrayMap; { ensures next image loads with default greyscale LUT } 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure PostambleMNA; 
var 
SLogTitleStr: GPCstr; 
begin 
if DoingMNAbatch then 
CloseSessionLog; 
err := CloseAWindow(HistoWindow); 
HistoMag := TempHistoMag; 
RestoreCompensation; 
DoingMNA := false; 
DoingMNAbatch := false; 
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DoingMIASMA := false; 
OpeningCellRGBimage := false; 
SuppressLog := false; 
SuppressMessages := false; 
SXMwindow := false; 
if AbortAnalysis then 
MNAstr := stringOf('Microneedle Analysis', cr, cr, 'Analysis aborted') 
else 
MNAstr := stringOf('Microneedle Analysis', cr, cr, 'Analysis complete'); 
SLogTitleStr := 'MNA-' {+ NaToStr(CellsLoadFolder.name)} + MakeDateTimeSuffix; 
SLogArrayFSpec := MakeFSpecInFolder(SLogTitleStr, CellsSaveFolder); 
SaveSLogToArray := false; 
SaveSLogArray; { save SLog Array to same folder as folder of images } 
ShowMessage(MNAstr); 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure MicroneedleSingle; { open and analyse a single image } 
begin { for diagnostics and calibration } 
PreambleMNA; 
MNAsingle := true; 
NavServWinTitle := 'Open One Image For MNA'; 
SOK := DoOpenNavServ; { open single image } 
if not SOK then exit; 
CellsTotalNumImages := 1; 
CellsLoadFolder := GetFolderSpec(FileSpec); 
CellsSaveFolder := CellsLoadFolder; 
FilePreambleMNA(-1); 
DoingMNAbatch := false; 
NumFilesInBatch := 1; { set for single-image analysis } 
FileIndexInThisFolder := 1; 
AnalyseMicroneedles(1); 
FilePostambleMNA(-1); 
PostambleMNA; 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
procedure MicroneedleAnalysis; 
var 
Folder, NumFiles, ImageNum: integer; 
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begin 
PreambleMNA; 
MNAsingle := false; 
if not NavServChooseFolder(FolderSpec) then exit; 
CellsLoadFolder := GetFolderSpec(FolderSpec); 
CellsSaveFolder := GetFolderSpec(CellsLoadFolder); 
{ get specs of files in selected folder and } 
if not GetAllCellsFSpecs then exit; { files in folders within selected folder } 
DoingMNAbatch := true; 
NumFilesInBatch := CellsTotalNumImages; { set global var for other routines } 
for Folder := 0 to CellsNumFolders do begin { for each folder... } 
NumFiles := CellsNumFilesInFolder[Folder]; 
FilesDoneInPrevFolders := CellsNumFilesInPrev[Folder]; { set global var } 
FilePreambleMNA(Folder); 
if (NumFiles > 0) and not AbortAnalysis then 
for ImageNum := 1 to NumFiles do begin { for each image in folder... } 
FileIndexInThisFolder := ImageNum; { set global var } 
MNAstr := NaToStr(CellsSortDirRec[Folder, ImageNum].RecFileSpec.name); 
UpdateMNAinfoWindow(MNAstr); 
with CellsSortDirRec[Folder, ImageNum] do begin 
FileSpec := RecFileSpec; 
SOK := DoOpen(FileSpec); 
end; 
AnalyseMicroneedles(ImageNum); 
FilePostambleMNA(Folder); 
if AbortMIASMA then leave; { pressing 'esc' will abort } 
end; 
if AbortMIASMA then leave; { pressing 'esc' will abort } 
end; 
PostambleMNA; 
end; 
{ ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––– } 
end. 
 
 
 
